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A CLCA protein (CL for chloride channel and CA for calcium activated) cloned from 
porcine ileum RNA was expressed and characterized.  The regulatory behavior, 
inhibitor sensitivity, and functional properties of chloride conductance associated with 
the expression of pCLCA1 cDNA were investigated in non-epithelial NIH/3T3 
fibroblasts and in an epithelial Caco-2 cell line. These properties were also investigated 
in freshly isolated retinal pigment epithelial (RPE) cells and in primary cultures of these 
cells which express an endogenous cCLCA1. In NIH/3T3 fibroblasts, the chloride 
efflux induced by pCLCA1 was directly activated by calcium. A and C kinase agonists 
were without effect. The electrogenic nature of chloride efflux was confirmed by 
detection of outwardly rectified chloride currents. Selected anion channel blockers 
inhibited both the pCLCA1 agonist-induced current and chloride efflux. The inhibitors 
also reduced Ussing chamber short circuit current and chloride efflux from primary 
RPE cultures. However, these same agents did not inhibit chloride efflux in fibroblasts 
expressing the cystic fibrosis transmembrane regulator (CFTR) conductive chloride 
channel. The expression of pCLCA1 increased cAMP/A kinase-dependent chloride ion 
release from fibroblasts and Caco-2 cells expressing CFTR. These pleiotropic effects of 
CLCA protein expression suggested that the protein may regulate the activity of 
chloride conductance, rather than functioning as a primary ion transporter.  This 
putative regulatory behavior was further investigated in Caco-2 cells. The rate of 36Cl- 
efflux and the amplitude of currents in patch clamp studies after activation of A kinase 
or intracellular Ca2+ mobilization was significantly increased in freshly passaged Caco-
2 cells expressing pCLCA1.  However, 36Cl- efflux and short circuit Ussing chamber 
 iii
studies in polarized Caco-2 cells provided evidence that both endogenous and pCLCA1-
dependent Ca2+-sensitive chloride conductance were lost from 14 day post-passage 
cells.  cAMP-dependent chloride conductance continued to be modulated by pCLCA1 
expression in differentiated 14 day post-passage Caco-2 cells, demonstrating the 
retention of  pCLCA1 effects in these mature cells. We conclude that pCLCA1 
expression enhances the sensitivity of endogenous chloride channels to both natural 
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ORCC........................outwardly rectifying chloride channel 
ORF...........................open reading frame  
OVA..........................ovalbumin 
PAGE.........................polyacrylamide gel electrophoesis 
PBS.............................phosphate-buffered saline 
PCR............................polymerase chain reaction 
PD...............................potential difference  
PI3K...........................phosphatidylinositol-3-kinase  
PKA...........................protein kinase A, cAMP-dependent protein kinase 
PKC...........................protein kinase C 
PKG...........................cGMP-dependent protein kinase 
PMA...........................phorbol-12-myristoyl-13-acetate  
pS................................picoSiemen 
Pyk2............................proline-rich tyrosine kinase 
RNA............................ribonucleic acid  
RPE.............................retinal pigment epithelium 
RT...............................reverse transcriptase 
SCID...........................severe combined immunodeficiency  




SNARE.......................soluble N-ethylmaleimide-sensitive factor attachment protein 
SOS............................Son of Sevenless   
TBS............................Tris-buffered saline  
TES............................N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid  
Th1.............................type 1 helper T  
Th2.............................type 2 helper T  
Tris.............................Tris[hydroxymethyl]aminomethane 
V.................................Voltage or Volts 
VMD..........................Bestrophin gene 
VWA..........................von Willebrand's Factor Domain A 
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 Despite nearly a decade of research, the understanding of the contributions of 
the CLCA (Cl for chloride channel, CA for calcium-activated) gene family members to 
chordate biochemical, physiological and pathological processes remains incomplete and 
unclear. The uncertainty about some unifying basis for the molecular function of the 
CLCA proteins arises at least partly from reports of a diverse array of apparently 
unrelated processes that have been associated with the expression of various CLCA 
protein isoforms. Some proposed CLCA roles appear to be in direct conflict. CLCA is 
reported to be central to tumor metastasis, but also appears to have an important role in 
tumor suppressor activity (Gruber and Pauli 1999c; Abdel-Ghany, Cheng et al. 2001; 
Elble and Pauli 2001; Abdel-Ghany, Cheng et al. 2002; Abdel-Ghany, Cheng et al. 
2003). In other cases the disease processes involving altered CLCA expression seem 
unrelated. CLCA proteins are major regulators of mucus production in the asthmatic 
airway, ion transport in the airway of cystic fibrosis patients, vascular smooth muscle 
tone affecting hypertension and erectile dysfunction, and of ion transport associated 
with retinal function that is disrupted in the pathology of Best's vitelliform macular 
dystrophy (Anderson and Welsh 1991; Nakanishi, Morita et al. 2001; Greenwood, 
Miller et al. 2002; Hoshino, Morita et al. 2002; Toda, Tulic et al. 2002; Hauber, 
Manoukian et al. 2003; Karkanis, DeYoung et al. 2003). By first describing the basic 
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biophysical properties associated with expression of isoforms of the CLCA family and 
then the pathophysiology of the implicated disease processes, we hope to provide the 
reader with a thread of logic to bind the apparently diverse functions of the proteins 
produced by the CLCA gene family.  First the cloning of the CLCA family will be 
surveyed, followed by predictions that have been made for protein structure, and 
function. Then what is currently known about the normal physiology of CLCA 
isoforms, their connections to disease conditions, and possible beneficial effects of 
pharmacological modulation of CLCA protein function will be explored.  
 
1.2. Cloning of the CLCA Gene Family 
 The CLCA gene family members are named for the species source from which 
they were cloned, and numbered in chronological order of cloning within each species. 
This unfortunate situation creates a need to present the history behind the cloning of the 
CLCA gene family in order to clarify why series numbers within each species do not 
correlate with functional attributes of the expressed proteins. The historical perspective 
also gives insight into why the proteins have been named for, and viewed by some to 
possess, chloride channel activity. Figure 1.1 gives the phylogenetic relationship 
between these published clones. 
 Secretory epithelial cell layers are known to possess a number of ion channels 
that are able to direct the flow of ions to produce net fluid movement into the lumen of 



















Figure 1.1. Phylogenetic tree of the published clones of the CLCA gene family.  Tree 
developed using Clustalw followed by Phylip Software.  The scale is substitution per 




 the apical membrane of these secretory cells are of special interest.  Regulation of 
chloride conductance channels by intracellular second messengers is the primary level 
of control for epithelial fluid secretion.  Increases in intracellular calcium ion 
concentration are known to activate chloride conductance, so there has been significant 
interest in identifying the protein(s) responsible for the conductive movement of 
chloride across the apical membrane of secretory epithelial cells. The cloning of the first 
CLCA cDNA sequence (bCLCA1) was reported in 1995 (Cunningham, Awayda et al. 
1995).  The clone was obtained by screening a gene expression library with a polyclonal 
antibody generated to a 36-38 kDa reduced protein purified from bovine tracheal 
epithelium. This antigenic peptide lacked intrinsic chloride channel properties in a lipid 
bilayer (Ran, Fuller et al. 1992; Cunningham, Awayda et al. 1995).  This non-
conducting protein was thought to be a subunit of a larger 140 kDa protein.  Purification 
of this 140 kDa protein under non-reducing conditions and reconstitution into planar 
lipid bilayers, caused the appearance of an anion channel whose activity was increased 
by activation of Ca2+ /calmodulin-dependent protein kinase.  It was hypothesized at that 
time that the original purified protein of 140 kDa was a homotetramer of identical 38 
kDa subunits, linked together by disulfide bonds which could be reduced to produce a 
64 kDa dimer and 38 kDa monomers. This clone was originally termed CaCC, but is 
now called bCLCA1 (Cunningham, Awayda et al. 1995; Fuller and Benos 2000b; Pauli, 
Abdel-Ghany et al. 2000; Fuller, Ji et al. 2001). 
 The second CLCA sequence (bCLCA2) was reported in 1997 (Elble, Widom et 
al. 1997). Like bCLCA1, bCLCA2 was obtained by screening a gene expression library 
with antibody. However, the monoclonal antibody used in this case had no connection 
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to inhibition of anion conductance.  This antibody was generated to identify an 
adhesion-receptor/ligand pair that mediated binding of lung-metastatic melanoma cells 
to lung matrix-modulated bovine aortic endothelial cells (Zhu, Cheng et al. 1991; Zhu 
and Pauli 1991; Zhu, Cheng et al. 1992; Zhu and Pauli 1993; Elble, Widom et al. 1997). 
The monoclonal antibody used in screening an expression library was shown to inhibit 
this specific adhesion to endothelial cells (Zhu, Cheng et al. 1992).  Expression of a 
clone identified in this screening produced a protein with properties that have been 
described as the lung endothelial cell adhesion molecule-1 (Lu ECAM-1) (Elble, 
Widom et al. 1997). Lu ECAM-1 is now termed bCLCA2 (Fuller and Benos 2000b; 
Pauli, Abdel-Ghany et al. 2000). 
 Two other cDNA clones with significant identity to bCLCA1 and 2 were 
reported in 1998 from screening a human gene library and a mouse lung cDNA library.  
  The human orthologue hCLCA1 was cloned using the open reading frame 
(ORF) sequence of the bCLCA2 cDNA as a probe in a human genomic library. A PCR-
based genomic walking and cloning strategy was employed to fill the gaps between 
isolated genomic clones and to obtain the full sequence and the putative promoter 
region of the gene (Gruber, Elble et al. 1998). The human CLCA1 gene was found to 
encompass 31902 bp and is located on chromosome 1p22-p31.  A total of 15 exons 
ranging from 90 to 604 bp in size are interspersed with 14 introns of 170 to 5651 bp 
(Gruber, Elble et al. 1998).  The start codon was found on the second exon.  A promoter 
region containing a TATA box precedes the predicted site of transcriptional initiation 
by 22 nucleotides (Gruber, Elble et al. 1998). The promoter region has a high GC 
content and there are numerous other potential binding sites for transciptional regulators 
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in this area.  A second consensus TATA box was also found to be located 950 bp 
upstream of the first exon  (Gruber, Elble et al. 1998). Mutation analysis of these 
putative transcriptional start sites has not been reported, so it is difficult to speculate on 
the individual importance of each. The hCLCA1 sequence was found independently in 
1999 using a Human Genome Sciences Expressed Sequence Tags (EST) database, 
screened with the bCLCA1 sequence. The group coined it HCaCC1, which is really 
hCLCA1 (Agnel, Vermat et al. 1999).  Primers have been generated to amplify the 2745 
bp ORF of hCLCA1 to obtain full length cDNA for functional expression.  
 Similarly, mCLCA1 was cloned from a mouse lung cDNA library using a 
bCLCA2 probe (Gandhi, Elble et al. 1998). Concurrently, an independent group found 
mCLCA1 in a EST database using bovine bCLCA1 sequence (Romio, Musante et al. 
1999). This group localized the mCLCA1 to chromosome 3 at the H2-H3 band. 
Because CLCA genes are numbered as they are cloned, it should be noted that 
mCLCA1 is not the human orthologue of hCLCA1 (Figure 1.1) even though they 
contain a considerable degree of sequence identity and their expressed forms may have 
many similar biophysical properties.  
     The sequences of a large number of CLCA isoforms were published in 1999.  
mCLCA2 was cloned from mouse mammary gland in a suppression subtractive 
hybridization on the involuting mammary gland (Lee, Ha et al. 1999). The human 
orthologue hCLCA2 was cloned from a human lung using a bCLCA1 cDNA probe 
(Gruber, Schreur et al. 1999). As with mCLCA2, hCLCA2 was expressed at relatively 
high levels in the mammary gland. hCLCA2 was also found independently at the same 
time and called hCaCC3 (Agnel, Vermat et al. 1999). This same group also 
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concurrently found what they called HCaCC2 now called hCLCA4 by matching an EST 
database to bovine bCLCA1 sequence (Agnel, Vermat et al. 1999).  
 Around the same time Gruber and Pauli reported the cloning of hCLCA3, the 
first fully secreted CLCA protein. hCLCA3 was cloned from human spleen cDNA and 
was found to be a secreted protein in several tissues (Gruber and Pauli 1999b).  
 Finally, Gob-5 or mCLCA3, which is the closest mouse orthologue to hCLCA1, 
was cloned from mouse gut cDNA (Komiya, Tanigawa et al. 1999). mCLCA3 and 
mCLCA1 co-localize on mouse chromosome 3 H2 - H3 (Romio, Musante et al. 1999; 
Leverkoehne and Gruber 2000).  
 In the human, hCLCA1, hCLCA2 and hCLCA3 are clustered on the short arm 
of chromosome 1 (1p22 -31)(Gruber and Pauli 1999a). This close clustering was 
unexpected given the low sequence identity (~ 60%) between the three CLCA isoforms 
(Gruber and Pauli 1999a). Recently, analysis of the human genome has shown 
hCLCA2, hCLCA1, hCLCA4 and hCLCA3 are lined up consecutively in the same 
orientation, encompassing 232 kB, with no other genes interspersed (Gruber, Elble et al. 
2002). An area 1617 bp upstream of the first intron codes for 24 different transcription 
factor binding sites, of unknown function significance. Gene clustering is often used as 
a mechanism for  controlling temporal gene expression by internal intron or bidrectional 
promoters (Keegan, Haerry et al. 1997; Zhang, Ding et al. 2003). However, any 
regulatory or functional significance of the CLCA gene clustering is not known.  
 In 2000 the full length sequence of the porcine CLCA clone (pCLCA1) was 
published (Gaspar, Racette et al. 2000). Unlike the other cloning strategies, pCLCA1 
was cloned using a monoclonal antibody which inhibited chloride channel conductance. 
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The antibody was developed against porcine ileal brush border vesicle protein, and the 
monoclonal antibody selected for inhibition of chloride conductance in the vesicles 
(Gabriel and Forsyth 1991; Gabriel, Racette et al. 1992). The inhibitory antibody was 
then used to screen a gene expression library. Although the 3' fragment of pCLCA1 was 
cloned in 1994, sequencing and expression of the full-length clone was only completed 
and published in 2000.  A high regional GC content and associated secondary structure 
contributed to difficulties in cloning and sequencing the pCLCA1 cDNA. The antibody 
selection strategy employed to identify this isoform provided a strong functional link to 
chloride conductance.  
 Reports of a calcium-activated chloride conductance in smooth muscle (Nelson, 
Conway et al. 1997; Hirakawa, Gericke et al. 1999) stimulated a search for CLCA 
proteins in this tissue. A recent addition to the CLCA family (mCLCA4) was cloned 
from mouse smooth muscle cell total RNA by RT-PCR using degenerate primers to 
bCLCA2 (Elble, Ji et al. 2002). It should be noted that mCLCA4 is not the orthologue 
to hCLCA4 (see Figure 1.1.)   
 Small segments of CLCA cDNA from other species have also been cloned. A 
portion of a rat orthologue rCLCA1 has been cloned from rat pancreas cDNA 
(Thevenod, Roussa et al. 2003).  A partial canine CLCA, cCLCA1 cloned from dog 
retinal pigment epithelium with primers specific for the porcine pCLCA1 has also been 
reported, and expression levels investigated (Loewen, Smith et al. 2003). 
 A hCLCA5 has been reported recently (Abdel-Ghany, Cheng et al. 2003). 




1.3 Tissue Expression 
1.3.1. Human Orthologues 
1.3.1.1. hCLCA1 
 Expression of hCLCA1 in vivo is mainly found in mucus secreting cells of large 
and small intestine (Gruber, Elble et al. 1998). A study using Northern blots found the 
largest expression in the small intestine, appendix and colon. Lower expression levels 
were found in the uterus, stomach, testis and kidney (Agnel, Vermat et al. 1999). 
However, another extensive study was only able to find expression in the small intestine 
and colon (Gruber, Elble et al. 1998). This same study, using highly stringent in situ 
hybridization conditions, identified specific cell types which expressed hCLCA1. 
Strong expression was detected in the cytosol of a subset of enterocytes scattered 
throughout the intestinal lining in the jejunum, ileum and colon. The majority of the 
mRNA signal was in cells at the base of the crypts. The goblet cells were most 
prominently stained. Expression in the small intestine and colon were also demonstrated 
by Northern blot and RT-PCR (Gruber, Elble et al. 1998). However, more recent reports 
have found induction of hCLCA1 expression in the airways under pathophysiological 
conditions (Hoshino, Morita et al. 2002) (Hauber, Manoukian et al. 2003). 
1.3.1.2. hCLCA2  
 The human orthologue hCLCA2 is expressed at highest levels in the trachea and 
mammary gland on Northern blotting under physiological conditions (Gruber, Schreur 
et al. 1999). It has also been found in nasal epithelium (Mall, Gonska et al. 2003). 
Strong expression is also found in most basal cells in stratified epithelia (Connon, 
Yamasaki et al. 2004). Although isolated from a lung cDNA library, hCLCA2 was not 
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detected in the lung by Northern blot hybridization. However, in the same study a weak 
RT-PCR signal for hCLCA2 was obtained from lung. But, the strongest signal was 
found in the trachea and mammary gland (Gruber, Schreur et al. 1999). Expression of 
hCLCA2 in mammary gland and trachea was confirmed independently by Northern blot 
(Agnel, Vermat et al. 1999). They were not able to find expression by Northern blot in 
the lung. However they detected  expression in the testis, prostate and uterus, which had 
not been identified as showing mRNA expression in the first study by the same group 
(Agnel, Vermat et al. 1999). The hCLCA2 orthologue was also found to be highly 
expressed in a nonmalignant transformed human mammary epithelial cell line MCF10A 
using both Northern blot and RT-PCR.  However, hCLCA2 expression in tumorigenic 
cell lines MDA-MB-231, MDA-MD-468 and MCF7 was not detected by Northern blot.  
These findings were in agreement with an in situ hybridization staining of acini and 
small in normal mammary tissue, but  there was an absence of staining in breast cancer 
samples (Gruber, Schreur et al. 1999). 
1.3.1.3. hCLCA3 
 The third human orthologue, hCLCA3, was originally cloned from spleen. The 
full length mRNA is expressed in the lung, trachea, mammary gland and thymus 
(Gruber and Pauli 1999b). Its presence has also been reported in nasal epithelium (Mall, 
Gonska et al. 2003). 
1.3.1.4. hCLCA4 
 Unlike the other human orthologues, hCLCA4 has a very high expression in 
neural tissue (Agnel, Vermat et al. 1999). On Northern blot analysis the amygdala, 
caudate nucleaus, cerebral cortex, frontal lobe, hippocampus, medulla oblongata, 
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occipital lobe, putamen, substantia nigra, temporal lobe, thalamus, acumbens expressed 
hCLCA4. Interestingly, the cerebellum and spinal cord did not show any evidence of 
hCLCA4 expression.  The strongest signal from hCLCA4 came from the colon, with 
twice the signal intensity of that found in neural tissue. Expression was also found in the 
bladder, uterus, prostate, stomach, testis, salivary gland, mammary gland, small 
intestine, appendix and trachea (Agnel, Vermat et al. 1999).  
 
1.3.2. Murine Orthologues  
1.3.2.1. mCLCA1 
 The strongest expression of mCLCA1 was detected in the lung, aorta, spleen and 
bone marrow using real-time RT-PCR quantitation normalized against expression of 
elongation factor 1a (Leverkoehne, Horstmeier et al. 2002). High levels have also been 
reported in the kidney and skin by Romio et al. (Romio, Musante et al. 1999).  Lower 
levels were detected in the esophagus, stomach, duodenum, jejunum, ileum, cecum, 
proximal colon, distal colon, rectum, pancreas, liver, gall bladder, parotid, nasal 
turbinate, trachea, heart, thymus, spleen, lymph nodes, kidney, urinary bladder, ovaries, 
uterus, testes, epididymis, penis, vesicular gland, adrenal gland, eye, tail skin, juvenile 
mammary gland, skeletal muscle, cerebral cortex, brain stem, medulla oblongata and 
cerebellum and throughout gestation in the placenta. Expression was undetectable in the 
prostate and the pregnant, lactating and involuting mammary gland. However, an 
independent study did find mCLCA1 expression in virgin, pregnant and lactating gland 
(Elble and Pauli 2001). Both studies shared the conclusion that mCLCA1 expression 
was lost during mammary gland involution (Elble and Pauli 2001; Leverkoehne, 
Horstmeier et al. 2002). In the developing fetus, mCLCA1 expression was not detected 
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until 10 days post-conception (d.p.c). The expression of mCLCA1 increases in the fetal 
liver from 10 d.p.c to 13.5 d.p.c. Similarly, the kidney increased its expression from day 
13.5 to day 18. Both the intestine and lung showed an increase in expression over 
gestation increasing from day 10 to day 13.5, however this increase dropped on day 18 
in both tissues (Leverkoehne, Horstmeier et al. 2002). This dynamic change in 
mCLCA1 expression over gestation points to a yet to be defined role of mCLCA1 in 
cell maturation and differentiation.   
 Unfortunately many of the earlier studies using in situ hybridization probes to 
localize expression of mCLCA1 mRNA did not take into account the existence of 
mCLCA2 (Gruber, Gandhi et al. 1998). However, the majority of the signal in Northern 
analysis and in situ hybridization staining of the spleen, lymphoid nodes and lung was 
most likely mCLCA1. It is also interesting to note that mCLCA1 is the only CLCA to 
be found in the cerebellum and brainstem (Leverkoehne, Horstmeier et al. 2002). This 
significantly differs from hCLCA4, which had extensive expression in other areas of the 
nervous system (Agnel, Vermat et al. 1999). Additionally, mCLCA2 in the same study 
was undetectable in cerebellum and brainstem (Gruber, Gandhi et al. 1998). These 
preliminary observations about temporal and tissue-specific expression patterns within 
the same physiological system could be broad hints of diverse roles of CLCA proteins 
in tissue development and functional differentiation. 
 Given the importance of a calcium-activated chloride conductance in renal 
epithelium, it was to be expected that a number of small CLCA segments with a high 
sequence identity to mCLCA1 and mCLCA2 would be available for cloning from a 
mouse inner medullary collecting tubule cell line (Boese, Glanville et al. 2000). 
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Subsequent RT-PCR of the mouse nephron found mCLCA1 in the glomeruli and thick 
ascending limb, but not in the proximal tubule and cortical collecting duct (Boese, 
Glanville et al. 2000). Interestingly, a study using a non-specific mCLCA1/ mCLCA2 
probe only identified CLCA in the tubular epithelial cells and found no signal in the 
glomeruli. The proximal tubule had the most intense staining with weaker staining in 
the loop of Henle and distal tubuli. The collecting duct was negative (Gruber, Gandhi et 
al. 1998). This difference is likely due to a specificity of the probe and primers used in 
the studies and a difference in the actual orthologue expressed at different areas within 
the kidney. Once again the differences may be evidence for distinct physiological roles 
of each CLCA orthologue.  
1.3.2.2. mCLCA2  
 The strongest mCLCA2 expression was detected in the mammary gland (Lee, 
Ha et al. 1999; Elble and Pauli 2001; Leverkoehne, Horstmeier et al. 2002). High 
expression was reported from pregnancy to involution as determined in two studies by 
RT-PCR (Elble and Pauli 2001; Leverkoehne, Horstmeier et al. 2002). However, an 
original study using Northern blot analysis only found mCLCA2 expression in the 
involuting stage (Lee, Ha et al. 1999). This difference may have arisen from differences 
in the stringency of the blot and the large expression at involution.  In situ hybridization 
in normal murine mammary tissue with a probe which would detect both mCLCA1 and 
mCLCA2 found staining in both alveolar and ductal epithelial cells (Gruber, Gandhi et 
al. 1998). Lower mCLCA2 levels were detected in the esophagus, stomach, duodenum, 
jejunum, ileum, cecum, proximal colon, distal colon, rectum, pancreas, liver, gall 
bladder, parotid, nasal turbinate, trachea, lung, heart, thoracic and abdominal aorta, 
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thymus, spleen, lymph nodes, kidney, urinary bladder, ovaries, uterus, testes, 
epididymis, penis, vesicular gland, adrenal gland, eye, tail skin, juvenile mammary 
gland, skeletal muscle, cerebral cortex, medulla oblongata (Leverkoehne, Horstmeier et 
al. 2002).  mCLCA2 was undetectable in the brainstem, cerebellum and prostate. In a 
real time quantitative RT-PCR, study the mammary gland seemed to express purely 
mCLCA2. This was the only tissue screen that had absolutely no mCLCA1 signal 
(Leverkoehne, Horstmeier et al. 2002). However, a study directly looking at mCLCA1 
and mCLCA2 expression patterns did find mCLCA1 at all stages except at the time of 
involution (Elble and Pauli 2001). mCLCA2 was detected in both the placenta and 
fetus. Like mCLCA1, mCLCA2 fetal expression was dynamic. At 8.5 d.p.c. the 
developing fetus had only mCLCA2 (Elble and Pauli 2001; Leverkoehne, Horstmeier et 
al. 2002). The mCLCA2 became undetectable a day later, and only mCLCA1 was 
expressed at 12.5 d.p.c (Elble and Pauli 2001; Leverkoehne, Horstmeier et al. 2002).  
Low levels of mCLCA2 mRNA were detected again in various tissues at 13.5 days and 
increased gradually until they exceeded mCLCA1 expression by 19 d.p.c.. Unlike 
mCLCA1, mCLCA2 is undetectable in the fetal liver (Leverkoehne, Horstmeier et al. 
2002). However, the dynamic interplay between these two isoforms of the CLCA gene 
family would once again suggest that they are involved in different physiological roles. 
It is interesting to note that the highest expression of mCLCA2 seems to be in those 
tissues with the high rate of cell division and cell death (Elble and Pauli 2001). A 
possible connection to cell cycle control or an apoptotic role for mCLCA2 could be 




 Expression of mCLCA3  is primarily in mucus secreting cells (Komiya, 
Tanigawa et al. 1999; Leverkoehne and Gruber 2002). It was originally cloned from, 
and found to have highest expression in the crypt of the large intestine (Komiya, 
Tanigawa et al. 1999). An extensive immunohistochemical study was undertaken for 
mCLCA3 showing exclusive expression in the digestive, respiratory tracts and uterus 
(Leverkoehne and Gruber 2002). The mCLCA3 antigen was not found in the 
gallbladder, kidney, pancreas, sublingual salivary glands, oviduct, mammary gland or 
prostate (Leverkoehne and Gruber 2002).  Concurrent staining for mucin and 
immunohistochemical localization of mCLCA3 antigen clearly indicated that mCLCA3 
was expressed only in the mucin-producing cells. But, not all mucin-producing cells 
demonstrated mCLCA3 expression. In the respiratory tract, high expression was seen in 
the trachea and major bronchi of single or clustered goblet cells. Staining was also 
found in the limited submucosal glands of the mouse in the upper trachea. All ciliated 
epithelial cells were negative.  Similar results were found in the uterine goblet cells and 
the mucinous cells of the uterine gland stained positive for mucin and mCLCA3. 
 In the stomach, the parietal and chief cells were negative, but the surface mucus 
cells were positive. All goblet cells stained positive for mCLCA3 expression in the 
duodenum, jejunum, and ileum. A dynamic expression pattern was seen in the crypt 
goblet cells in both the large and small intestine, with expression only in approximately 
the upper two-thirds of the crypt, whereas weak, or no, staining was observed in the 
basal third (Leverkoehne and Gruber 2002). The physiological importance of this 
distribution pattern for gastrointestinal mCLCA3 has not been determined, but it may be 
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significant that difference in expression correlate with the crypt-villus axis. Staining 
was not found in those cells which migrate to the crypts and undergo apoptosis but was 
seen in those that migrate to the luminal apex of the villus and are sloughed off 
(Leverkoehne and Gruber 2002). CLCA proteins have been promoted as proapoptotic 
(Elble and Pauli 2001), but it is the cell group directed toward apoptotic removal at the 
base of the crypts that loses mCLCA3 expression. However, mCLCA2 and mCLCA1 
expression may increase as mCLCA3 levels decline, and play some role in apoptosis at 
the base of the crypts. Although mCLCA1 and 2 expression has been identified in the 
crypts, their histological localization within the GI crypts has not been determined 
(Gruber, Gandhi et al. 1998).  It is also interesting to note the detection of CLCA1 and 
possibly CLCA2 by in situ hybridization in the ciliated tracheal epithelial cells, which 
are not associated with mucus secretion (Gruber, Gandhi et al. 1998). These findings 
support an emerging pattern where in each CLCA family member could perform 
discrete physiologic functions as cells mature and differentiate within the same tissue.  
 The development of a good antibody allowed intracellular localization of the 
mCLCA3 antigen (Leverkoehne and Gruber 2002). In simple paraffin embedded tissue 
sections the cytosol was stained positive with a diffuse granular pattern. Goblet cells 
often had an intensely stained apical membrane. A similar staining pattern was found in 
glycolmethacrylate (GMA)-embedded histological preparations that permit better 
access of the antibody to the tissue.  However, obvious labeling was noted around the 
mucin granules. This result led to an immune transmission electron microscopy study 
using gold-labeled secondary antibodies which associated mCLCA3 with the peripheral 
membrane of mucin granules in positively staining cells. No labeling was found in the 
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center of the granule, cytosol, nucleus, other organelles or along the basolateral 
membrane of goblet cells (Leverkoehne and Gruber 2002) . These studies suggest a 
connection of mCLCA3 to mucin production.  
1.3.2.4. mCLCA4 
 Cloned from smooth muscle, mCLCA4 was detected in the gastrointestinal tract, 
uterus, lung and heart in a multiple cDNA array using gene-specific primers. A large 
component of mCLCA4 cDNA expression was detected by RT-PCR  in the smooth 
muscle of the dissected tunic muscularis of the bladder and stomach (Elble and Pauli 
2001). In situ hybridization with a mCLCA4-specific probe was performed to determine 
cell-specific expression in these mixed organs. However, the degree of specificity of the 
probe used to detect mCLCA4 in this study was not clear, as it spanned a combination 
of 3' ORF (from mCLCA4 base 2670) to an unspecified position in the 3'- untranslated 
region. The ability of the probe to distinguish mCLCA4 mRNA from mCLCA1 and 2 
was not determined. This probe produced a very strong signal in the pulmonary vein, 
aorta, and atrioventricular bundle with a much lower level in cardiac muscle, coronary 
artery and endothelium. In the lung, both the bronchioles and blood vessels were 
labeled. In the gastrointestinal tract, labeling was associated more with the mucosa than 
the muscularis tunica. This mucosal labeling was most intense towards the villus tip 
(Elble,  Ji et al. 2002). It should be noted that this is the first CLCA with a reported 
increase in expression towards the villus tip. mCLCA1 and possibly 2 are thought to be 
primarily expressed in the crypt (Gruber, Gandhi et al. 1998). mCLCA3 is associated 
with upper cypt and mid-shaft of the villus (Leverkoehne and Gruber 2002). Again we 
see differing expression patterns of each isoform within a tissue that associate with 
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major differences in cell physiology. Adipose and connective tissue were consistently 
negative (Elble and Pauli 2001).  
 
1.3.3. Bovine Orthologues 
1.3.3.1. bCLCA1 
 The bCLCA1 orthologue is primarily expressed on the brush border of ciliated 
tracheal epithelial cells (Elble, Widom et al. 1997). This is the tissue from which it was 
originally cloned (Cunningham, Awayda et al. 1995).  This expression site is similar to 
that reported for mCLCA1/2 (Gruber, Gandhi et al. 1998). The expression in other 
tissue is not currently known. 
1.3.3.2. bCLCA2 
 The bCLCA2 orthologue is primarily thought of as a luminal membrane protein 
of the venular endothelia of the lungs and the spleen. However, antibodies to bCLCA2 
located a strong antigen signal in endothelia of small to medium size venules as well as 
in the respiratory epithelial of the bronchi and trachea (Elble, Widom et al. 1997). The 
antigen of bronchial epithelium was deemed to be mainly on intracellular vesicles. The 
expression in the tracheal epithelium was predominately in the apical plasma 
membrane. However, due to the lack of information on the other bovine CLCA 
isoforms it is likely that several orthologues may have been cross-reacting with the 
screening antibody.  The antibody reaction in the tracheal epithelium is most likely with 





1.3.4. Porcine Orthologues 
1.3.4.1. pCLCA1 
 Original studies using the IgM monoclonal antibody used to clone pCLCA1 had 
distinct staining on the enterocyte border of the villi. Labeling intensity was distributed 
over the mucosal surface, with the most intense staining observed in the mid to upper 
crypt region (Racette, Gabriel et al. 1996). When pCLCA1 cDNA sequence became 
available a CLCA mRNA was identified by in situ hybridization in the ileal mucosa. 
But, a more diffuse staining was found in the crypt-villus axis. In the trachea pCLCA1 
mRNA expression was localized to surface epithelium and the underlying submucosal 
glands. The most intense staining was found in a subset of the submucosal glands 
(Gaspar, Racette et al. 2000). These tissues were also positive for pCLCA1 expression 
when tested by RT-PCR. pCLCA1 expression was not detected in the colon. RT-PCR 
identified pCLCA1 mRNA in the parotid, sublingual and submandibular salivary glands 
(Gaspar, Racette et al. 2000). Other tissues which are known to express a variety of 
chloride channels including the exocrine pancreas, cardiac and skeletal muscle, liver 
and kidney did not reveal any pCLCA1 mRNA (Gaspar, Racette et al. 2000).   
 
1.3.5. Canine Orthologue 
1.3.5.1 cCLCA1 
 Antibodies generated against pCLCA1 were used to stain canine retinal pigment 
epithelial cells (Loewen, Smith et al. 2003). Intense staining was seen in the basolateral 
membrane of the epithelium, which is really the apical secretory side. The Muller cells, 
which are reported to maintain appropriate extracellular environment for retinal 
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neurons, also showed significant cCLCA1 expression. (Loewen, Grahn et al., 
unpublished data)  
1.3.6. Rat Orthologue 
1.3.6.1 rCLCA1 
 Antibodies generated to rCLCA1 reacted extensively in the pancreas. On 
cellular localization most of the staining was associated with the zymogen granules 
(Thevenod, Roussa et al. 2003). Interestingly, a independent study was unable to detect 
expression of hCLCA1, the closest orthologue to the rCLCA1 or hCLCA2 in a 
pancreatic duct adenocarcinoma cell line with calcium-activated chloride conductance 
(Fong, Argent et al. 2003). This negative finding is consistent with observations by 
others that CLCA expression does not always correlate with the presence of calcium-
activated chloride currents (Loewen, Bekar et al. unpublished observations, 2004).  It is 
also in agreement with the loss of expression of CLCA products in carcinoma cell lines 
(Elble and Pauli 2001).   
 
1.4. CLCA Structure 
1.4.1. Human Orthologues  
1.4.1.1. hCLCA1 
 hCLCA1 It is predicted that the cDNA for the hCLCA1 gene encodes a 914 
amino acid protein with a calculated molecular weight of 100.9  kDa (Gruber, Elble et 
al. 1998). Four putative transmembrane domains have been proposed for the intact 
protein based on major hydrophobic regions, combined with a predicted helical 
sequence. A signal sequence is present in the first 20 amino acids with a predicted 
signal sequence cleavage site at amino acids 20 or 21. The predicted sequence motifs in 
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the protein include 9 potential sites for asparagine-linked glycosylation, 13 consensus 
sites for PKC phosphorylation and 3 consensus sites for phosphorylation by 
Ca2+/calmodulin-dependent kinase II. No PKA or tyrosine phosphorylation consensus 
sequences were found (Gruber, Elble et al. 1998).  
 In vitro translation of the human CLCA1 resulted in a 100 kDa product that 
increased in size to 125 kDa in the presence of canine pancreatic microsomes, 
indicating extensive glycosylation.  
 Structure modeling predictions for the protein are complicated by post-
translational processing that can include proteolytic cleavage. Some insight into the 
structure has been obtained by inserting an antigenic epitope into various regions in the 
amino acid sequence. However, several of the tagged constructs were resistant to 
normal processing by proteases, indicating that the cleavage may be conformationally 
dependent. This was not entirely unexpected, as the majority of the cleavage sites were 
consensus sequences for monobasic proteases which are significantly affected by 
protein confirmation (Schwartz and Devi 1986; Devi 1991). Insertion of the c-myc 
epitope (EQKLISEEDL) between aa366/367 or 492/493 resulted in a 90 kDa 
polypeptide, but little or no full length 125 kDa product. These locations for the epitope 
apparently interfered with the ability of the smaller cleaved ~ 40 kDa product to interact 
with the larger 90 kDa subunit.  In contrast, varying ratios of both 125 kDa and 90 kDa 
were produced when the epitope was placed at aa27/28 and aa593/594. It was difficult 
to determine whether the 125 kDa product in the last two epitope placements was due to 
subunit association or uncleaved polypeptide because the ~ 40 kDa fragment could not 
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be detected. These difficulties were illustrated with an epitope placed at 877/879 to 
identify the ~ 40 kDa product that only produced a 125 kDa product.  
 These disruptions of protein processing by epitope insertion indicate the 
importance of relatively small inserted amino acid segments to overall protein structure.  
Possible effects of structural changes on membrane topology may also be a significant 
concern when considering the predictions of membrane association and topology 
produced by surface biotinylation and fluorescent labeling studies.  
 After cell surface biotinylation, immunoprecipitation and streptavidin probing, 
the N terminal epitopes inserted after amino acids 90 or 125 immunoprecipitated with 
37, 39 and 41 kDa product. This would indicate that all three of these fragments are 
inserted into the apical membrane.  These smaller polypeptides are thought to be the 
glycosylated products from proteolytic processing at one of two monobasic cleavage 
sites, either 660/661 and 718/719. Results from the c-myc epitope insertion experiments 
produced a model with an extracellular N and C terminus, and four transmembrane 
domains. The 37 to 41 kDa amino terminal cleaved product is assumed to be entirely 
extracellular (Gruber, Schreur et al. 1999; Pauli, Abdel-Ghany et al. 2000). However, 
possible effects of disruption of structure and processing caused by c-myc epitope 
insertion should not be ignored when considering the validity of this model.  
 It should be noted that a significantly different model for hCLCA1 structure and 
relationship to the membrane has been predicted (Whittaker and Hynes 2002).  Using 
SMART predictions based on sequence homology to other proteins they suggest that the 
CLCA family members consist of a central (extracellular) VWA domain and a single 
transmembrane domain near the C terminus. The significant disparity between the 
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alternate models arises from predictions about the folding and topography of the amino-
terminal half of the protein.  The alternatives suggest that this region of the protein 
contains either two helical transmembrane domains (TM1 and TM2), or it is entirely 
extracellular, folded with secondary and tertiary structure appropriate to form a VWA 
domain.  
 The VWA domains are recognized for involvement in protein-protein 
interactions.  There is direct evidence from two independent systems for the interaction 
of CLCA proteins with other protein species.  Functional effects of hetero-oligomeric 
CLCA interactions have been demonstrated for cell binding and mitogenic signaling via 
integrins (Abdel-Ghany, Cheng et al. 2001; Abdel-Ghany, Cheng et al. 2002; Abdel-
Ghany, Cheng et al. 2003), and for ion channel modulation via the  β 1-subunit of the 
large conductance potassium channel (Greenwood, Miller et al. 2002). There is also 
indirect evidence for modulatory effects of CLCA expression on chloride conductance, 
suggesting that some chloride conductance channels may function as hetero-oligomeric 
structures. The literature contains precedents for VWA domain involvement in ion 
channel subunit interactions.  In the case of voltage-gated calcium channels, the pore-
forming α1 subunit is modulated by the α2δ VWA domain-containing subunit complex 
to alter the properties of the channel (Hobom, Dai et al. 2000; Whittaker and Hynes 
2002).  In addition to involvement in straightforward protein-protein interactions, some 
VWA domains contain an internal structural element called a metal-ion dependent 
adhesion site or MIDAS domain.  These domains are composed of non-contiguous 
amino acid sequence that can be organized into a complete cation binding structure 
through normal VWA folding. Magnesium and calcium binding to MIDAS domains, 
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and participation of the bound cations in stabilizing protein-protein interactions has 
been demonstrated.  Several predicted CLCA structures contain amino acid sequence 
meeting the requirements for VWA folding and MIDAS function (Whittaker and Hynes 
2002). Calcium binding within the MIDAS domain in CLCA proteins could participate 
in a signaling response to alter the conductivity of a chloride ion channel.  These 
observations could be the basis for an attractive hypothesis connecting CLCA proteins 
to the assembly and regulation of chloride channels. However, the MIDAS domain is 
normally composed of extracellular polypeptide structure, while effects of Ca2+ 
ionophores on chloride conductance associated with CLCA expression imply that 
changes in intracellular Ca2+ concentration are the basis for physiological regulation of 
this chloride conductance.  In addition, in spite of excellent amino acid sequence 
homologies, there has been no direct evidence for VWA domain formation and function 
in CLCA proteins (see Figure 1.2).  
1.4.1.2. hCLCA2 
 The hCLCA2 orthologue is predicted to form a 943 amino acid polypeptide 
(Gruber, Schreur et al. 1999).  It contains a canonical signal sequence with a predicted 
signal peptidase cleavage site between amino acids 31 and 32.  The predicted size of the 
full-length protein is a 104 kDa. This is confirmed by a primary translation product of 
105 kDa from an in vitro translation assay. Glycosylation of the product using 
microsomal membranes increased the size to 120 kDa. As with other orthologues, the 
translated product appears to undergo proteolytic processing. Placement of a c-myc 





















Figure1.2. Alignment of the closest mammalian orthologues mCLCA3 (gob-5) and 
hCLCA1 with pCLCA1. The amino acid sequence identity for pCLCA1:hCLCA1 was 
78 %, pCLCA1:mCLCA3 was 73 % and hCLCA1:mCLCA3 was 75 % as determined 
by Clustalw software. The VWA domain and the major transmembrane domains 
predicted by Gruber et al. are outlined.  Phosphorylation consensus sequences on the 
major cytoplasmic loop are identified 
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present in whole cell lysate. The N-terminal tag was found on an 86 kDa protein and a 
34 kDa protein was identified when the tag was situated near the C terminus. It is 
presumed that the cleavage occurs at the monobasic proteolytic 673/674 cleavage site. 
 Deglycosylation of these products resulted in a size reduction that would 
correspond with 4 glycosylation sites on the 86 kDa subunit and one on the smaller 34 
kDa fragment. Asn to Gln mutation abolished glycosylation sites and resulted in a ~ 2 
kDa size change. Mutants made at N terminal N150Q indicating an extracellular N 
terminus, and the N522Q substitution indicated an extracellular loop between predicted 
transmembrane domains 2 and 3. A N822Q mutation indicated an extracellular loop in 
the smaller cleaved product between transmembrane domains 4 and 5.   
 A protein protection assay digesting all internal loops resulted in a 30 kDa 
product thought to be the N terminus plus transmembrane domain 1. The digest also 
produced an 18 kDa product that was thought to consist of transmembrane domains 2 
and 3 and the first extracellular loop, and a 21 kDa product resulting in the final two 
transmembrane domains and the extracellular loop. This gave the interpreted 5 
transmembrane domain structure of hCLCA2.  It should also be noted that the two units 
were detected in surface-biotinylated, nonpermeablized HEK-293 cells, suggesting that 
both the larger and the smaller subunits are expressed on the cell surface. In this model 
the internal loops contained seven PKC phosphorylation sites. However, there were no 
consensus sites for Ca2+/calmodulin protein kinase II or cAMP-dependent protein 
kinase (Gruber, Schreur et al. 1999).  HCLCA2 as well as several other CLCA proteins 
contain a  β4 integrin binding domain (Abdel-Ghany, Cheng et al. 2003). The 




 Initial analysis of the hCLCA3 gene readily revealed a very different  structural 
product for this member of the family (Gruber and Pauli 1999b). hCLCA3 has a high 
degree of identity to the CLCA consensus sequence, but, unlike the other members of 
the gene family, it contains two open reading frames (ORF). Both these reading frames 
terminate early, producing significantly smaller products than other family members. 
The ORF1 on the 3.6 kb gene product codes for a 262 amino acid polypeptide 
containing the N terminus and the signal sequence of a standard CLCA protein. The 
second ORF codes for amino acids corresponding to positions 266 to 461 in an intact 
CLCA protein. Together, the two ORFs code for approximately the first 1/3 of the full 
length CLCA protein. Analysis of this sequence predicts that ORF1 lacks potential 
transmembrane domains. ORF2 does not have a signal sequence, but codes for two 
hydrophobic domains with significant sequence identity to the first two transmembrane 
domains of other CLCA family members. In vivo transcription and translation in a TNT 
T7 coupled reticulocyte lysate system produced 30 and 22 kDa products corresponding 
to calculated size for ORF1 and ORF2 respectively. In vitro glycosylation increased the 
weight of the 30 kDa protein to 37 kDa and did not change the 22 kDa protein. It is 
thought that the increase in size was due to carbohydrate addition to three consensus 
sites for N-linked glycosylation observed in its amino acid sequence. However, a tagged 
ORF1 peptide was the only product identified in HEK 293 cells transfected with 
constructs coding for expression of both ORF1 and ORF2.  The excreted ORF1 product 
could also be detected upon immunoblotting the supernatant from transfected cells. It is 
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also interesting to note that ORF1 translation terminates before the VWA domain is 
produced, so hCLCA3 is the only CLCA which lacks the potential to form a VWA 
domain (Gruber and Pauli 1999b).    
1.4.1.4. hCLCA4  
Unfortunately there is currently no structural data for the hCLCA4 clone.  
 
1.4.2. Mouse Orthologues 
1.4.2.1. mCLCA1 
 The predicted size of 100 kDa correlates with the in vitro translated size of 100 
kDa for this 902 amino acid protein. A signal sequence was noted at the amino terminus 
of the protein (Gandhi, Elble et al. 1998). Glycosylation of the translated product with 
canine microsomes increased the size to approximately 125 kDa. On expression in HEK 
293 cells antibodies to the N-terminal end identified products of 130, 125 and 90 kDa. 
Antibodies that detected a carboxyl-terminal epitope identified a triplet of bands 
ranging in size from 32 to 38 kDa. It was suggested that the alternate glycoforms of 125 
and 130 kDa, are postranslationally processed into the 90 and 38/32 kDa components. A 
general 4 transmembrane domain structure was proposed for this gene, leaving the C 
terminus without a transmembrane domain. 
1.4.2.2. mCLCA2.  
 Little or no structural data is available on mCLCA2. Its closest orthologue is 
thought to be hCLCA2. It has been reported without accompanying data that mCLCA2 
yields similar processed products as those observed for mCLCA1 when expressed in 
HEK293 cells (Elble and Pauli 2001).   
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1.4.2.3. mCLCA3 
 The mCLCA3 cDNA coded for a 100 kDa protein in an in vitro translation 
assay.  The product increased in size to approximately 110 kDa after glycosylation with 
microsomal membranes (Leverkoehne and Gruber 2002). After microsomal protease 
treatment, only a 35 kDa product was detected, which, in the proposed model, would 
correlate with the N terminus being extracellular.  A 90 kDa product was identified 
using these same antibodies as a probe in HEK293 and COS-7 cells transiently 
transfected with mCLCA3. These antibodies also identified a 90 kDa product in both 
the large and small intestine, with the expression being more intense in the small 
intestine. Interestingly, a 45 kDa product was also detected in the large, but not in the 
small intestine (Leverkoehne and Gruber 2002). This enterocyte product remains 
unexplained, but is thought to be a fragment of a truncated portion of the amino 
terminus of the protein with similarities to the secreted 37 kDa amino terminus of 
hCLCA3. The fragment represents either another isoform within the gut or a cell type 
specific difference in cleavage of the mCLCA3 protein (Figure 1.2).     
1.4.2.4. mCLCA4 
 To date there is limited information on the structure of mCLCA4. The primary 
structure contains many similarities to mCLCA1 and 2.  It is 909 amino acids in length, 
with a conserved cleaved amino terminal signal and a second monobasic cleavage site 
which results in a 90 and 30 to 40 kDa products (Elble, Ji et al. 2002). The primary 
structure also contains most of the calcium/calmodulin kinase II sites found in 
mCLCA1 and mCLCA2.  
1.4.3. Bovine Orthologues  
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1.4.3.1 bCLCA1 
 The primary structure of bCLCA1 is thought to consist of 903 amino acids, 
giving a predicting product of 100 kDa (Cunningham, Awayda et al. 1995). On motif 
analysis it is predicted of have 15 protein kinase C acceptor sites, 10 Ca2+/calmodulin-
dependent protein kinase sites, and three tyrosine kinase sites. Four transmembrane 
domains and an amino terminal signal sequence were suggested based on hydropathy 
plots. In vitro translation yielded the predicted 100 kDa product. On glycosylation with 
canine pancreatic microsomes, the molecular weight shifted to 140 kDa. This correlated 
with the original 140 kDa purified chloride conducting product. However, it did not 
reduce to the smaller fragments observed with the purified tracheal product (Ran, Fuller 
et al. 1992). This was assumed to be due to the lack of monobasic protease cleavage 
activity in the in vitro translation assay, although it was considered possible that the 
bCLCA1 protein was not the antigen containing the original epitope involved in 
chloride transport in the trachea. Polyclonal antibodies generated against an N terminal 
fragment of the bCLCA1 clone recognized a reduced 36/38 kDa bovine tracheal lysate 
product similar to the antigen identified by the original antibodies that were used to 
clone bCLCA1 (Ran, Fuller et al. 1992; Cunningham, Awayda et al. 1995). However, 
these polyclonal antibodies were never used on the in vitro translated or the oocyte-
expressed clone. It was hypothesized the original purified protein of 140 kDa consisted 
of four identical 38 kDa subunits linked together by disulfide bonds and only reduced to 
64 and 38 kDa due to exceptionally strong disulfide bonding between two of the 
identical subunits (Ran, Fuller et al. 1992). However, the sequence data and the 
identification of the 100 kDa unglycosylated form of bCLCA1 indicate that the 38 kDa 
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protein is a post-translational cleavage product associating with a larger fragment of the 
original translated protein (Cunningham, Awayda et al. 1995). This model has now 
been promoted for the other cloned isoforms and orthologues. 
 
1.4.3.2.bCLCA2 
 The cloned sequence had a predicted hydrophobic amino terminal signal 
sequence and cleavage site for membrane association. As seen in bCLCA1, a 
hydropathy plot predicted 4 transmembrane domains. In vitro translation resulted in a 
101 kDa product without glycosylation and 120 kDa with glycosylation.  
 Deglycosylation of  native bCLCA2 with N-glycosidase F from endothelial cells 
reduced the apparent size of 38 and 32 kDa polypeptides to 22 kDa, and the 90 kDa 
band to 77 kDa, giving the predicted deglycosylated size of the processed bCLCA2 
clone (Elble, Widom et al. 1997). This is consistent with an original study 
immunoprecipitating bCLCA2 (Lu-ECAM-1) as a 90 kDa protein using an antibody to 
N terminal amino acid sequence (Zhu and Pauli 1991). Immunoblot with antibodies to 
the N terminus of bCLCA2 identified products at 90, 120, and 130 kDa but not at 38 or 
32 kDa.  Antibodies generated against C terminal sequence identified products of 38, 
32, 120 and 130 kDa but not 90 kDa. This demonstrates that the 90 kDa polypeptide has 
no epitope in common with the 32 or 38 kDa fragments. But the 120 and 130 kDa 
proteins do share epitopes, indicating that products above 100 kDa can be separated into 
two non-identical proteins (Elble, Widom et al. 1997). The earlier suggestions of a 
homo-tetrameric structure for this protein (Ran, Fuller et al. 1992) are not supported by 
these experimental observations.  Similar results were found with expression of 
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bCLCA2 in human embryonic kidney cells (HEK 293).  Immunoblotting detected 120, 
90 and 38 kDa products. Interestingly, the 130 and 32 kDa products observed in bovine 
aortic endothelial cells were not detected. This likely indicates differences in 
glycosylation between the expression system and the native expression in the 
endothelial cell (Elble, Widom et al. 1997).  
 
1.4.4 Porcine Orthologues 
1.4.4.1 pCLCA1 
 The full-length pCLCA1 transcript was estimated to be ~ 2.9 kb on Northern 
blot analysis. The full length cloned sequence contained 3,079 base pairs and a 2,751 
base open reading frame which is predicted to encode a 917 amino acid protein with a 
molecular mass of 100.7 kDa (Gaspar, Racette et al. 2000).  Its closest orthologue is 
hCLCA1, sharing 78% amino acid sequence identity. The areas with the greatest 
sequence differences between these related genes were in the putative extracellular N 
terminus between amino acids K181 and S323, and in the proposed cytosolic loop lying 
between transmembrane domains 3 and 4. The high similarity for amino acid sequence 
and hydrophobicity between pCLCA1 and the closest human orthologue, hCLCA1, 
suggested a similar transmembrane topology for the two proteins.  Modeling this 
structure according to the suggestions of Gruber et al. (Gruber, Schreur et al. 1999) 
would give an extracellular amino terminus followed by four transmembrane domains 
and a hydrophobic C-terminus (Fig 1.2 )(Gaspar, Racette et al. 2000).  
 The predicted pCLCA1 protein is similar to several other CLCA proteins, 
containing a signal sequence for membrane targeting, and potential proteolytic cleavage 
sites which are shared with hCLCA1. There is an amidation cleavage site at residue 140 
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and two monobasic proteolytic cleavage sites at R662 and another at K720.  Both of 
these monobasic proteolytic cleavage sites would be located in the C- terminal 
extracellular loop if the predicted structural topology from Fig 1.2 is correct. These 
multiple sites for potential proteolytic cleavage appear to be significantly dependent on 
protein conformation for actual post-translational processing. This could account for the 
multiple sizes of protein (~130, 90 and 60 kDa) detected by Western blotting or 
immunoprecipitation of brush border vesicles protein with an inhibitory antibody 
(Gabriel, Racette et al. 1992; Racette, Gabriel et al. 1996).  It should be noted that the 
original antibody that inhibited brush border conductive chloride transport was 
generated from electro-eluted protein fractions of porcine ileal brush border.  
Monoclonal antibody selected on the same basis was used for cDNA library screening.  
The only antigen pool yielding antibody that inhibited chloride conductance was a high 
molecular weight fraction  >110 kDa (Gabriel and Forsyth 1991; Gabriel, Racette et al. 
1992).  The pCLCA1 ortholouge would have avoided proteolytic processing, or lower 
molecular weight cleavage fragments of pCLCA1 would have had to associate with 
other proteins to give this molecular mass to the antigen.  The extent to which currently 
available evidence supports varying degrees of proteolytic processing, versus 
association of processed fragments of pCLCA1, with other unidentified proteins is not 
clear.  Expression of exogenous pCLCA1 in transfected Caco-2 cells produced a ~ 60 
kDa product upon Western blotting which was present at much lower levels in control 
transfected cells.  The antibody used for this screening was developed to an amino-
terminal peptide (C250- K266) of pCLCA1.  It is also possible that the processing of 
CLCA isoforms may vary with expression in different tissues. As is often mentioned in 
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the literature, not all isoforms or orthologues in every tissue are processed into the 
commonest ~ 90 and ~ 35 kDa fragments (Pauli, Abdel-Ghany et al. 2000; Fuller, Ji et 
al. 2001). This is supported by the evidence that a  ~ 60 kDa bCLCA1 fragment and ~ 
60 kDa pCLCA1 product were expressed in epithelial cells, as well as a preliminary 
report of a ~ 60 kDa protein contributing to anion conductance in the rabbit ileum 
(Peerce, Seifert et al. 1991; Ran, Fuller et al. 1992)   
 Similar to other CLCA clones, pCLCA amino acid sequence from V307 to 
Q462 has extensive homology with sequences that form a VWA domain (Figure 1.2). 
The previously noted incompatibility between an extracellular VWA domain and the 
predicted four transmembrane domains (Gruber, Schreur et al. 1999) also applies to 
pCLCA1. Within pCLCA1's putative VWA domain there is a perfect non-contiguous 
consensus sequence for a MIDAS motif (D-x-S-x-S...T...D) beginning at 313D.  
hCLCA1 has a similar motif.  Loewen et al. have presented evidence for a direct 
regulatory role of calcium in the modulation of chloride conductance by pCLCA1 
(Loewen, Gabriel et al. 2002), but no connection has been made between Ca2+ binding 
to this MIDAS site and the regulation of pCLCA1. However, structural modeling of the 
pCLCA1 MIDAS domain does reveal appropriate folding (Figure 1.3).  
 The pCLCA1 sequence contains 14 potential C kinase phosphorylation sites. 
The most amino terminal four sites lie before the first predicted transmembrane domain. 
This places them in the extracellular space if predicted transmembrane topology is 
correct.  Four of the C kinase sites found within the predicted cytosolic loop between 











Figure 1.3. Structural modeling of the von Willebrand A MIDAS domain in pCLCA1.  
Amino acids 310 to 415 of pCLCA1 were aligned with and spliced into the alpha-2 
integrin collagen receptor sequence. Clustalw gave a sequence identity of 48 % of the 
hybrid to the integrin alpha-2 VWA domain. This new hybrid sequence was modeled  
using Swiss Model to the solved structure of the alpha-2 integrin VWA domain of the I 
domain designated 1DZI(Emsley, King et al. 1997; Emsley, Knight et al. 2000). Grey is 
1DZI template structure/sequence.  Yellow is pCLCA1 sequence in model hybrid. Red 
= Asp, green = Ser, blue = Thr, and the orange ball is the calcium ion.  Note the 
classical Rossmann fold with the open twisted β sheet surrounded by α helices on both 
sides. Also note the metal ion coordination site at the surface which defines this 
Rossmann fold as the VWA domain. The pCLCA1 hybrid MIDAS seems to have the 
appropriate coordinates for ion binding in this model. A weak Thr 383 bond would be 
expected given interatomic distances in this model.
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unique site in this same loop.  Also found in this loop is a strong A-kinase site  which is 
unique to pCLCA1 (Gaspar, Racette et al. 2000). Unfortunately, the effects of 
mutagenesis of this highly phosphorylated loop in the modulation of chloride 
conductance by CLCA proteins has not been reported 
1.5. Functional Expression 
1.5.1. Human Orthologues  
1.5.1.1. hCLCA1 
  Initial functional characterization of hCLCA1 involved transient expression in 
HEK 293 human embryonic kidney cells (Gruber, Elble et al. 1998). Transfection with 
hCLCA1 increased calcium-activated whole cell currents from 1.57 ± 0.72 pA/ pF in 
control cells to 11.06 pA/pF in transfected cells, producing a time-independent 
outwardly rectifying current.  This current was said to be "electrically isolated" for 
chloride, based on the blockage of cation current using large bulky cations. 
Unfortunately however, the chloride dependence of the current was not determined.  
These putative chloride currents were reduced by DIDS, DTT, and niflumic acid. 
However, DIDS is the only one of these inhibitors known to be primarily a blocker of 
chloride channels. Interestingly, this study presents the only single channel patch clamp 
study of the CLCA proteins. It was reported that hCLCA1 had a slope conductance of 
13.4 pS in cell-attached conformation after the addition of ionomycin in the presence of 
1 mM Ca2+ (Gruber, Elble et al. 1998). Apparently no difficulties were encountered in 
this study with the background non-selective and anion currents previously reported in 




 When HEK 293 cells were transiently transfected, hCLC2 produced a calcium-
activated, non time-dependent, outwardly rectifying increase in whole cell current. 
Transfection increased the whole cell current from 1.52 ± 1.83 pA/pF in control to 
10.77 ± 3.8 in transfected cells (Gruber, Schreur et al. 1999). Once again, neither the 
background current in untransfected cells nor the chloride-dependence of the current 
produced in transfected cells has been explored.  However, the "electrically isolated" 
anion current was blocked by DIDS, DTT, NFA and Tamoxifen (Gruber, Schreur et al. 
1999).  
1.5.1.3. hCLCA3 and hCLCA4. 
 There are no current reports of ion transport functional data on hCLCA3 and 
hCLCA4.  
 
1.5.2. Mouse Orthologues 
1.5.2.1. mCLCA1 
 Two independent groups characterized mCLCA1 concurrently (Gandhi, Elble et 
al. 1998; Romio, Musante et al. 1999) in different expression models. As reported for 
the human CLCAs, expression of mCLCA1 in HEK293 cells caused the appearance of 
a significant calcium-activated chloride current. The current was non time-dependent 
and outwardly rectifying (Gandhi, Elble et al. 1998). The current increased from 
2.05±1.09 pA/pF to10.23 pA/pF upon addition of ionomycin. Background Cl- currents 
were apparently insignificant in this study and the anionic dependence of the current 
was not determined. NFA, DTT and DIDS inhibited the reported chloride current. 
Romio et al. concurrently cloned and expressed mCLCA1 in Xenopus oocytes (Romio, 
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Musante et al. 1999). In cRNA injected oocytes, there was a significant increase in 
oocyte current without calcium activation. At -80 mV, the current in mCLCA1 mRNA-
injected oocytes was -398 ± 136 nA compared to -97 ± 12 nA for water-injected 
oocytes.  The current in the mCLCA1-injected oocytes was chloride-dependent, but 
there was no chloride dependence for the current from water-injected oocytes. The lack 
of an Erev shift when bath solution was changed to low NaCl indicated that the 
background current was a combination of both anion and cation currents. Both DIDS 
and niflumic acid inhibited chloride current in mCLCA1-injected oocytes. However, 
they also reduced the endogenous current of the water-injected oocytes. Interestingly, 
the application of a Ca2+ ionophore (ionomycin) caused a transient increase in current to 
1805 ± 473 nA in mCLCA1-expressing oocytes compared to 1109 ± 389 nA in control 
oocytes. However, this difference in the stimulated currents between mCLCA1 and 
mock-injected oocytes was not statistically significant (Romio, Musante et al. 1999). 
Due to the large background currents it is difficult to determine the calcium-activated 
dependence of chloride conductance associated with CLCA expression in Xenopus 
oocytes. 
 More recent studies have shown enlarged whole cell currents induced by 
mCLCA1 expression (Britton, Ohya et al. 2002; Greenwood, Miller et al. 2002). 
Generally mCLCA1 expression in HEK 293 cells resulted in a mildly outwardly 
rectifing, time independent current. This current was only elicited when 2 mM Ca2+ was 
placed in the pipette. The Ca2+-activated currents did not increase above control values 
when 500 nM Ca2+ was present. The stimulated mCLCA1 current was found to be more 
permeable to SCN- than Cl-, which was more permeable than isethionate (Britton, Ohya 
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et al. 2002). This is the permeability sequence established by this group for Ca2+-
activated chloride channels in smooth muscle from which they cloned mCLCA1 
(Britton, Ohya et al. 2002). Unfortunately, the anion dependence of the whole cell 
current in control HEK 293 cells was not assessed.  
 The mCLCA1-dependent calcium-stimulated current changed significantly 
when co-expressed with a potassium channel β-subunit (Greenwood, Miller et al. 2002). 
This co-expression changed the current from time-independent to time-dependent, as 
well as increasing the total whole cell conductance. Co-expression also resulted in a 
greater sensitivity to activation by calcium. Addition of 500 nM Ca2+ in the pipette 
solution could stimulate the anion current in β-subunit mCLCA1 expressing cells. This 
difference in current and agonist sensitivity was shown by a mammalian two-hybrid 
system to be the result of a direct interaction between β-subunit and mCLCA1. 
Unfortunately, the anionic dependence of the current was only assessed through the 
permeability ratios for SCN- and Cl- which were consistent with those found in smooth 
muscle. Again, as with several other CLCA studies, the background currents were not 
shown or characterized (Greenwood, Miller et al. 2002).  
  However, the study by Greenwood et al. was the first report suggesting that a 
CLCA protein required coexpression with other proteins in order to produce functional 
chloride channels. It demonstrated that the currents induced on CLCA1 expression 
could be modified by an accessory subunit, suggesting that CLCA proteins may be part 




1.5.2.2. mCLCA2  
 There is currently no electrophysiological data on mCLCA2.  Given that it is the 
closest murine orthologue to hCLCA2, it may have similar electrophysiological 
parameters.  
1.5.2.3 mCLCA3 
 The effects of mCLCA3 or Gob 5 expression have been characterized briefly in 
HEK293 cells (Winpenny, Lavery et al. 2002).  mCLCA3 expression increased an 
outwardly rectifying current without agonist addition. Current densities at +60 mV 
increased from 59 ± 17 to 230 ± 47  pA/pF.  Addition of 10 mM EGTA to the pipette 
solution significantly decreased these currents (Winpenny, Lavery et al. 2002).  
1.5.2.4 mCLCA4 
   Increasing intracellular calcium by treating with ionomycin or methacholine 
evoked  transient inward currents in mCLCA4-transfected cells held at a controlled 
undefined voltage (Elble, Ji et al. 2002). This would be consistent with the inward 
movement of cations or the outward movement of anions. In this case, a strong anionic 
dependence to the stimulated current was shown by a shift in the current-voltage 
relationship to the equilibrium potential of chloride when bath solution was switched to 
low chloride after ionomycin addition. Unlike previously characterized isoforms, the 
current was found to be non-rectifying. The transient nature of the current was thought 
to be analogous to the Ca2+-independent inactivation of the smooth muscle Ca2+-
activated chloride channel.  This inward current was found to be spontaneous, similar to 
those in smooth muscle cells that are induced by a "calcium spark" and are involved in 
buffering the membrane potential, relaxation and spontaneous rhythmic contraction of 
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smooth muscle (Nelson, Cheng et al. 1995) (Jaggar, Porter et al. 2000). Current-voltage 
relationships in non-transfected cells were not examined, as voltage-clamped inward 
currents were not seen (Elble, Ji et al. 2002).  
 
1.5.3. Bovine Orthologues  
1.5.3.1. bCLCA1  
 Oocytes transfected with bCLCA1 cRNA had a significantly larger current than 
water-injected oocytes (Cunningham, Awayda et al. 1995). At a holding potential of -
100 mV, the mean current for water-injected oocytes was -96 ± 25 pA and -2052 ± 528 
pA in oocytes injected with bCLCA1 mRNA. At +90 mV the currents were 457 ± 209 
pA (water-injected) and 8084 ± 1700 pA for bCLCA1 mRNA-injected oocytes. 
bCLCA1 expression clearly increased an endogenous outwardly-rectifying current.  
This current was sensitive to DIDS and DTT but insensitive to niflumic acid. Addition 
of 1 µm ionomycin to oocytes resulted in the activation of endogenous chloride 
channels which were inhibited by niflumic acid. Unfortunately, data showing the effect 
of the ionophore on bCLCA1-injected oocytes was not presented or discussed 
(Cunningham, Awayda et al. 1995).  
 When bCLCA1 was expressed in COS-7 cells, a non-rectifying, Ca2+-activated, 
DTT-inhibitable current was produced (Cunningham, Awayda et al. 1995). The 
bCLCA1 current was unlike that seen with most of the other CLCA family members 
which produced outwardly rectified currents. However, none of the other family 
members have been characterized using COS-7 cells. It is interesting to note that the 
currents induced in the oocytes had a both time-dependent and rectifying quality, 
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whereas those induced in the COS-7 cells had neither (Cunningham, Awayda et al. 
1995). This suggests that bCLCA1 may be working with different cellular components 
in different cell lines to affect the activity of Ca2+-activated chloride channels.  
 Lipid bilayers were constructed from oocytes membranes that had been injected 
with bCLCA1 cRNA (Cunningham, Awayda et al. 1995). Recordings from these 
vesicles had a unit channel conductance of 21 pS. The open probability increased from 
0.41 ± 0.07 to 0.60 ± 0.08 in the presence of Ca2+ added only to the side opposite to that 
where DIDS was added. The channel was inhibited by DIDS and DTT, but insensitive 
to niflumic acid. The channel had an 8:1 anion to cation selectivity ratio and 3:1 
selectivity for iodide over chloride under bionic conditions. The biophysical properties 
were similar to those found for a purified chloride channel from bovine trachea. Some 
bilayers in the study did have a Ca2+-activated chloride conductance that was inhibited 
by niflumic acid. This was said to be the endogenous Ca2+-activated chloride channel of 
the oocyte. Unfortunately, bilayer studies were not performed on purified bCLCA1 in 
an artificial bilayer.  
 
 Other researchers, using bCLCA1 as a control for mCLCA1 characterization, 
found that they were able to significantly inhibit bCLCA1-induced current by 78 % 
with niflumic acid. Subsequent addition of DIDS (100 µM) caused a further 33 % 
inhibition of the anion current (Romio, Musante et al. 1999). Differences in oocyte 





1.5.4. Porcine Orthologue 
1.5.4.1. pCLCA1 
 Effects of pCLCA1 expression on chloride conductance have been studied 
extensively in NIH/3T3 cells (Gaspar, Racette et al. 2000; Loewen, Gabriel et al. 2002; 
Loewen, Smith et al. 2003).  pCLCA1 was found to increase a calcium-activated 36Cl-  
efflux from NIH/3T3 cells. Agonists for calcium-dependent protein kinase (PKC) 
phorbol-12- myristate-13-acetate (PMA) or cAMP-dependent protein kinase (PKA) 
forskolin and isobutyl-1-methylxanthine (IBMX) had no effect on conductance. 
However, application of 10 µm ionomycin significantly increased 36Cl-efflux from 
transfected cells. Inhibition of this effect by the membrane-permeable Ca2+ chelator 1,2 
bis (2-aminophenoxy) ethane-N,N,N',N'-tetraaceticacid acetooxymethylester (BAPTA-
AM), combined with the lack of inhibition by the  calcium calmodulin kinase II 
(CaMKII) inhibitor KN-93, suggested that calcium directly regulates pCLCA1 effects 
on chloride transport. The pCLCA1 effect on chloride efflux was inhibited by bulky 
organic anions including 5-nitro-2-(3-phenylpropylamino) benzoate (NPPB), 
glibenclaminde, diphenylamine carboxylate (DPC) and α-phenylcinnamate (α-PC). 
Both NPPB and DPC inhibited the calcium-activated chloride conductance at much 
lower concentrations than were required for inhibition of CFTR. NPPB was effective at 
a concentration similar to that which was required to inhibit Ca2+-activated chloride 
conductance in Xenopus oocytes (Loewen, Gabriel et al. 2002).  
 In a patch clamp study, pCLCA1 increased an endogenous Ca2+-activated 
chloride conductance, making the current more anion dependent, as determined by a 
low chloride shift to the anion Nernstian equilibrium potential (Loewen, Gabriel et al. 
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2002). The current induced by pCLCA1 expression was found to be outwardly 
rectifying and time-dependent. This time-dependence has not been seen in the 
characterization of other CLCA proteins, and it might be a result of expression in 
NIH/3T3 fibroblasts having different member components on which to act. As seen in 
the 36Cl- efflux, DIDS did not inhibit whole cell chloride current, but NPPB, DPC, and 
α-PC were inhibitory (Loewen, Gabriel et al. 2002).  It should be noted that both DTT 
and DIDS have been reported to be consistent inhibitors of chloride current activity in 
previous studies with different CLCA proteins and different expression systems 
(Cunningham, Awayda et al. 1995; Gandhi, Elble et al. 1998; Gruber, Elble et al. 1998), 
but were not inhibitory for pCLCA1 in this study.   
 The study of pCLCA1 expression in an a non-epithelial fibroblast cell line gave 
some insight to its function as a Ca2+-dependent chloride channel regulator (Loewen, 
Bekar et al. 2002). In addition, transfection of epithelial Caco-2 human colon carcinoma 
cell line significantly altered the kinetics of cAMP-activated chloride conductance, 
possibly through some interaction with CFTR (Loewen, Bekar et al. 2002). The 
pCLCA1 and PKA-dependent currents were found to be anion-dependent, time-
independent and non-rectifying. The effects of pCLCA1 expression on PKA-dependent 
chloride conductance were evident in both freshly passaged and in differentiated 
epithelial cells, both of which have endogenous CFTR-mediated chloride conductance. 
This modulation of chloride conductance by pCLCA1 expression was also seen when 
CFTR and pCLCA1 were co-expressed in non-epithelial NIH/3T3 fibroblasts (Loewen, 
Smith et al. 2003).  
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  Expression of pCLCA1 also alters the characteristics of chloride conductance 
activated by calcium ionophore or PKA agonists in Caco-2 epithelial cells. The Ca2+-
dependent 36Cl- efflux effects of pCLCA1 expression stimulated a time-dependent 
outwardly rectifying current by patch clamp (Loewen, Bekar et al. 2004). However the 
endogenous Ca2+-activated chloride conductance is only found in freshly passaged 
Caco-2 cells. As the cells mature, they lose Ca2+-activated chloride conductance. When 
endogenous Ca2+-activated chloride conductance disappears, the ability of pCLCA1 to 
activate a Ca2+-dependent chloride conductance is also lost (Loewen, Bekar et al. 2004). 
This separate line of evidence supports previous observations of the importance of 
contributions of the endogenous chloride channel activity of the host expression system 
to the properties of the chloride channels observed upon CLCA-expression.  
 
1.5.5. Rat Orthologue 
1.5.5.1 rCLCA1 
 This CLCA isoform has been identified in rat pancreas.  It has not been fully 
cloned or functionally characterized, but it has been indirectly implicated in bicarbonate 
transport and vesicle exocytosis in the pancreas.   
 
1.5.6. Canine Orthologue  
1.5.6.1. cCLCA1 
 The cCLCA1-cDNA has been produced from canine retinal pigment epithelium 
mRNA, but this canine variant has not been fully cloned to permit functional 
expression.  The cloned fragment of the cCLCA1 isoform has a significant degree of 
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identity to porcine pCLCA1.  Its tissue localization suggests that it has a strong 
association with secretory epithelial cells in the canine retina (Loewen, Smith et al. 
2003).  
 
1.6. Pathophysiologic Connections to CLCA Expression 
1.6.1. CLCA in Asthma 
 Orthologues of the CLCA gene family have been shown to be over-expressed 
and to have a key role in mediating the bronchial allergic asthmatic response, especially 
the over-production of mucus (Nakanishi, Morita et al. 2001; Hoshino, Morita et al. 
2002; Toda, Tulic et al. 2002). 
 
1.6.1.1. Asthma and the Genesis of its Mediators 
 Bronchial allergic asthma is a serious inflammatory condition of the airways 
resulting in bronchial narrowing, constriction and CLCA-dependent overproduction of 
mucus. (Busse and Lemanske 2001; Toda, Tulic et al. 2002). Simplistically, the 
uncontrolled inflammatory response, which is accompanied by the overexpression of 
CLCA protein, is thought to occur through a  dysregulation between type 1 helper T 
(Th1) and type 2 helper T (Th2) cell immune responses to disease (Robinson, Hamid et 
al. 1992; Walker, Bauer et al. 1994; Humbert, Durham et al. 1996; Nakamura, Ghaffar 
et al. 1999; Busse and Lemanske 2001; Arima, Umeshita-Suyama et al. 2002; El Biaze, 
Boniface et al. 2003). The Th1-immunological response involving cytokines 
(interleukin 2 and interferon- γ) is seen as a cell-mediated response and is associated 
with disease in situations such as infection with Mycobacterium tuberculosis, measles 
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virus, hepatitis A virus or poor hygiene (Strachan 1989; Matricardi, Rosmini et al. 1997; 
Shirakawa, Enomoto et al. 1997; Mattes and Karmaus 1999; Bremner, Carey et al. 
2003). The Th2 disease response involving cytokines (interleukins 4, 5, 6, 9, and 13) is 
generally thought of as humoral, involving the stimulation of B cells and the production 
of IgE. The IgE binds to IgE receptors on mast cells, lymphocytes, eosinophils, platelets 
and macrophages. Binding of allergen to the IgE results in the release of inflammatory 
mediators from mast cells and activation and potentiation of an inflammatory response 
(Busse and Lemanske 2001).  
 Proper priming of the immune system to differing immunological challenges is 
essential to develop a normal Th1 response.  The Th1 response then has a role in 
modulating the Th2 response. An uncontrolled Th2 response, dominates the disease 
state of asthma. This association between Th2 cytokine expression response and asthma 
is demonstrated in Th2 asthma models. Functional blockade of the Th2 cytokine 
pathways significantly dampens the asthmatic response (Brusselle, Kips et al. 1994; 
Foster, Hogan et al. 1996).  
 
1.6.1.2. Th2 cytokines mediate CLCA expression 
 The Th2 response and the associated cytokines appear to be directly linked to 
CLCA over-expression in the asthmatic patient. A study using subtractive hybridization 
between a Th2 cytokine IL-9 over-expressing mouse versus a wild-type mouse 
identified significant over-expression of mCLCA3, the closest murine orthologue to 
hCLCA1 (Zhou, Dong et al. 2001). Induction of mCLCA3 expression was also found 
when Th2 cytokines IL-4 and IL-13 were introduced into tracheas of anesthetized mice 
daily for 10 days (Zhou, Dong et al. 2001). Interestingly, instilled Th1 cytokine 
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interferon gamma (INF γ) did not induce expression of mCLCA3.  Similar results were 
found using an allergic asthma mouse model of ovalbumin (OVA) sensitization. 
Induction of mCLCA3 was found in the lung and bronchi in normal mice after OVA 
challenge (Nakanishi, Morita et al. 2001). Subsequent adenoviral gene transfer with an 
antisense mCLCA3 construct suppressed the pathology of the allergic asthma through 
prevention of airway hyperresponsiveness (AHR) and mucus overproduction. When this 
same model was treated with a sense mCLCA3 mRNA construct there was severe AHR 
and mucus production (Nakanishi, Morita et al. 2001). In vitro over-expression of 
mCLCA3 or its closest human orthologue hCLCA1 in human mucoepidermoid cells 
(NCI-H292) resulted in overall increased mucus secretion, as well as over-expression of 
the major secretory mucin gene of asthma, MUC5AC (Hoshino, Morita et al. 2002). 
Similar results were found in the asthmatic patient, with an increase in hCLCA1 that 
correlated with an increase in mucus and IL-9 receptor (Hoshino, Morita et al. 2002) 
(Toda, Tulic et al. 2002) ( Figure 1.4).   
 Most current asthma treatment is focused on leukocytes and airway smooth 
muscle hyper-responsiveness. The identification of relationships between the function 
of hCLCA1 as a chloride channel regulator, and its integral role in mucus production in 
the asthmatic airway are of considerable interest. This relationship suggests that 
hCLCA1might be a potential therapeutic target in patients suffering from asthma. 
 Exposure of human bronchial epithelial cells to Th2 cytokines, interleukins 13 
or 4, greatly increases the magnitude and duration of activated calcium-dependent 
chloride conductance (Danahay, Atherton et al. 2002; Atherton, Jones et al. 2003). This 







Figure 1.4. Hypothetical roles for CLCA protein in the asthmatic airway. Increased 
expression of CLCA is presumably cytokine-driven.  CLCA could then (1) increase the 
transcription or translation of MUC genes; (2) Increase the transport of mucin to the 
plasma membrane by increasing the condensation (packaging process) by acidification 
of the mucin granule; (3) Take part in the membrane fusing process by interaction with 
the SNARE apparatus; (4) Facilitate the ion transport component of the exocytosis 
process. CLCA protein may also have a role in increasing net ion/fluid transport 
(increasing chloride conductance and decreasing sodium absorption) to the inflamed 





absorption to a secretory phenotype. This is accomplished by decreasing sodium 
absorption and increasing apical chloride conductance. It is hypothesized that 
inflammation may trigger this phenotypic switch as an evolved response to flush 
particulate and secreted mucus out of the airway. An excellent model for this strategy 
exists in pseudohypoaldosteronism, where increasing the secretion by decreasing 
absorption significantly increases the rate of mucociliary clearance (Kerem, Bistritzer et 
al. 1999; Bistritzer, Kerem et al. 2002; Danahay, Atherton et al. 2002).  
 A functional increase in calcium-activated chloride conductance has been 
reported in airway hyper-responsiveness (AHR). The pharmacologic sensitivity of this 
induced chloride conductance is similar to that reported for CLCA-stimulated 
conductance (Danahay, Atherton et al. 2002; Atherton, Mesher et al. 2003). There is no 
direct evidence connecting CLCA induction with the Th2 cytokine-mediated increase in 
Ca2+-activated chloride conductance, but CLCA could have a dual function to connect 
and co-ordinate these two events.  Increases in epithelial mucus production generate a 
need to increase the clearance of the mucus through increased local fluid secretion from 
the epithelium.  
 If CLCA proteins can modulate Ca2+-activated chloride channels, then an 
increase in Ca2+-activated chloride conductance should accompany the induction of 
increased CLCA expression by inflammatory mediators. Linkages between CLCA 
protein and mucus secretion are less clear. It is obvious from previous studies that 
inhibiting CLCA expression inhibits mucus production (Nakanishi, Morita et al. 2001). 
The identification of mCLCA3 expression in mucin granules membranes of the 
respiratory and gastrointestinal tract implicates this protein in mucin storage or release 
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(Leverkoehne and Gruber 2002). It was suggested that mCLCA3 is needed for mucin 
maturation. Negatively charged mucus glycoproteins require strong acidification for 
mucin condensation in the granules. Granule acidification could occur via a H+-ATPase 
with electroneutrality maintained by a parallel CLCA-modulated chloride conductance 
(Verdugo 1991; Espinosa, Noe et al. 2002; Leverkoehne and Gruber 2002; Thevenod 
2002). Potassium release and Ca2+ entry into the vesicles may also be important in the 
condensation process (Espinosa, Noe et al. 2002; Thevenod 2002).  
 CLCA proteins could also participate in mucus secretion by promoting 
rehydration of condensed mucins or by connecting mucin granule docking proteins with 
the proteins of exocytosis. Upon stimulation, the mucin granules dock and fuse with the 
plasma membrane though a process involving two classes of Ca2+-dependent and 
independent docking fusion proteins called the soluble N-ethylmaleimide-sensitive 
factor attachment protein (SNARE). The V-SNARE (synaptobrevin) proteins are on the 
vesicle and T-SNARE (syntaxin and SNAP-25) proteins on the plasma membrane 
(McNew, Parlati et al. 2000; Parlati, McNew et al. 2000). Families of V- and T- 
SNAREs share motifs for binding interactions, allowing appropriate fusion to the 
correct membrane (Li, Low et al. 2002; Weimbs, Low et al. 2003). SNARE machinery 
permits fusing granules to form a pore through the cytoplasmic membrane. The mucin 
is released through this pore upon its rehydration by influx of extracellular solution 
through the pore, as well as by controlled ionic flux through granule membrane from 
the cytosol (Thevenod 2002). CLCA protein could mediate the ion transport required 
for mucin rehydration through the vesicle membrane during exocytosis (Figure 1.4.).  
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 If modulation of chloride conductance by CLCA proteins is involved in mucin 
secretion, then inhibition of chloride conductance could be an interesting anti-asthma 
strategy.   Zhou et al. have shown that putative inhibitors of the chloride conductance 
associated with CLCA protein expression can inhibit mucus secretion (Zhou, Shapiro et 
al. 2002). However, on closer examination, the putative inhibitors were found to inhibit 
calcium entry into the epithelial cells, independent of a chloride channel blockage effect 
(Bertrand, Danahay et al. 2003). It was determined that the mechanism for niflumic acid 
interference with mucin exocytosis involved blocking Ca2+ entry, rather than chloride 
conductance.  Calcium ion entry is central to the process of mucin exocytosis, triggering 
activation of the SNARE complex (Bertrand, Danahay et al. 2003). Unfortunately this 
finding does not clarify the role for CLCA protein in the regulatory mechanisms for 
mucin secretion. The answer to this puzzle may lie in a better understanding of the 
ability of CLCA proteins to modulate chloride channel activity.  
 
1.6.2. CLCA - Role in Cystic Fibrosis  
 Cystic fibrosis disease affects most if not all secretory epithelial tissues in the 
body. The fundamental cause of this disease is dysregulation of epithelial ion transport 
(Matsui, Grubb et al. 1998; Matsui, Davis et al. 2000). CLCA expression in secretory 
epithelial cells and its function as a modulator of chloride conductance makes it a 
secondary focal point, after CFTR, in investigating possible compensatory mechanisms 
for defective epithelial ion transport. (Gaspar, Racette et al. 2000; Loewen, Bekar et al. 
2002; Loewen, Gabriel et al. 2002; Loewen, Smith et al. 2003; Loewen, Bekar et al. 
2004). 
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1.6.2.1. CLCA in the Normal Epithelium 
 In a normal epithelium the electrical driving force for the chloride ion transport 
that is modulated by CLCA proteins comes from coupling the hydrolysis of ATP to the 
inward transport of 2 K+ ions and the outward transport of 3 Na+ ions by the basolateral 
3Na+/2K+ ATPase, (Kirk, Halm et al. 1980; Klaassen and Depont 1994; Lewis 1996). 
This vectoral cation transport results in an inwardly-directed Na+ concentration gradient 
that drives the electroneutral entry of Na+, K+ and Cl- into the cell through the 
basolaterally-located Na+-K+-2Cl- cotransporter (O'Grady, Musch et al. 1986; O'Grady, 
Palfrey et al. 1987). The charge separation provided by the stoichiometry of the 
3Na+/2K+ ATPase and the basolateral K+ conductance lowers the resting membrane 
potential, creating a driving force for chloride to exit the epithelial cell through CLCA- 
modulated anion conductance channels in the apical membrane (Lewis 1996; Cotton 
2000; Loewen, MacDonald et al. 2000; Loewen, Bekar et al. 2002; Loewen, Gabriel et 
al. 2002; Loewen, Smith et al. 2003; Loewen, Bekar et al. 2004). Sodium follows 
paracellularly to maintain electrical neutrality, resulting in a secretory epithelium. 
However, a decrease or loss of the apical chloride conductance can cause sodium to be 
drawn back into the cell by the electro-chemical gradient created by the 3Na+/2K+ 
ATPase, making the epithelium absorptive. Chloride then follows the sodium 






1.6.2.2. CLCA in the Diseased CF Epithelium 
 The CLCA orthologues have  a modulatory role on the normal transepithelial 
sodium chloride transport which is defective in the genetic disease of cystic fibrosis 
(Matsui, Grubb et al. 1998; Loewen, MacDonald et al. 2000; Matsui, Davis et al. 2000; 
Loewen, Bekar et al. 2002; Loewen, Gabriel et al. 2002; Loewen, Smith et al. 2003; 
Loewen, Bekar et al. 2004).  The genetic abnormality in transport is caused by a 
mutation in the cystic fibrosis conductance regulator (CFTR). CFTR has two major 
functions relevant to the status of fluid movement across secretory epithelia (Figure 
1.5.). It is the major apical chloride transporting channel of epithelium and it down-
regulates the activity of the apical absorptive sodium channel in epithelium (ENaC) 
(Kunzelmann, Kathofer et al. 1995; Stutts, Canessa et al. 1995). The commonest 
mutation in CFTR causing clinical disease involves the deletion of the codon specifying 
a phenylalanine residue at position 508 (F508) (Kerem, Rommens et al. 1989; Riordan, 
Rommens et al. 1989).  CFTR molecules lacking residue F508 can function normally, 
but their transport through the normal maturation pathway of the ER and Golgi is 
interrupted, and very little  F508 CFTR protein is found in the cytoplasmic membrane 
(Cheng, Gregory et al. 1990). Diminished numbers of CFTR molecules at the apical 
membrane of secretory tracheal epithelial cells decreases the production of airway 
surface liquid (ASL), the thin film of fluid covering the luminal aspect of airway 
epithelial cells (Matsui, Grubb et al. 1998). This lack of CFTR also indirectly increases 
salt and fluid absorption via the loss of normal negative effects of CFTR on sodium 
absorption by ENaC.  The resulting reductions in the ASL volume (Cotton, Stutts et al. 
1987; Matsui, Grubb et al. 1998) increase the viscosity of airway mucus, decrease 
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mucocilliary clearance, and favor bacterial colonization of the mucosal surface (Lyczak, 
Cannon et al. 2002; Pier 2002).  
 It has been suggested that activation of an alternative chloride channel in the 
apical membrane of CF epithelium could compensate for the lack of CFTR. It is very 
likely that CLCA would have a modulatory effect on such an alternative channel given 
its effects on both cAMP and Ca2+-activated chloride conductance (Gruber, Elble et al. 
1998; Loewen, Bekar et al. 2002; Loewen, Gabriel et al. 2002; Loewen, Smith et al. 
2003; Loewen, Bekar et al. 2004). This situation may occur in the CFTR knockout 
mouse where up-regulation of a Ca2+-activated chloride channel appears to protect 
against lung pathology (Snouwaert, Brigman et al. 1992; Grubb, Vick et al. 1994; 
Gabriel, Makhlina et al. 2000; Thomas, Gabriel et al. 2000; Tarran, Loewen et al. 
2002).  This Ca2+-activated chloride channel is also found in human CF patients, but it 
lacks sufficient activity to maintain normal ASL hydration and prevent disease 
(Boucher, Cheng et al. 1989) (Willumsen and Boucher 1989; Anderson and Welsh 
1991). Activation of this channel through purinergic receptors has been explored as a 
potential therapy for CF patients (Clarke and Boucher 1992; Yerxa, Sabater et al. 2002). 
However, activation of a Ca2+-dependent chloride conductance does not replace the 
inhibitory effects of CFTR on ENaC, and persistent sodium absorption continues to 
contribute to ASL dehydration and potential airway pathology (Cotton, Stutts et al. 
1987; Matsui, Grubb et al. 1998). The role of CLCA proteins in cystic fibrosis disease is 
unclear. Both hCLCA1 and Ca2+-activated chloride conductance have been shown to be 
increased in the CF airway (Boucher, Cheng et al. 1989; Willumsen and Boucher 1989; 


















Figure1.5. Possible roles by which a CLCA protein (pCLCA1) could contribute to 
epithelial ion transport in the CF patient.  Modulation of apical chloride conductance by 
CLCA protein interactions may have beneficial effects on ion transport in the CF 
patient. Beneficial mechanisms would occur through increasing the activity of CaCC or 






Enhanced CLCA activity could have beneficial effects by interacting with other 
proteins to increase apical chloride conductance, and reduce the net absorptive flux, if 
not actually switching the diseased epithelium to a net secretory state. This could be an 
effective strategy, as CLCA proteins have been shown to significantly increase both 
endogenous Ca2+-activated and cAMP-activated chloride conductance (Loewen, Gabriel 
et al. 2002; Loewen, Bekar et al. 2004) (Figure 1.5). 
 However, the involvement of hCLCA1 in mucus secretion must be considered 
when contemplating attempts to upregulate CLCA activity in CF patients. It is even 
possible that elevations in hCLCA1 expression in CF patients could be detrimental by 
contributing to mucus over-production and airway obstruction. Parallels have been 
drawn between elevated levels of hCLCA1 expression in AHR in asthmatic patients and 
significantly increased hCLCA1 levels associated with the inflammatory processes of 
CF (Hauber, Manoukian et al. 2003).  Agents such as niflumic acid that were thought to 
inhibit hCLCA1 conductance may be clinically beneficial through reduction of mucus 
production (Karkanis, DeYoung et al. 2003).  Future efforts should be directed toward 
dissecting out desired effects of CLCA proteins on net fluid secretion from less 
appropriate stimulation of mucus secretion, since the effects of niflumic acid may not be 
mediated through inhibition of the chloride conductance of hCLCA1 (Bertrand, 
Danahay et al. 2003).  However, it is also possible that an obligatory linkage between 
the modulation of chloride conductance by CLCA proteins and stimulatory effects of 
CLCA proteins on mucus secretion may be so close as to render CLCA useless as 




1.6.3 Oncologic Importance of CLCA 
 Orthologues of the CLCA gene family have been shown to play two seemingly 
contradictory roles in cancer metastasis. Within the transformed cell, CLCA functions 
as a tumor suppressor, likely through its modulation of ion transport. Expression of 
CLCA protein is usually lost in tumor cell lines (Gruber and Pauli 1999c; Elble and 
Pauli 2001; Li, Cowell et al. 2004). However, tumor cells which have lost CLCA 
expression then bind endothelial-expressed CLCA via a novel endothelial CLCA/β4 
tumor cell adhesion which results in intravascular metastatic arrest and a mitogenic 
signal for intravascular tumor growth followed by tissue invasion(Zhu and Pauli 1991; 
Zhu, Cheng et al. 1992; Zhu and Pauli 1993; Abdel-Ghany, Cheng et al. 2001; Abdel-
Ghany, Cheng et al. 2002; Abdel-Ghany, Cheng et al. 2003). 
 
1.6.3.1. CLCA Tumor Supressor 
1.6.3.1.1. CLCA Tumor Suppressor is Lost in Tumorigenic Cell Lines 
 One piece of evidence that CLCA has tumor suppressor properties is its loss in 
tumorigenic cell lines (Gruber and Pauli 1999c; Elble and Pauli 2001; Li, Cowell et al. 
2004). Two studies from the same group have shown that CLCA2 (mCLCA2 or 
hCLCA2) expression has a significant impact on in vivo and in vitro growth of tumor 
cells (Gruber and Pauli 1999c; Elble and Pauli 2001). An initial study demonstrated 
non-tumorigenic breast epithelial cells (MCF10 A and MDA-MB-453) expressed 
hCLCA2. Transformed tumorigenic cells lines (MDA-MB-231, MDA-MB-435, MDA-
MB 468 and MCF7) however did not (Gruber and Pauli 1999c). This lack of hCLCA2 
expression was not caused by a genomic deletion. PCR amplification confirmed the 
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presence of the promoter region and the CLCA2 gene in the chromosomal region 1p22 -
31 to which the CLCA gene family has been mapped. This loss of CLCA2 expression in 
tumorgenic cell lines was due to transcriptional down-regulation of the gene or 
abnormal RNA processing (Gruber and Pauli 1999c; Li, Cowell et al. 2004). 
Intron/exon junction information in mCLCA2 transcripts was used to identify PCR  
products of mCLCA2 cDNA from JC and CSML-0  adenocarcinoma cell lines as splice 
variants rather than genomic deletions (Elble and Pauli 2001). However, mCLCA1 is 
also normally expressed in mammary tissue, and mCLCA1 transcripts were not found 
in these tumor cells, suggesting disrupted expression at the promoter level in the tumor 
(Elble and Pauli 2001; Li, Cowell et al. 2004).  
 Cell migration through 8 µm pore polycarbonate membranes of a chemotaxis 
chamber measures potential cell invasiveness. Reintroducing CLCA2 into these 
tumorigenic cell lines significantly reduced migratory ability in MDA-MB-435 cells, a 
line with low migratory ability, but only slightly reduced it in MDA-MB-231 a cell line 
with high migratory ability. Both transfected cell lines had significantly reduced in vitro 
invasion through a film of Matrigel in a chemotaxis chamber (Gruber and Pauli 1999c). 
CLCA2 expression did not change growth rate or anchorage-independent growth of 
these cells in soft and hard agar. Transfection of MDA-MB1-231 cells with a vector 
expressing mCLCA2 significantly reduced the number of animals with tumors, and 
reduced tumor size in subcutaneously injected nude mice when compared to control 
MDA-MB-231 inoculates (Gruber and Pauli 1999c). Similarly, mice receiving 
intravenous MDA-MB-231 cells transfected with CLCA2 had no tumors or 
significantly fewer tumors in their lungs when compared with mice receiving MDA-
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MB-231 control cells which usually died within 8 weeks. Unfortunately, in vitro 
decreases in invasiveness and migration as indicators of tumor transformation/metastic 
potential, without changes in growth rate or anchorage-independent growth, do not 
totally account for the loss of tumorigenicity in this study.  An undetermined phenotypic 
effect of CLCA in relation of cell differentiation still needs to be defined.  
 Subsequent studies by an independent group confirmed the relationship between 
loss of hCLCA2 expression and tumorigenicity, and the authors provide titillating 
evidence that hCLCA2 is the product of the hitherto unidentified 1p31 breast cancer 
tumor suppressor gene.  They identified hypermethylation of the CLCA promoter 
region to be the major mechanism for loss to expression of CLCA in tumorgenic cells 
(Li, Cowell et al. 2004).   
 
1.6.3.1.2. CLCA and Cell Cycle Tumor Suppression 
 The mechanism of CLCA tumor suppressive effects have not been fully worked 
out. However, there is a growing body of evidence showing that the activity of both 
anion channels which are modulated by CLCA, and independent cation channels have a 
significant impact on cell cycle control(Kim, Kang et al. 1999; Wohlrab and Markwardt 
1999; Malhi, Irani et al. 2000; Loewen, Bekar et al. 2002; Loewen, Gabriel et al. 2002; 
Kim, Kang et al. 2003). Blockage of potassium conductance in a variety of cell types 
results in reduced cellular proliferation and synchronization at G0/G1 of the cell cycle 
(DeCoursey, Chandy et al. 1984; Nilius and Wohlrab 1992; Woodfork, Wonderlin et al. 
1995; Wang, Melkoumian et al. 1998; Wohlrab and Markwardt 1999; Malhi, Irani et al. 
2000).  Decreasing chloride conductance causes the opposite effect, increasing cell 
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proliferation and protecting from apoptotic death (Deane and Mannie 1992; Wilson and 
Chiu 1993; Wohlrab and Markwardt 1999; Kim, Kang et al. 2003). The cell cycle-
specific chloride current was found to be highest during G1 and lowest during S phase 
(Villaz, Cinniger et al. 1995; Ullrich and Sontheimer 1997). If stimulatory effects of 
CLCA on chloride conductance contribute to these currents, then CLCA expression or 
activity could be significantly down-regulated in tumorgenic cell lines, and activation of 
this channel modulator could be a novel strategic approach to suppressing growth of 
transformed cells (Gruber and Pauli 1999c; Kim, Kang et al. 1999; Elble and Pauli 
2001; Kim, Kang et al. 2003).  
 
1.6.3.1.3. CLCA Over-Expression May Affect Cell Cycle 
 Aberrant cell morphology found with mCLCA2 over-expression has been 
interpreted as strong supporting evidence for CLCA modulation of cell cycle. The over-
expressing cells tended to be larger and multinucleated (Elble and Pauli 2001).  It is 
interesting that previous studies did not reveal this morphology problem, but the level of 
expression of the mCLCA2 protein may be important.  The morphological differences 
could be a consequence of abnormalities in cell cycle control (Elble and Pauli 2001). If 
inappropriate amounts or timing of CLCA expression affect chloride channel activity it 
could disrupt the intricate depolarization and polarization accompanying the cell cycle. 
Any resulting blockage at one specific point in the cell cycle could cause abnormal 
morphology. Multinuclear giant cells are associated with the disruption of many cellular 
pathways leading to arrest at various points in the cell cycle (Murray 1994). However, 
specific cell cycle studies have not yet been done.   
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1.6.3.1.4. CLCA Proapoptoic Tumor Supression 
 CLCA2 could be suppressing tumor growth through proapoptotic effects 
(Gruber and Pauli 1999c). CLCA2 expression could create a permissive environment or 
tip the balance towards apoptosis if cells receive the correct signal.  This would explain 
the absence in changes in growth rate or anchorage-independent growth in culture 
conditions where the cellular environment did not favor apoptosis. This hypothesis was 
illustrated by a study which found that transfection of the mammary epithelial cell line 
HC11 with mCLCA2 significantly increased the rate of apoptosis when subjected to 
serum starvation compared to a control cell (Elble and Pauli 2001).  Additionally, if the 
HC11 cell line which is not normally tumorgenic is selected for resistance to 
detachment-induced apoptosis (anoikis), mCLCA1 message was lost and mCLCA2 was 
assumed to be aberrantly spliced and not functional. These cells are then tumorigenic 
when injected into mice (Elble and Pauli 2001).  It was also interesting that cells 
transfected with mCLCA1 or mCLCA2 and selected by resistance to Zeocin all died 
within a four-week period (Elble and Pauli 2001). However, this slow growth and death 
was not found in the original study of stable transfectants selected and maintained with 
G418 (Gruber and Pauli 1999c). This difference may be due to the distinct mechanisms 
of the selective drugs. Zeocin is an antibiotic in the bleomycin family. It causes cell 
death by intercalating into, and cleaving, DNA (Ghosh, Mendoza et al. 2002; Mekid, 
Tounekti et al. 2003). This type of stress activates the p53 apoptotic pathway and, at 
higher doses, independent pathways. G418 or Geneticin binds to the 80S ribosome and 
prevents protein synthesis in eukaryotic cells without directly inducing apoptosis.  This 
means that Zeocin-selected, but not G418-selected cells, are always fighting apoptosis. 
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Combining this stress with proapoptotic effects of hCLCA2 could account for poor 
growth and increased apoptosis seen with Zeocin and not G418.  
 
1.6.3.1.5. CLCA's Proapoptotic Mechansim 
 This information brings up an important question.  How do the effects of CLCA 
protein on anion conduction result in proapoptotic responses?  A number of reports 
have shown that blockage of chloride conductance increases cell proliferation and 
confers protection from apoptotic death (Gottlieb and Dosanjh 1996; Szabo, Lepple-
Wienhues et al. 1998; Wohlrab and Markwardt 1999; Kim, Kang et al. 2003). 
Generally, there is an influx of calcium in the initial stages of apoptosis which activates 
both potassium and chloride channels (Orrenius, Zhivotovsky et al. 2003). One possible 
apoptotic scenario would have increasing potassium conductance hyperpolarizing the 
cell, increasing the driving force for anion conductance through the already open 
calcium-activated chloride channel. Then intracellular pH could be lowered by 
bicarbonate exiting through the anion conducting channel. A reduction in the 
intracellular pH would increase the activity of caspase 3, cause destruction of DNA and 
trigger an apoptotic cascade (Segal and Beem 2001).  Expression of CLCA could 
activate anion conductance to stimulate the exit of bicarbonate or chloride, resulting in a 






1.6.3.2. CLCA in Metastasis 
1.6.3.2.1. CLCA is a Cell Adhesion Molecule for Lung Tumor Metastasis 
 The bCLCA2 (Lu-ECAM-1) orthologue was originally cloned with an antibody 
which blocked the adhesion-receptor/ligand pair that mediates binding of lung 
metastatic melanoma cells to bovine aortic endothelial cells (Zhu, Cheng et al. 1991; 
Zhu and Pauli 1993; Goetz, el-Sabban et al. 1996; Elble, Widom et al. 1997). The 
origins of this clone led to the hypothesis that CLCA was the molecular identity of the 
endothelial adhesion molecule to which spreading hematogenous tumor cells bound,  
resulting in vascular arrest before tumor growth and invasion. Studies involving human 
tissue identified hCLCA2 as the human counterpart to the original bCLCA2  (Lu-
ECAM-1) clone (Abdel-Ghany, Cheng et al. 2001) Like bCLCA2, hCLCA2 is 
expressed by endothelial cells from different lung vascular compartments (Zhu and 
Pauli 1991; Abdel-Ghany, Cheng et al. 2001).  This expression was found to be 
paramount for the establishment and colonization of human breast cancer cell lines 
(Abdel-Ghany, Cheng et al. 2001).  
 
1.6.3.2.2. CLCA Binds Only Lung Colonizing Tumorigenic Cell Lines in vitro.  
 Only hematogenous lung colonizing tumorigenic cells where able to bind to 
HEK293-hCLCA2 expressing cell lines (Abdel-Ghany, Cheng et al. 2001). The MDA-
MB-231 cell line, which colonizes the lungs of nude mice following intravenous 
injection, would bind at a 75% efficiency to a hCLCA2 expressing monolayer of HEK 
293 cells (Abdel-Ghany, Cheng et al. 2001) 
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 Cell lines such as MBA-MB-435 which only form metastases after orthotopic 
tumor xenografts and are unable to form metastasis on IV injection, or MCF 7 cell lines 
which are not tumorigenic only bound at ~ 4 and 7 % respectively to HEK 293 
hCLCA2 expressing monolayers (Abdel-Ghany, Cheng et al. 2001). This evidence 
suggests that hematogenous metastastsis and lung colonization is dependent on the 
ability of the tumor cell line to bind to CLCA. 
 
1.6.3.2.3. CLCA Binds to β4 integrin in Tumorigenic Cell Lines 
 The nature of the ligand in the tumorigenic cell lines that binds to CLCA 
proteins was determined using hCLCA2-myc constructs expressed in HEK 293 cells.  
MDA-MB-231 cells were biotinylated, then bound to hCLCA2-myc expressing 
HEK293 cells. The bound cells were harvested together and immunoprecipitated with 
anti-myc antibody. Anti-streptavidin-HRP identified a single band of 205 kDa on 
Western blotting. Subsequent probing with specific antibodies identified the 
immunoprecipitated band as β4 integrin, and confirmed that it had indeed co-
precipitated with hCLCA2 (Abdel-Ghany, Cheng et al. 2001).  
 The direct binding of hCLCA2 to β4 integrin was also demonstrated in a far 
Western blot of the β4 integrin cell lysate with myc-hCLCA2 construct and anti-myc 
antibodies (Abdel-Ghany, Cheng et al. 2001). 
 
1.6.3.2.4 β4 integrin Expression Correlates With CLCA Binding and Metastasis in 
Tumorigenic Cell lines  
 In further studies involving additional cancer cells lines which expressed 
different levels of β4 integrin, there was a strong correlation between the level of β4 
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integrin expression and the adhesion of HEK 293 cells expressing hCLCA2. A similar 
correlation was observed in vivo between β4 integrin expression in tumorigenic cell 
lines, and the number of lung metastases observed in nude mice given the different 
cells.  
 Similarly, in syngeneic animals using integrin Kirsten-Ras-transformed 
Balb/3T3 oncogenic cell line with induced over-expression of β4 integrin, there was an 
increase in adhesion of these cells to mCLCA1 as well as an increase in the number of 
metastatic colonies in the lung found on induction. It should be noted that location of 
the metastases is consistent with reported sites of mCLCA1 expression in the mouse. 
This result provides more evidence that β4 integrin binding to CLCA is important for 
hematogenous metastasis.  
 Antibodies to either β4 integrin or hCLCA2 were able to inhibit binding of the 
hCLCA2-expressing HEK 293 cells to the MDA-MB-231 cell line. The binding to 
hCLCA2 expressing cells was found to be specific for β4 integrin, as antibodies directed 
to other integrins did not affect binding. Additionally, specific cleavage of β4 integrin 
on the cell surface with matrilysin greatly reduced binding. The importance of the 
interaction between the two proteins in hematogenous metastasis was confirmed by 
using antibodies to hCLCA2 and β4 integrin injected concurrently in the nude mouse 
model.  This treatment greatly reduced lung metastases by 84 % and 100 %.  The ability 
of  hCLCA2 and β4 integrin to interact in a far Western blot, as well as inactivation of 
the binding process with cleavage of β4 subunit indicates that the associated α6 integrin 
subunit, which β4 usually associates with in vivo to bind to laminin, is not needed for 
this binding interaction process to occur (Abdel-Ghany, Cheng et al. 2001).  
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1.6.3.2.5. CLCA / β4 Integrin Binding Not Sufficient for Tumorigenesis in Non-
tumorigenic Cell lines 
 Although CLCA/β4 integrin binding is need for lung metastasis to occur, there 
are undefined molecular events which must be in place before tumorigensis can occur 
(Abdel-Ghany, Cheng et al. 2001). Cell lines which are not tumorigenic and were 
selected for β4 expression or transfected with β4 had increased binding to CLCA but did 
not result in increased lung colonization (Abdel-Ghany, Cheng et al. 2001).  
 Specifically, the MDA-MB-435 cell line has a low level of endogenous β4 
integrin expression.  When this cell line was transfected to overexpress β4 integrin, the 
adhesion of the cells to hCLCA2 was increased compared to the untransfected cells.  
The adhesion levels in the over-expressing MDA-MB-435 cell line were similar  to 
those in the MDA-MB-435 L2 line which was selected for over expression of β4 
integrin (Abdel-Ghany, Cheng et al. 2001).  Interestingly, the over-expression of β4 
integrin in MDA-MB-435 cells increased adhesion to hCLCA2 in vitro, but did not 
cause increased lung colonization. This was unlike the correlative data obtained from 
metastatic cell lines whose colonizing abilities increase with the level of β4 integrin. The 
authors attributed this discrepancy to the over-expressed β4 integrin interacting with an 
intrinsic protein that would affect metastasis but not in vitro adhesion to hCLCA2 
(Abdel-Ghany, Cheng et al. 2001).  
. There is additional evidence that overexpression of β4 integrin may be 
necessary, but not sufficient for metastasis. This is seen with β4 integrin over-expression 
in the metastatically incompetent MDA-MB-468 cell line. This cell line had a relatively 
normal growth phenotype in vitro, and a slow adenomatous growth in vivo.  Moderate 
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levels of β4 expression in this cell line did not correlate with a lack of in vivo metastases 
for these cells.  Apparently, β4 integrin effects on metastasis are somewhat cell-type 
dependent.  In general, β4 integrin expression leads to lung metatasis only in those 
cancer cells which have the genotype of over-expression combined with down-
regulation of the appropriate genes (Abdel-Ghany, Cheng et al. 2001). 
 It is possible that over-expressed β4 integrin in the non-tumorgenic cell line is 
interacting with an unidentified membrane protein. This suggestion is supported by 
evidence of β4 and α6 integrins co-immunoprecipitating from the metatastic MDA-MB-
231 cell line but not in the non-metastatic MDA-MB-435. When this cell line is 
transfected with, and over-expresses β4 integrin (MDA-MB-435 β4) it was found to 
have an increased adherence to hCLCA2 in vivo, but is unable to produce metastatic 
long colonies. Failure to co-immunoprecipitate β4 and α6 integrins may be the result of 
the β4 integrin interacting with something other than its normal α6 counterpart in the 
MDA-MB-435 β4 cells. The unidentified protein could then exert a dominant negative 
effect on metastasis. It appears that the  β4 integrin is needed for binding to 
endothelium, and that the interactions between the α6 and β4 pair are required to 
promote metastasis (Abdel-Ghany, Cheng et al. 2001). Nonetheless, other groups have 
found that the β4 integrin is central to increasing lung metastic performance and cDNA 
arrays have shown a definitive increase in  β4 integrin with increased metastatic 




1.6.3.2.6. CLCA binds to β4 Integrin Binding Though a Specific Domain  
 CLCA interaction with the β4 integrin is mediated through a specific binding 
domain that favors the association of these proteins. β4 integrin-binding motifs are 
present in both the 90 and 35 kDa subunits in most CLCA family members (Abdel-
Ghany, Cheng et al. 2003). These binding domains belong to the addressins, which are 
distinct vascular addresses used by both immune and blood borne cancer cells to 
colonize specific organs (Ruoslahti and Rajotte 2000). It is believed that cell binding in 
lung metastatic cancer is particularly mediated through binding of the β4 integrin to the 
CLCA addressin (Abdel-Ghany, Cheng et al. 2003).  
 The binding motifs in the CLCA for the β4 integrin protein have been identified 
and functionally demonstrated in both 90 and 35 kDa products of CLCA processing 
(Abdel-Ghany, Cheng et al. 2003).  This was accomplished using a series of 
polypeptides encompassing the length of both the 90 kDa as well as the 35 kDa product. 
Antibodies which blocked β4/CLCA adhesion were used to immunoprecipitate 
polypeptide fragments containing the potential binding motifs. These polypeptides were 
then used to coat microtitre plates and the binding of the β4 integrin/metastatic cell line 
MDA-MB-231 cell was assessed. These assays generally identified an area which 
would be in the second extracellular domain of hCLCA2, bCLCA2 and mCLCA1, as 
defined by the proposed current topographical models (Gandhi, Elble et al. 1998; 
Gruber, Schreur et al. 1999). A computer-aided motif search found sequences at amino 
acids 479 to 488 in hCLCA2 which could account for the binding activity occurring in 
the 90 kDa fragment. A second binding motif was found at amino acids 740 to 749 in 
the 35 kDa segment (Abdel-Ghany, Cheng et al. 2003).  Similar binding domains were 
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found in bCLCA2 and mCLCA1. F(S/N)R(I/L/V)(S/T)S is the general consensus 
sequence for the binding (Abdel-Ghany, Cheng et al. 2003). Both the 90 kDa and the 35 
kDa motifs bound specifically to the β4 integrin when expressed and purified, but not to 
β1, β3, fibronectin or BSA in ELISA and "pull-down assays". Adhesion was found to 
increase with concentration of ligand and was Mn2+ but not Mg2+ or Ca2+-dependent.  
These purified binding motifs were also able to bind to lung-metastatic MDA-MB-231 
cancer cells.  Incubation of tumorigenic cells with purified binding motifs was found to 
significantly block lung colonization after intravenous injection of these cells into 
SCID/ beige mice and prevent binding (Abdel-Ghany, Cheng et al. 2003). 
 The β4 integrin binding domain in hCLCA2 is not conserved in the hCLCA1 90 
kDa segment, but is present in the hCLCA1 35 kDa segment. The sequence disruption 
in the 90 kDa  was caused by the substitution of amino acids G473 A474 for SR 
resulting in the sequence FGALSS which lacks β4 integrin binding activity (Abdel-
Ghany, Cheng et al. 2003) (Abdel-Ghany, Cheng et al. 2003). Both β4 integrin binding 
motifs are disrupted in pCLCA1 and mCLCA3 (Gob-5).  The corresponding pCLCA1 
90 kDa sequence is identical to that in hCLCA1 (FGALSS) and the 35kDa change is 
(FSRTAS). The mCLCA3 90 kDa 4 integrin binding domain region is changed to 
(FAALSS) and the 35kDa sequence is (FSRT(deletion)SS). The lack of conservation of 
these binding domains among major CLCA orthologues may be an indicator of 
significant functional divergence within the CLCA protein family (Figure 1.6). 
 As previously observed, there are two alternative models for the membrane 


















Figure 1.6. Mitogenic signal cascade induced by endothelial CLCA binding to β4 
integrin on metastatic cell. Note the absence of phosphorylation of the β4 cytoplasmic 
tail and the dependence on FAK and Src for initiation of the signal transduction 
cascade. In addition, note the absence of activation of the PI3K pathway 
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transmembrane domains, where the 90 kDa β4 binding domain would be located on an 
extracellular loop between TM2 and TM3. However, theoretical modeling based on 
integrin structure predicts a large extracellular von Willebrand's Factor A (VWA)-like 
domain in the hCLCA2 protein. If this VWA folding should occur, the 90 kDa β4 
binding motif would still be extracellular, but now it would be toward the C-terminal 
end of the folded VWFA domain. Hence the functional data arising from studies of 
CLCA protein binding to the the β4 integrin do not resolve the issue of the two 
conflicting topologies.   
 
1.6.3.2.7. Novel β4 integrin binding domain binds to CLCA 
 The binding of CLCA to the β4 integrin is mediated through a novel CLCA 
binding domain in the β4 integrin (Abdel-Ghany, Cheng et al. 2001; Abdel-Ghany, 
Cheng et al. 2003)  
 Binding to the specificity-determining loop (SDL) was predicted, as this is a 
non-conserved loop sequence that has been associated before with ligand binding 
(Puzon-McLaughlin and Takada 1996; Takagi, Kamata et al. 1997).  A short purified 
fusion protein, of β4 segments, corresponding to the predicted loop of β1 and β3 
integrins, found previously to be important in integrin binding, was constructed and 
tested to determine the binding domain (Takagi, Kamata et al. 1997). An area in the β4 
SDL sequence (amino acids 184-203) bound to CLCA in ELISA and pull-down assays. 
The same sequence from the β1 integrin did not bind. The relevance of the binding to 
hCLCA2 was confirmed by using the synthetic peptide sequence of the β4 loop to block 
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metastatic cell line adhesion of CLCA protein (Abdel-Ghany, Cheng et al. 2003) 
(Figure 1.6). 
 The binding of the β4 integrin to laminin-5 has been attributed to a binding site 
at the N terminus of the SDL loop as determined by point mutations K177A and Q182L 
(Tsuruta, Hopkinson et al. 2003). However, as described above, the β4 integrin to CLCA 
binding appears to involve the C terminal part of the SDL (Abdel-Ghany, Cheng et al. 
2003). Hence it is likely that laminin-5 and hCLCA2 interact with different SDL 
binding motifs. This difference in interaction may explain the difference in the 
mitogenic pathways activated by β4 integrin when binding to CLCA or laminin. 
 
1.6.3.2.8. Mitogenic Signaling of CLCA /β4 Integrin Binding 
 As previously discussed, the binding of β4 integrin to hCLCA2 is important for 
cell adhesion in the beginning stages of lung metastasis (Zhu, Cheng et al. 1992; Abdel-
Ghany, Cheng et al. 2001). Once adhered, the tumor can either extravasate early, 
resulting in immediate tissue invasion, or it can undergo extensive intravascular growth. 
Extensive intravascular growth results in the tumor cells coming to occupy the entire 
circumference of the vessel lumen. The vessel wall disintegrates and the tumor 
progresses into the adjacent tissue (Vaage and Harlos 1987; Lapis, Paku et al. 1988) 
(Vaage and Harlos 1987; Lapis, Paku et al. 1988). It is the β4 integrin/CLCA binding 
that provides the mitogenic stimulation important for intravascular growth (Abdel-
Ghany, Cheng et al. 2001; Abdel-Ghany, Cheng et al. 2002) (Figure 1.6).  
 The signal cascade which results in intravascular tumor growth from the β4 
integrin/CLCA binding has been investigated (Abdel-Ghany, Cheng et al. 2002). 
Possible mitogen signal cascades from the β4 integrin which have shown activation in 
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the past are the focal adhesion kinase (FAK), proline-rich tyrosine kinase-2 (Pyk2), and 
phosphatidylinositol 3 kinase (PI3K)(Schlaepfer, Hauck et al. 1999; Zhao and Guan 
2000; Mercurio, Rabinovitz et al. 2001). When β4-expressing B16-F10 cells are serum 
deprived and plated onto mCLCA1 coated dishes, only FAK was found to be 
significantly activated. A direct interaction was found between ligated mCLCA1/β4 
integrin and FAK, as FAK was only co-immunoprecipated with β4 integrin ligated to 
mCLCA1. This interaction was dependent on mCLCA1/β4 integrin ligation.  It was 
assumed that complex formation between FAK and β4 integrin results in the auto-
phosphorylation of FAK (Abdel-Ghany, Cheng et al. 2002) (Figure 1.6).  
 
1.6.3.2.9. A Novel β4 Mitogenic Signaling Pathway  
 A model for the role of β4 integrin in a mitogenic pathway has evolved over the 
past decade. Initial experiments revealed that laminin or antibody-induced ligation of 
the α6 β4 complex resulted in the Shc associating with a phosphotyrosine-containing β4 
subunit ( Figure1.7). The adaptor protein Shc is then phosphorylated, which recruits 
Grb2 and potentially activates the ras MAP kinase pathway, through the recruitment of 
SOS (Mainiero, Pepe et al. 1995; Tsuruta, Hopkinson et al. 2003). The binding of Shc 
to β4 also activates phosphoinositide-3-OH kinase (PI3K) through a yet undefined 
mechanism, which in turn activates Akt  kinase resulting in phosphorylation of Bad as 
well as activation of oncogenic transcription factors and cell survival (Shaw, Rabinovitz 
et al. 1997; Tang, Nie et al. 1999; Gambaletta, Marchetti et al. 2000; Trusolino, Bertotti 
et al. 2001; Chung, Bachelder et al. 2002).  Mutagenic studies of the  β4 cytoplasmic tail 
show that Shc preferentially bound to tyrosines 1440 and 1456 (Dans, Gagnoux-







Figure 1.7. Accepted mitogenic signal transduction pathway from β4 binding to laminin. 
Note the initial dependents of Met kinase and the direct phosphorylation of the β4 or the 
Erb-B2 activation of the cascade. Also note the activation of the PI3 K/Akt pathway for 
cell survival. Additionally, the presence of Shc and the absence of Src and FAK should 





binding is thought to be mediated in part through the Met tyrosine kinase of the receptor 
for the hepatocyte growth factor (HGF)(Trusolino, Bertotti et al. 2001).  Similarly, the 
ErbB-2 receptor oncogene was found to mediate its effects through binding with the 
cytoplasmic tail of the  4 integrin and activation of the PI3K(Gambaletta, Marchetti et 
al. 2000) ( Figure 1.7). Interestingly neither of these oncogenic effects required the 
extracellular domains of β4 subunit. Thus, the β4 subunit is acting more as a modulator 
of oncogenic signals. The events accompanying the initial phosphorylation during 
laminin or antibody binding of β4, and release of its own mitogenic cascade, is still 
uncertain.  
 In comparison to the activation pathway described above, the binding of CLCA 
to the β4 subunit is thought to initiate a novel signal transduction phosphorylation 
sequence (Figure 1.6). The CLCA-initiated cascade is described as Met, ErbB-2  
independent, and not requiring phosphorylation of the cytoplasmic tail or Shc binding 
domain of the  β4 subunit for downstream signaling (Abdel-Ghany, Cheng et al. 2002). 
In additional there is no activation of PI3K (Abdel-Ghany, Cheng et al. 2002)
 Instead, the CLCA pathway proceeds from CLCA binding with β4 integrin to the 
aggregation of Focal adhesion kinase (FAK) with the β4 cytoplasmic tail through a yet 
undetermined mechanism. The close association of FAK with β4 results in 
autophosphorylation at tyrosine 397, causing the binding of Src, protein tyrosine kinase 
which then phosphorylates FAK at tyrosine 925.  Phosphorylated FAK binds Grb2 and 
then recruits SOS, leading to the activation of the Ras-MAP kinase pathway involving 
extracellular signal-regulated kinase (ERK) (Abdel-Ghany, Cheng et al. 2002).  A 
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similar pathway has been described in astrocytoma cells and the transforming growth 
factor-β-inducible gene h3 (Kim, Yun et al. 2003).  
 In addition to FAK, downstream Src kinase and ERK were also found to be 
activated (Abdel-Ghany, Cheng et al. 2002). ERK reached maximum activation slightly 
after FAK. However Src was constitutively activated in the tumor cell line.  Antibodies 
which blocked the adhesion of mCLCA1 to β4 integrin also blocked FAK and ERK 
activation.  
 The activation of FAK by the mCLCA1/ β4 integrin complex was somewhat 
unique, as this activation was not seen when cells were grown on laminin which binds 
β4 integrin.  Transfection of the cell line with the dominant negative FAK (FANK) (a 
non-kinase FAK) blocked activation of ERK. Transfection with the wild type FAK 
significantly increased ERK activation upon ligation with mCLCA1 (Abdel-Ghany, 
Cheng et al. 2002).  
 The FAK-mediated activation of ERK was found to be Src dependent (Abdel-
Ghany, Cheng et al. 2002) as the dominate negative FAKY397F did not allow 
phosphorylation, and reduced complex formation between Src and FAK. Impairing Src 
binding also impaired Src phosphorylation of FAK for growth factor receptor-bound 
protein (Grb) binding. Antibodies directed against α-Grb co-immunoprecipitated FAK 
but not FAKY397F, indicating that the activated Src must bind the autophosphorylated 
FAK at 397 and phosphorylate Y925 to allow Grb2 binding which then allows 
activation of ERK (Abdel-Ghany, Cheng et al. 2002). 
 Briefly, the binding of Grb 2 allows the translocation of Son of Sevenless (SOS) 
to the membrane to increase the guanine nucleotide exchange of Ras (Rozakis-Adcock, 
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Fernley et al. 1993; Downward 1996). GTP Ras has increased activity and activates the 
downstream mitogen-activated protein kinase pathways (MAPK) or Raf/MEK/ERK 
(Alberola-Ila and Hernandez-Hoyos 2003; Smalley 2003). In the GTP-bound state, Ras 
interacts with and activates Raf which phosphorylates MEK which in turn 
phosphorylates ERK which goes on to phosphorylate a number of transcription factors, 
activating the cell cycle and causing proliferation.  
 It is interesting to note that both dominant negative cell lines of B16-F10 
melanoma cell produced as described above had greatly reduced lung metastatic 
potential (Abdel-Ghany, Cheng et al. 2002). This is evidence for the importance of 
CLCA contributions to this pathway of tumor metastasis. In addition, this CLCA-
activated pathway may also be important in those metastases that undergo extravasation 
before growth because the ERK activation can also induce the production of invasive 
products such as metalloproteinase, and even increase drug resistance (Alberola-Ila and 
Hernandez-Hoyos 2003).  
 
1.6.3.2.10. Tumor Invasion 
 Despite the activation of a cellular proliferation cascade there is little invasion 
into the actual organ until the vessel becomes filled with mammary tumor cells (Vaage 
and Harlos 1987; Lapis, Paku et al. 1988; Abdel-Ghany, Cheng et al. 2002). There 
almost seems to be a need to restrict some of the blood supply before tumor invasion 
occurs through the vasculature. It is also possible that β4/mCLCA1 interactions may 
activate an endothelial chloride conductance which, as indicated previously, could tip 
the endothelial cell wall towards apoptosis cascade. The tumor could invade by first 
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filling the vessel and restricting blood supply to the endothelium which in turn, becomes 
slightly hypoxic, dropping the intracellular pH. The β4/mCLCA1 could then participate 
in opening a channel to allow chloride entry, electrically balancing the hydrogen ion 
production and facilitating a rapid drop in intracellular pH (Figure 1.6). This pH drop 
would activate caspases and the apoptotic cascade (Brenner and Kroemer 2000; Segal 
and Beem 2001). The endothelial cells will die, and the tumor invades.  
 
1.6.4. Mammary Gland Involution  Different CLCA ortholgues are expressed at times 
times during the cycle of mammary gland development, lactation and involution. Most 
importantly this dynamic change is central for the the proper involution of the 
mammary gland.   
1.6.4.1. Lactation 
 During late stages of pregnancy, high levels of estrogen, progesterone, prolactin 
and growth hormone cause increased growth of stroma, ductal systems, lobules, 
budding of alveoli and development of secretory characteristics in the cells of the 
alveoli (Nandi 1958; Neville, McFadden et al. 2002). Although growth promoting, the 
inhibitory effects of estrogen and progesterone on actual lactation are lost at parturition. 
The developed mammary tissue is maintained with only the somatic sensory/neuronal 
hormonal reflex of lactogenic prolactin and oxytocin surges at the time of nursing 
(Neville, McFadden et al. 2002).   
 The tissue CLCA isoform expression pattern in the mouse mammary gland 
quickly switches from mCLCA1 to mCLCA2 expression if this somato-sensory nipple 
stimulation is not maintained (Lee, Ha et al. 1999; Elble and Pauli 2001; Leverkoehne, 
 80
Horstmeier et al. 2002).  This change in expression was used as the basis for obtaining 
the original mCLCA2 clone, which involved a suppressive subtractive process of 
lactating vs involuting mammary gland (Lee, Ha et al. 1999).  Further investigation 
revealed that mCLCA1 was expressed primarily during lactation and mCLCA2 was 
expressed during the first stage of involution (Elble and Pauli 2001). 
 
1.6.4.2. Involution  
 Mammary involution is generally divided into two phases (Lund, Romer et al. 
1996). The first phase encompass the first three days after nursing has stopped. This 
involves the engorgement of the gland with milk which accumulates in the lumen of the 
ducts, and initial apoptosis of epithelial cells (Lund, Romer et al. 1996). It is believed 
that the stasis of milk causes distention of the alveoli leading to restricted blood flow 
from the increased pressure, and mechanical stress that causes a mild hypoxia (Jerry, 
Dickinson et al. 2002; Stefanon, Colitti et al. 2002). Both reduced mammary blood flow 
and increased positive alveolar pressure measured in the initial phase are thought to 
induce apoptosis (Fleet and Peaker 1978). In the initial stage, at a cellular level, there is 
strong activation of p53 apoptotic pathways and other apopotic factors (Lund, Romer et 
al. 1996; Jerry, Dickinson et al. 2002).   
 
1.6.4.3. Involution and CLCA 
 It was found that mCLCA1 expression was lost in stage 1 of involution and 
mCLCA2 as induced at days 2 and 3 post-weaning. Expression of mCLCA2 then 
stopped on day 4, the beginning of the second phase of mammary involution, which 
involves the expression of stromal protease and the beginning of tissue remodeling 
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(Lund, Romer et al. 1996; Lee, Ha et al. 1999; Elble and Pauli 2001). The role which 
mCLCA1 and mCLCA2 play in the cycle of mammary development and involution is 
not fully understood.  
 The strong correlation between expression of mCLCA2 and the apoptotic 
intermediate Bax once again connects CLCA proteins to apoptotic tumor-suppressor 
activity. Studies from both serum-starved HC11 mammary tumor cell line and 
mammary tissue in the first stage of involution reveal an increase in expression of an 
apoptotic factor termed Bax (Elble and Pauli 2001; Jerry, Dickinson et al. 2002). The 
expression of Bax is usually, but not always upregulated by activated p53. Bax, in turn, 
stimulates the mitochondria to release cytochrome C which activate caspases-8 and -9.  
More caspase activation follows, causing selective destruction of cellular structure, 
organelles and genomic DNA (Brenner and Kroemer 2000).  Interestingly, the cell line 
used in this study was p53 independent, indicating multiple apoptotic pathways for the 
involution phase (Abdel-Ghany, Cheng et al. 2002). The normally oncogenic STAT3 
activation and its activation of leucine zipper CCAAT-enhancer binding protein (c/EBP 
delta) is an example of such multiple pathways in mammary gland apoptosis (Levy and 
Lee 2002; Kritikou, Sharkey et al. 2003) .   
 The factors that induce and maintain the apoptotic cascade through the initial 
phase of involution are not fully known. Many factors are involved and the CLCA 
proteins could play a role.  It has been suggested that mCLCA2 is a constitutively 
activated form of mCLCA1 specializing in stress response (Elble and Pauli 2001). As 
previously indicated, factors such as CLCA proteins that activate anion conductance 
may help to push a cell into apoptosis (Kim, Kang et al. 1999). Participation of anion 
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conductance in cytoplasmic acidification can be important for the activation of caspases 
even in the presence of cytochrome c (Segal and Beem 2001). 
 
1.6.4.4. CLCA's Possible Role in Milk Yield  
  Genetically selecting or pharmacologically manipulating CLCA ability to induce 
mammary gland apopotosis could have a significant impact on milk yield. During the 
normal cycle of lactation in the cow there is a gradual decline in mammary cell number 
occurring through a slight excess in the rate of apoptosis in relation to the production of 
new cells (Capuco, Wood et al. 2001). A similar situation is seen the goat, but not in the 
rat, where the decrease in milk yield through lactation is due to a reduced secretory 
capacity per cell (Knight, Docherty et al. 1984; Knight and Peaker 1984).   
 Thus, in the cow, an increased rate of cell replacement or decreased apoptosis 
during lactation may provide a means to increase persistency of lactation. Increasing 
cell replacement has shown to be a controversial yet economically viable option with 
the use of bovine somatotropin, which appears to increase the rate of cell renewal in the 
lactating mammary gland (Capuco, Wood et al. 2001; Baldi, Modina et al. 2002). 
However, decreasing the rate of apoptosis has not been a significant pharmacological 
target. Hydrocortisone was shown to inhibit involution, but it did not stop induction of 
the apoptotic cascade (Lund, Romer et al. 1996).   
 It is believed that the initial apoptotic cascade is induced locally by milk stasis 
within the alveoli (Jerry, Dickinson et al. 2002; Stefanon, Colitti et al. 2002). This is 
evident from the apoptotic changes in milked and non-milked glands on the same 
animal. It is then possible that part of the decline in lactation in the post-partum animal 
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may be due to induction of minor apoptosis via small periods of interruption in milk 
removal (Stefanon, Colitti et al. 2002). Thus, manipulation of CLCA2 function to 
decrease this minor apopotosis throughout lactation could have a significant impact in 
the total lactation yield of an animal. 
 
1.6.5. CLCA Vascular Tone and Pathologies  Orthologues of the CLCA gene family 
are expressed in vascular smooth muscle (Britton, Ohya et al. 2002; Elble, Ji et al. 2002; 
Leverkoehne, Horstmeier et al. 2002). CLCA has been shown to modulate Ca2+-
activated chloride conductance as well as interact with the subunits of the Ca2+-
activated potassium (BK) channel (Greenwood, Miller et al. 2002; Loewen, Gabriel et 
al. 2002; Loewen, Bekar et al. 2004).  Both Ca2+-activated chloride conductance and 
postassium conductance control vascular tone making a modulating protein such as 
CLCA a viable drug target in hypertension and erectile dysfunction.  
 
1.6.5.1. Hypertension  
 Hypertension or an increased vascular tone in humans is defined as the mean 
arterial blood pressure being greater than 110 mm Hg. This usually results from the 
diastolic pressure greater than 90 mm Hg and the systolic pressure greater than 140 mm 
Hg (WHO 1999; Chobanian, Bakris et al. 2003; Fagard and Van den Enden 2003). 
Sustained increases in vascular tone can be very detrimental. Increased blood pressure 
is known contribute to the development of congestive heart failure due to an increased 
workload on the heart, and small renal hemorrhage causing renal failure.  Hypertension 
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also predisposes to coronary artery disease and stroke (Chobanian, Bakris et al. 2003; 
Rashid, Leonardi-Bee et al. 2003).   
 Hypertension can result from, or be modulated through changes to the 
renin/angiotensin system (Chobanian, Bakris et al. 2003). The regulation of blood 
pressure begins with the rate of renal clearance of sodium by the glomerulus of the 
kidney.  Renal clearance of sodium determines the amount of chloride presented to the 
macula densa, which determines the rate of the Na+K+2Cl- co-transporter in the macula 
densa (Schlatter, Salomonsson et al. 1989). Upon a decrease in the rate of the 
Na+K+2Cl- co-transporter, the macula densa then signals the juxtaglomerular cells, via a 
cyclooxygenase-2 inhibited process, to release renin (Greenberg, Lorenz et al. 1993; 
Cheng, Wang et al. 1999; Breyer and Harris 2001).  Renin is converted to angiotensin I 
and angiotensin II in the lung. Angiotensin II is a vasoactive substance causing 
vasoconstriction and increased blood pressure through contraction of the smooth muscle 
of the vasculature, increased glomerular sodium chloride clearance, and increased 
activity of the Na+K+2Cl- co-transporter.  These effects combine to cause a decrease in 
renin release (Harris and Breyer 2001). The release of aldosterone by angiotensin II also 
increases blood pressure by volume intake in the distal collecting duct of the kidney, 
which also increases glomerular sodium chloride clearance and decreases renin release. 
This system does permit modulation of vascular tone and its malfunction results in 
hypertension, but the actual etiology of most chronic hypertension is unknown (Watson 
2003).  
 Hypertension is often treated by modulation of the renin-angiotensin system, 
either by blocking angiotensin receptors or preventing the conversion of renin to 
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angiotensin to decrease vascular tone (Chobanian, Bakris et al. 2003). An alternative to 
inhibiting agonists of hypertension would be to modulate vasoconstriction.  This might 
be accomplished through manipulating the interplay of potassium, chloride, as in the 
case of CLCA, and calcium channels that regulate the membrane potential to determine 
the influx of calcium into the smooth muscle cell (Jackson 2000).  
 In smooth muscle, the equilibrium potential for chloride is more positive than 
the resting membrane potential, while the potassium equilibrium is more negative 
(Chipperfield and Harper 2000). The net result is that the opening of a chloride channel 
will result in depolarization of the membrane, whereas activation of a potassium 
conductance will result in hyperpolarization (Jackson 2000). Negative charges leave the 
cell upon chloride channel activation, resulting in membrane depolarization from ~ -60 
mV to a chloride equilibrium potential of ~ -30 mV. This depolarization results in the 
activation of L-type calcium channels which permits an influx of Ca2+ that causes 
muscle contraction. Unlike the contraction in skeletal muscle, the majority of the Ca2+ 
for vascular smooth muscle contraction comes from the extracellular compartment after 
depolarization and activation of L-type Ca2+ channels (Nelson, Patlak et al. 1990; 
Hughes 1995). Simplistically, it is believed that the influx of Ca2+ ions binds 
calmodulin, resulting in a complex which activates myosin light chain kinase (Pfitzer 
2001). The resulting phosphorylation of myosin allows myosin/actin cross-bridging and 
initiates the "ratchet theory" of contraction through the hydrolysis of ATP (Tyska, 
Dupuis et al. 1999; Kad, Rovner et al. 2003). Then the same Ca2+ which activates 
contraction also activates Ca2+-activated potassium channels resulting in positive 
cations leaving, hyperpolarization and inactivation of L-type Ca2+ channels, stopping 
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muscle contraction (Nelson, Patlak et al. 1990; Chipperfield and Harper 2000; Jackson 
2000).  
 Thus, an agonist-induced increase in potassium and decrease in chloride channel 
conductance in smooth muscle will result in muscle relaxation, vasodilation and 
hypotension. Conversely, an agonist that decreases potassium conductance or increases 
chloride channel conductance will cause muscle contraction, vasoconstriction and 
hypertension as is the case for angiotensin or norepinephrine (Figure 1.8.). This can be 
seen by the inhibition of norephephrine or angiotensin II-induced chloride conductance 
which significantly reduces smooth muscle contraction (Guibert, Marthan et al. 1997; 
Wang and Kotlikoff 1997). Given CLCA smooth muscle expression and the effects of 
CLCA expression on Ca2+-activated chloride currents and  molecular interaction with 
subunits of the BK potassium channel, it is likely that this gene family plays a part in 
agonist-induced smooth muscle contraction (Britton, Ohya et al. 2002; Elble, Ji et al. 
2002). 
 The molecular mechanism of basal vascular tone is just beginning to be 
understood.  The basal vascular tone is thought to be maintained by "calcium sparks" 
(Nelson, Cheng et al. 1995; Jaggar, Porter et al. 2000) which originate from a 
ryanodine-sensitive Ca2+ release channel in the sarcoplasmic reticulum (Jaggar, Porter 
et al. 2000). This Ca2+ release is only local and does not cause contraction. But it does 
result in the activation of the large-conductance Ca2+-activated K+ (BK) channels. This 
BK channel is made up of a pore-forming  α-subunit and the  β1 subunit that regulates 
its Ca2+-sensitive activity (Amberg, Bonev et al. 2003). The importance of this subunit 







Figure 1.8. Physiological consequences of smooth muscle chloride channel activation or 
inactivation. Chloride channel activation results in membrane depolarization and 






hypertensive (Brenner, Perez et al. 2000). The  β1 subunit expression was down-
regulated in genetically hypertensive rats (Amberg and Santana 2003). In addition, 
where prolonged exposure to angiotensin II in the rodent model made the rats 
hypertensive, the rats were also found to down-regulate the β1 subunit (Amberg, Bonev 
et al. 2003). This down-regulation correlated with in vivo whole cell and single channel 
studies reporting a decrease in the channel sensitivity to Ca2+ (Amberg, Bonev et al. 
2003).   
 Recent findings by two independent groups have implicated the CLCA gene 
family in vascular tone and in calcium sparks (Britton, Ohya et al. 2002; Elble, Ji et al. 
2002). Both groups identified the expression of CLCA in the vascular smooth muscle of 
the mouse. Neither group's clones elicited whole cell recordings that are normally 
associated with the presence of Ca2+-activated chloride channels of smooth muscle HEK 
293 cells. However, mCLCA4 did result in expression of a Ca2+-activated inward 
current (Elble, Ji et al. 2002).  This would be consistent with the outward movement of 
chloride depolarizing the cell. This current was found to be non-rectifying and time 
independent.  Similarly, the clone of mCLCA1 from murine portal vein was time-
independent and only slightly rectifying upon stimulation by Ca2+ (Greenwood, Miller 
et al. 2002).  These types of biophysical properties were not seen in smooth muscle cell 
recordings, which produce time-dependent currents with strong rectification.   
 However, on cotransfection with the β1 subunit of the BK potassium channel the 
resulting current became very similar to the smooth muscle recordings (Greenwood, 
Miller et al. 2002).  The effect of β1 subunit on CLCA was found to be a direct protein-
protein interaction as determined by a mammalian two hybrid system (Greenwood, 
 89
Miller et al. 2002). Unfortunately, they did not determine the effect of cotransfection on 
the inward-induced current.  The inward current, or outward movement of chloride, 
would likely have been reduced in the dual transfection, given the strong rectification 
induced by the β1 subunit. In smooth muscle, an interaction of CLCA with β1 subunit 
would reduce the depolarization of the membrane by suppressing chloride conductance 
and preventing contraction. 
 In smooth muscle, the "calcium spark" may occur through the β1 BK subunit 
interactions that reduce the stimulatory effects of CLCA proteins on chloride 
conductance. This makes endogenous chloride channels more rectifying, and stops 
chloride release. In contrast to the "spark", there is larger Ca2+ release on agonist 
addition. At higher Ca2+ levels, there is a significantly larger inward current or 
(movement of chloride out of the cell) in the dual CLCA β 1 transfected cells 
(Greenwood, Miller et al. 2002). Thus, at lower Ca2+ levels during "sparks", the 
outward flux of chloride may be inhibited by the β1 subunit interactions with a CLCA 
protein. At higher Ca2+ levels this inhibitory effect is lost. Thus, modulation of an 
endogenous chloride conductance by altering CLCA activity in the smooth muscle cells 
could have a significant impact on hypertensive subjects.  
 
1.6.5.2. Role of CLCA in Penile Erection 
 Upon genital arousal, nitric oxide (NO), produced by nitric oxide synthase, is 
released from the nonadrenergic-noncholinergic nerves as well as from the cavernosal 
smooth muscles and endothelial cells (Archer 2002). The NO free radical activates 
guanylate cyclase, producing cyclic guanosine monophosphate (cGMP) in the smooth 
muscle of the corpus cavernosum. The cGMP activates cGMP-dependent protein kinase 
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(PKG) which phosphorylates and activates the high conductance Ca2+-sensitive 
potassium channel (BKCa2+), the ATP inhibited KATP and voltage activated Kv 
channel. The net result is hyperpolarization of the cell membrane and inactivation of 
Ca2+ channels (Archer, Huang et al. 1994; Kubo, Nakaya et al. 1994; Zhao, Wang et al. 
1997; Archer 2002).  The resulting decrease in intracellular Ca2+ causes smooth muscle 
relaxation and vasodilation.  The corpus cavernosum is then flooded with blood, 
expanding its thick fibrous coat and crimping off the venous drains resulting in 
sustained tumescence (Archer 2002). The impact of cGMP on vascular Ca2+-activated 
chloride conductance and the importance of the PKG effects on this process can be seen 
in the success of the type 5 phosphodiesterase inhibitor Sildenafil (VIAGRA). 
 Both CLCA and Ca2+-activated chloride conductance are found in penis smooth 
muscle vasculature (Leverkoehne, Horstmeier et al. 2002; Karkanis, DeYoung et al. 
2003) .  Injection of inhibitors of CLCA/ Ca2+-activated chloride channels into corpus 
cavernosum of a rat greatly increased both the pressure/rigidity and time of the penile 
erection (Karkanis, DeYoung et al. 2003) ( Figure 1.8). Patch clamp studies on resting 
human and rat corpus cavernosum found spontaneous depolarizing inward chloride 
currents mediated through "Ca2+ sparks". These currents were inhibited by a cGMP 
analogue (Karkanis, DeYoung et al. 2003), indicating that the contracted resting state of 
the corpus cavernosum is mediated through Ca2+-activated chloride channels. In 
addition, a non voltage-dependent chloride channel is activated by the α-1 adrenergic 
agonist phenylephrine, which has been shown to increase intracellular Ca2+. 
Phenylephrine has also been used to mimic the sympathetic stimulation which causes 
detumescence at the resolution of the sexual act (Karkanis, DeYoung et al. 2003). Thus, 
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the Ca2+-activated chloride channel maintains the unstimulated penis flaccid and 
resolves the erection upon its activation (Figure 1.8).  
 Given the inhibitory effects of cGMP analogues in vivo and the presence of 
CLCA expression in the corpus cavernosus, it follows that tissue-specific inhibition of 
the stimulatory effects of CLCA on chloride conductance could provide an alternative 
pharmacologic target in treating erectile dysfunction. However, tissue-specific 
inhibition of CLCA may not be a realistic goal unless there are tissue-specific CLCA 
isoforms involved in controlling smooth muscle tone in the corpus cavernosum.  If 
systemic vasculature and corpus cavernosum CLCA isoforms are identical, then 
pharmacological modulation of CLCA activity for erectile proposes could cause 
significant side effects in the form of systemic hypotension. Hence the CLCA proteins 
are probably not as attractive as the cyclic GMP phosphodiesterase as pharmacologic 
targets for treating erectile dysfunction.  
 
1.6.6. CLCA  Bestrophins and Retinopathy 
 Bestrophins are proteins named from the disease where they malfunction, Best's  
vitelliform macular dystrophy.  Bestrophins are of particular current interest as 
candidates for the molecular identity of Ca2+-activated chloride conductance. However, 
they too may be modulators, or only a single component of a multi-subunit chloride 
channel. A better understanding of CLCA and Bestrophins may give more insight into 
this disease and into the molecular identity of the components that make up the Ca2+-
activated chloride conductance. 
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 Best's vitelliform macular dystrophy (BMD) is an autosomal dominant inherited 
disorder of the eye, with juvenile onset. The disease is characterized by a vitelliform 
("egg yolk" or "vitelline") macular (discolored spots) lesion easily visible during a 
fundus examination (Benson, Kolker et al. 1975). The vitelliform lesion is due to 
deposition of lipofuscin (fatty pigment)-like material within and below the retinal 
pigment epithelium (Frangieh, Green et al. 1982; Weingeist, Kobrin et al. 1982). This 
often results in degeneration of the retinal pigment epithelial cells (O'Gorman, Flaherty 
et al. 1988).  However, the most defining clinical feature of the disease is a light peak to 
dark trough ratio in the electrooculogram (EOG) of less than 1.5, without abnormalities 
in the electroretinogram (ERG) (Cross and Bard 1974). The EOG measures the late 
response of the eye to light. It is the result of depolarization of the basal plasma 
membrane of the retinal pigment epithelium (RPE) (Gallemore, Griff et al. 1988; 
Gallemore, Steinberg et al. 1989). It is thought that this depolarization is normally 
caused by a Ca2+-sensitive chloride channel which is activated by some yet undefined 
signal from the stimulated retina (Gallemore, Griff et al. 1988). The net result of the 
depolarization is transport of fluid and salt away from the retinal rods and cones and 
into the choriocapillaris vascular drainage out of the eye.  
 The general ion and fluid transport mechanism of the RPE is thought to be 
similar to that in other secretory epithelia, except for a reversal from the normal "apical" 
and "basal" nomenclature.  The Na+-K+-ATPase located in the "apical" membrane 
adjacent to the retinal rod and cone photoreceptors generates a large sodium gradient 
across the membrane (Tsuboi, Manabe et al. 1986; Tsuboi 1987; Bialek and Miller 
1994). This sodium gradient is coupled the uptake of Cl- and K+ by the Na+K+ 2Cl- 
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cotransporter, also localized mainly to the "apical" membrane. As for other secretory 
epithelia, intracellular potassium and chloride are maintained at concentrations above 
their respective equilibrium potentials. The vectoral arrangement of ion transport 
proteins includes a "basolateral" chloride conductance, permitting net fluid movement 
from the vitreous to the choroid in an apical to basal direction (Bialek and Miller 1994). 
The release of Cl- from the basolateral membrane is generally under the control of Ca2+ 
(Loewen, Smith et al. 2003). The rate of chloride release increases in the light-evoked 
EOG (Gallemore, Steinberg et al. 1989). Thus, it is natural to speculate that part of the 
pathology of BMD is a defect in basolateral Ca2+-activated chloride conductance.  
 The mutation responsible for BMD was found in the gene coding for a 68 kDa 
protein named bestrophin. This protein has become a new molecular candidate for the 
Ca2+-activated chloride channel (Petrukhin, Koisti et al. 1998) whose activity may be 
modulated by CLCA proteins. Overall 79 different mutations have been found in BMD 
patients (Marmorstein, McLaughlin et al. 2002) (summarized at the VMD2 mutation 
data base, www.uni-wuerzburg.de/humangenetics/vmd2.html). These include missense, 
single amino acid deletions, splice site and frameshift mutations (Marquardt, Stohr et al. 
1998; Petrukhin, Koisti et al. 1998; Allikmets, Seddon et al. 1999; Bakall, Marknell et 
al. 1999; Caldwell, Kakuk et al. 1999) (Kramer, White et al. 2000; Lotery, Munier et al. 
2000; Palomba, Rozzo et al. 2000; Eksandh, Bakall et al. 2001) (Marchant, Gogat et al. 
2001). Bestrophins shares homology with the Caenorhabditis elegans RFP gene family, 
named for the presence of a conserved RFP amino acid sequence motif which is found 
in 26 transmembrane proteins with related sequences grouped in worm family eight 
(Stohr, Marquardt et al. 2002).   
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 Four bestrophin isoforms have been found in humans (Marquardt, Stohr et al. 
1998; Petrukhin, Koisti et al. 1998; Tsunenari, Sun et al. 2003). hBest1 or VMD2, the 
mutated gene in BMD, is expressed in RPE, retina and testes. hBest2 or VMD2L1 
protein is found in RPE, colon and testes, hBest3 or VMD2L3 expression was found  in 
skeletal muscle, brain, spinal cord, bone marrow, retina, thymus and testes, hBest4 or 
VMD2L2 was found predominantly in the colon and weakly in fetal brain, spinal cord, 
retina, lung, trachea, testes and placenta (Stohr, Marquardt et al. 2002; Tsunenari, Sun 
et al. 2003). It is interesting that hBest1, hBest2 and hBest4 are highly expressed in the 
RPE and colon, two tissues with active ion and fluid transport (Tsunenari, Sun et al. 
2003). Electrophysiological experiments with expressed Best1 and 2 as well as 
Caenorhabditis elegans RFP proteins in HEK 293 cells generated chloride currents 
which increased with increasing intracellular Ca2+ concentration (Sun, Tsunenari et al. 
2002; Tsunenari, Sun et al. 2003). This correlates with the basolateral localization of 
hBest1 in the RPE, and supports the possibility that bestrophins are calcium-activated 
chloride channels (Marmorstein, Marmorstein et al. 2000).  However, hBest 1 was 
unable to produce a detectable chloride current when expressed in Xenopus oocytes 
(Tsunenari, Sun et al. 2003).  Apparently HEK 293 cells contain an accessory subunit 
that may be required for bestrophin to function. In a subsequent study, Xenopus 
bestrophin produced a Ca2+-activated chloride current when expressed in HEK 293 cells 
(Qu, Wei et al. 2003). Introduction of a non-conducting mutation produces a dominate 
negative effect in wild type oocytes channels (Qu, Wei et al. 2003). It seems likely that 
Bestrophins may have a significant impact on Ca2+-activated chloride conductance, but 
that these proteins are not working alone.   
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 The confusion surrounding differing results from different groups using 
different expression systems may be informative pieces of the Ca2+-activated chloride 
channel puzzle. A potassium channel β1 subunit modulates a CLCA induced current 
(Greenwood, Miller et al. 2002). CFTR cAMP induced chloride currents are modulated 
by CLCA (Loewen, Bekar et al. 2002). Differences in CLCA-dependent whole cell 
chloride currents are associated with different expression systems (Cunningham, 
Awayda et al. 1995; Loewen, Bekar et al. 2002; Loewen, Gabriel et al. 2002). 
Mammalian bestrophin proteins induce large chloride currents upon expression in 
mammalian but not amphibian cells (Tsunenari, Sun et al. 2003). The amphibian 
bestrophins have a significant impact on both mammalian and amphibian Ca2+-activated 
chloride conductance (Qu, Wei et al. 2003).  Is a mammalian CLCA protein needed to 
make mammalian bestrophin work in the amphibian expression system? 
 The CLCA proteins hCLCA1, mCLCA3 and pCLCA1 are logical candidates to 
control the activity of bestrophins. Both the CLCA proteins and the bestrophins have 
been functionally connected to Ca2+-activated chloride conductance, but neither protein 
seems fully functional without expression in a proper complimentary background. A 
recent study has demonstrated that CLCA is localized to the basolateral membrane of 
the RPE (Loewen, Bekar et al. 2004), in the same location as bestrophins, and in the 
area where Ca2+-activated chloride conductance must function (Gallemore, Steinberg et 
al. 1989). It is an intriguing possibility that some combination of suitable CLCA and 
bestrophin proteins may constitute at least a part of the molecular identity of a Ca2+-
activated chloride channel.   
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 The combination of the known facts and the speculative points surrounding this 
puzzle raise the possibility that the molecular components of Ca2+-activated chloride 
channels have mostly if not entirely been cloned. The varied properties of chloride 
conductance associated with CLCA expression in different systems argue that these 
proteins are at best a component; perhaps a regulatory component, of a Ca2+-dependent 
chloride channel, requiring the presence of other proteins to reconstitute complete 
chloride conductance activity.  Critical co-expression and protein interaction 
experiments are required to connect the pieces to this puzzle and to define the 
permutations and combinations of membrane proteins that produce and regulate the 
activity of Ca2+-dependent chloride conductance. 
 
1.7. Summary 
 The CLCA gene family, although clustered together on a small portion of the 
chordate genome, is both structurally and functionally diverse. The functional diversity 
of this gene family implicates the members in a number of interesting physiological and 
pathological processes.  The underlying question of whether its role in these processes 
is to function as a chloride channel, or to contribute to modulating the chloride 
conductance of other proteins has been addressed in the experiments that follow. 
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Chapter 2. OBJECTIVES 
 
 
2.1. Specific objectives of the studies presented herein were to: 
 
1) Determine pCLCA1 effects on agonist-induced chloride conductance upon 
heterologous expression in a non-epithelial cell line with low chloride channel 
background activity (Chapter 5). 
2) Determine pCLCA1 effects on endogenous chloride currents upon heterologous 
expression in an epithelial cell line (Chapter 6). 
3) Explore pCLCA1 contribution to chloride conductance in a tissue with endogenous 
pCLCA1 expression (Chapter 7). 
4) Investigate the role of pCLCA1 in the Ca2+-dependent chloride current in cells that 
have a natural developmental loss of this agonist response (Chapter 8). 
 
2.2. Overall Objective:  
 Apical chloride conductance in enterocytes is important in the pathophysiology 
of neonatal diarrhea. Uncontrolled activation of the apical chloride conductance by 
bacterial enterotoxins results in dehydration, acidosis, hyperkalemia and death due to 
cardiac failure. An improved knowledge of the molecular pathophysiology could 
contribute to a better understanding of neonatal diarrhea and to the implementation of 
new treatment or prevention strategies. The identification of the major molecular 
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components of epithelial chloride transport in the apical membrane of ileal enterocytes 
has been the long term goal of the laboratory originating this particular project.    
 pCLCA1 was cloned from a ileal gene expression library with antibodies that 
inhibited apical chloride transport of porcine enterocytes. The protein produced by the 
cloned gene was studied to determine what effects pCLCA1 might have on chloride 
conductance, either by its own intrinsic channel properties or by its regulatory effects on 
other chloride channel proteins. 
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Chapter 3.   HYPOTHESIS 
 
The pCLCA1 protein is able to alter apical epithelial chloride channel activity through 
some innate ability to form a chloride channel, or to affect the activity of other proteins 




Chapter 4. GENERAL MATERIALS, METHODS, PROCEDURES AND 
CONSIDERATIONS 
 
 This chapter provides an overview of the theoretical background to the 
experimental setup used in studying chloride conductance, which is not found within 
the manuscript chapters. Some equations and details of experimental procedures which 
are only briefly referenced in the individual manuscript chapters are also found here. 
 
4.1. Patch-Clamp 
 Whole cell patch clamp was used to measure whole cell electrical current under 
voltage-clamp conditions. Using a micro-manipulator and microscope, a glass micro- 
pipette containing a physiological buffer under positive pressure is lowered gently onto 
the surface of a cell submerged in a physiological buffer. The positive pressure is 
released and slight negative pressure applied until a gigaohm seal (10 9 Ω) ("gigaseal") 
is formed between the pipette and the plasma membrane. This membrane to glass seal is 
highly important for low noise recordings of single channels in the membrane. It is also 
important when larger negative pressure is applied to disrupt the membrane within the 
pipette, allowing dialysis of the cell with pipette solution to produce what is described 
as the "whole cell configuration". The tightness of the gigaseal prevents current leak 
between the pipette electrode and the reference electrode in the bathing solution. It also 








Figure 4.1.  Patch Clamp current-to-voltage converter circuit.  The op-amp varies the 
voltage output VB at a very rapid and precise rate so that Vp = Vref and the voltage 
clamp is maintained even with a potential drop in Vp due to current measurement.  This 
circuit also allows the measurement of VB - Vref to determine the Ip.  The VB - Vp 
measurement is no longer needed as Vp = Vref (Sakmann 1995; Walz 2002).
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pipette contents then act as a fluid bridge connecting the headstage amplifier input to 
the interior of the cell.   
 Within the headstage of the amplifier, a voltage-to-current converter maintains 
the voltage clamp of the cell membrane by a constant (Vp) voltage as set by the (Vref) 
voltage ( Figure 1.4).  
 To determine the membrane current, voltage is passed from a source VB to the 
pipette electrode across a resistor of high impedance. The voltage drop across this 
resistance, as determined by the difference between VB and Vp, is proportional to the 
current flow between the pipette and membrane, which then can be used to determine 
the membrane current ( Figure 1.4. ).  
 However, the voltage drop also results in a voltage loss.  To maintain a voltage 
clamp despite a voltage loss, an operation amplifier (OAmp) is used to automatically 
input voltage (compensate for the voltage loss) generating an opposing current (pipette 
to VB if the membrane current is away from the pipette). Thus, the reported membrane 
current would be the opposite of the opposing current used to maintain pipette voltages 
and the resulting voltage clamp (Sakmann 1995; Walz 2002). 
 
4.2. Reversal Potentials to Determine Anion Dependence of Current 
 The ionic nature of the whole cell current is assessed by the change in the 
equilibrium potential or  Erev ( the membrane voltage at which no current flows) 
resulting from a lowering or increasing bath or pipette ion concentration.  An Erev 
movement towards the calculated Erev of a particular ion is used to identify the ion 
producing the current. This shift is called a " Nernstian shift " because the equilibrium 
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potential shifts towards the calculated Erev of the major conducting ion across a 
membrane as determined by the Nernst Equation (Nernst 1888; Hille 2001).  
 The Nernst equation is calculated with the assumption that the equilibrium 
potential ( E ), varies linearly with absolute temperature (T  =  t oC + 273.15) in Kelvin 
and logarithmically with ion concentration ( see equation 4.1,4.2 ). 
 
where (R) is the ideal gas constant at 8.3145 V C mol-1 K-1.   
4.2.1. Boyle's and Avogadro's Law Define "R" the Ideal Gas Constant 
 The following describes the derivation and concept of the ideal gas constant (R) 
used in the Nernst Equation. Discussion of the Nernst equation continues in the next 
paragraph. The ideal gas constant (R) is defined by the ideal gas equation PV = nRT 
which is a summary of Boyle's law; that the volume of an ideal gas varies inversely to 
the pressure, if the temperature remains constant, and Avogadro's law that at a fixed 
temperature and pressure, the volume of a gas is directly proportional to the amount of 
gas.  R is usually derived with reference to standard temperature and pressure, assuming 
that 1 mol gas = 24.789 L at 25 o C which is equal to 1 bar = 105 pascal ( Pa ) = 105 
newton per square meter (N m-2).  This is based on Boyle's results which shows that the 
density of mecury is13.546 gm/mL due to acceleration of gravity, g = 9.81 m s-2, which 
is approximately equal to 1 bar.  It is not based on standard temperature and pressure of 




















( Equation 4.2 ) 
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to voltage difficult.  Given the relations 1 L = 10 -3 m3 and 1 bar = 10 5 Pa = 10 5 N m-2 
and 1 N m = 1 J = 1 VC (volt coulomb) because 1 volt = 1 joule/coulomb we can define 
the total free energy of the ionic solution as R (Equation 4.3) (Barrow 1988; Hille 
2001).  
 
 Z is defined as the valence of the ion, n the number of moles and F is Faraday's 
constant = 9.6485 X104 C mol-1. This is the amount of charge required to deposit one 
gram atomic mass (one mole) of a single-valence element on an electrode in units of 
coulombs (1 coulomb is 1.602 X 10-19 electrons).  These factors allow conversion of the 
energy R (which is the total free energy of the solution) to total possible voltage. The 
 
 







24.789 L 1 bar
298.15 K 1 mol
0.083143 L bar K 1 mol 1
   





105 N m 2
1 bar
  
  =  8.3143 N m K 1 mol 1
  
  =  8.3143 J K-1 mol-1
    
  =  8.3143 V C K-1 mol-1    





voltage which is generated depends on the separation of the solution across the plasma 
membrane as determined by equations 4.1 & 4.2 (Hille 2001).  
 To correspond to the physiological convention, all membrane potentials are 
measured inside minus outside. Thus, when using a cation the denominator is the inside 
concentration and when using an anion the denominator is the outside concentration 
(Hille 2001).  
 However, the Nernst equation only allows an approximation of the Erev, because 
ionic solutions are not ideal gases. One possible way to circumvent this problem is to 
use ion activities rather then concentrations (Altenberg 1996; Hille 2001). The ion 
activity is different from the free concentration.  The ion activity is generally lower at 
physiological solute concentration because the mobility of ion in solution is restricted 
by ion-ion and ion-solvent interactions (Altenberg 1996).  The correction factor 
required to convert free concentration to activity is the activity coefficient. This is based 
on the premise that the nonideal contribution to free energy of ions in solution can be 
interpreted as the difference between the energy required to create the ion in solution 
where there are no interionic interactions and the energy where there are such 





where γ is the activity coefficient, Z is the valency and µ is the ionic strength. (see 
(Barrow 1988) for derivation). Unfortunately, the derivation does not take into account 
( Equation 4.4 ) log .γ µ± + −= 05091Z Z
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the (multi-ionic) nature of many physiological buffers. In addition, many complex ions 
deviate from derived coefficients, indicating that effects other than electrostatic ones 
need to be taken into account (Barrow 1988). Thus, the use of such a coefficient is of 
limited use in a physiological buffer. Additionally, given the usual background current 
and leakage in most experiments, concentration calculations are usually adequate. When 
determining the major ionic contribution to the current, one usually looks for the shift 
towards the Nernst equilibrium potential rather than precisely obtaining that potential. 
      
4.3. Pipet Junction Potentials  
 Liquid junction potential is the potential difference between two solutions of 
differing composition. Potential difference results from separation of charge that occurs 
when anions and cations of different mobilities diffuse across boundaries (Sakmann 
1995). In the case of patch clamp, the boundary and solution difference is between the 
pipet and the bath solutions. When a pipet solution containing a large bulky anion such 
as glutamate with low mobility is used with a cation with high mobility such as 
potassium, a large junction potential can develop as the potassium ions move quickly 
into the bath solution leaving the glutamate behind, and creating a potential difference.  
 It is normal to use the pipette offset to compensate for this potential at the 
beginning of an experiment when the pipette is placed into the bath. However, on whole 
cell access the potential no longer exists because as the cell equilibrates with pipette 
solution. The plasma membrane then prevents a liquid-liquid junction effect.  
 However, the pipette potential is compensated for by the pipette offset when the 
pipette is originally placed in the bath. To determine the actual voltage placed on the 
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cell membrane during the experiment the original junction potential has to be measured 
or calculated.  Computer based calculations based on ion mobility in the pClamp 8.1 
software (Axon instruments, Foster City, CA) were used. Measurements were also 
performed. This was accomplished by placing the amplifier in current clamp mode and 
measuring the voltage produced after changing the bath solution from one composed of 
the internal pipette solution to the experimental bath solution.  The reference electrode 
was a flowing 3 M KCl electrode to minimize junction potentials at this electrode.    
 
4.4. Trans-Epithelial Current Measurements in the Ussing Chamber 
 Trans-epithelial current was assessed in a Ussing chamber.  This apparatus 
permits measurement of the voltage or current produced across an epithelium by 
transepithelial ion movement (Ussing 1951; Cotton 1996). The experimental tissue is 
placed with apical and basolateral sides of the epithelium facing opposite and isolated 
baths. The two baths only communicate though an aperture which is spanned by the 
epithelium. The electrical properties of the epithelium are then studied using a two 
electrode system. One set of electrodes, one electrode in the bath on each side of the 
tissue, measures the transepithelial voltage. A second set of electrodes delivers a current 
or a voltage across the epithelium. The system is usually run either open circuit 
(measuring the voltage produced) or short circuit (measuring Isc, which is the current 
required to voltage clamp at 0 mV). We generally use the open circuit condition as, in 
our experience, it results in a healthier tissue and better recordings.  
 
 To determine the resistance of the tissue (an indication of the integrity of the 
tissue examined), the tissue is pulsed to a known current (∆I), usually 10 µA. Using the 
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resulting voltage change (∆V), one can then determine the resistance of the tissue. If 
resistance of the tissue is known, then short circuit current of the tissue can be 




 Alternatively, the system can be run in short circuit and the tissue resistance can 
be determined by inducing a known voltage pulse. The resulting current is then 
measured and resistance is calculated (Equation 4.6).  
4.6. Chloride Efflux 
 Efflux of 36Cl-gives an assessment of permeability of the cell membrane to the 
chloride ion. Increases or decreases in permeability are measured, but the technique 
does not give insight into how the chloride is released from the cell. In particular, it 
does not distinguish between electrogenic and electroneutral ion transport. It is also 
highly influenced by cell physiology, as the driving force for chloride efflux is not 
externally controlled in most experimental setups. 
 Generally, cells were loaded by incubation in an isotonic loading buffer (see 
specific chapters for buffers) containing 2 Ci/ml of 36Cl- for 2 hours.  The loading buffer 
was created by adding added Na+ 36Cl- at ~ 1 Ci /ul to the efflux buffer.   36Cl- is shipped 


















NaOH need to neutralize the H36Cl was determined from the specific activity, A 
(mCi/g), the radiochemical concentration, B (mCi/ml), the volume of radionucleide in 
mls, C, and the molecular weights Cl- = 35.5 g/mol and NaOH = 40 g /mol.   
 The 36Cl- addition to loading buffer only increases the NaCl concentration (140 
mM) by ~ 2 mM. After complete equilibration with loading buffer, the cells were 
washed rapidly 5 times with efflux buffer. The final wash was designated the start of the 
efflux. One ml of efflux buffer was replaced every two minutes through the time course 
of the efflux.  The removed buffer was placed in 1.5 ml of Beckman Redisafe 
scintillation cocktail and counted on a Beckman LS3800 counter.  The 36Cl- 
concentration in the loading buffer was determined by measuring 36Cl- cpm/ml, which 
was divided by the number of nmol Cl-/ml in the buffer to give cpm per nmol Cl-.  This 
allowed the calculation of "nmol Cl- release" used in Chapter 5. Other measures of 
chloride release are specified where relevant in each chapter.   
 
4.7. RNA Preparation and RT-PCR 
 RNA was harvested under the usual chaotropic conditions using guanidinium-
thiocyanate to disrupt RNase and prevent RNA degradation. DNA was removed with 
DNAase. The phenol was acidified to prevent partitioning of the RNA from the aqueous 
phase into phenol.  Propanol and ethanol were used to precipitate the RNA. Total RNA 




  mCi / ml
36.5g / mol X     mCi / g
X  ml X  40g / mol  g of NaOH= D (Equation 4.7) 
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polymerase chain reaction (PCR). Specific reaction conditions are outlined in each 
chapter.  All reactions cycled in the order of melting (production of single strand DNA), 
annealing (binding of primer) and extension (extension of primer by Taq DNA 
polymerase) to drive the exponential growth of the product determined by specific 
primers (Saiki, Gelfand et al. 1988). Primer design was computer-aided, with special 
efforts to avoid primer sequence that promoted non-specific template binding, hairpin 
and primer dimer formation. A high GC content was preferred at the 3' end of the 
primer to assure specific and strong annealing. Magnesium concentrations were 
sometimes altered from the default value in ± 0.1 mM increments to deal with difficult 
templates. It is presumed that magnesium ions shield charges on the phosphate 
backbone of the DNA, thereby reducing secondary structure. 
 
4.8. CLCA1 Antibody Production 
 
 Antibody-epitope interaction is considered to be noncovalent bonding (not 
sharing of valance electrons in bond). The forces that are involved include:  
 
1. Hydrogen bonding which is formed when a H atom bound to a highly 
electronegative atom is simultaneously attracted to a small highly 
electronegative atom of a neighboring molecule. Hydrogen bonding can occur 
only with H atoms because all other atoms have inner-shell electrons to shield 
their nuclei.  
2. Ionic bonds form between charged amino acids that attract each other through 
electrostatic forces.  
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3. van der Waals interactions are weak bonds between two uncharged atoms that 
have developed electric dipoles due to interactions with nearby atoms.  
4. Hydrophobic bonds, which are caused by the intrinsic attractions between 
nonpolar amino acid subunits in an aqueous environment.  Hydrophobic 
bonding is based on maximizing thermodynamic stability by minimizing the 
entropy decrease needed to order water molecules around hydrophobic portions 
of molecules (Lehninger 1993). The hydrophobic bonds usually contribute the 
greatest part of the energy to the antibody-antigen interaction, which is why 
many of the programs used to select a preferred antigenic region are based on 
amino acid residue hydrophobicity.  
 
 The importance of hydrophobicity can seen in the successful application of the 
Hopp and Woods method that predicts the location of antigenic determinants by finding 
area of greatest local hydrophobicity (Hopp and Woods 1981). Along with a database of 
known antigenic sites, this method gives a fairly good prediction of antigenic regions of 
a protein (Thornton, Edwards et al. 1986). These methods were employed using 
computer software PCGENE to identify a small peptide which was then synthetically 
produced, conjugated to keyhole limpet hemocyanin and used to immunize two rabbits 
(Sigma-Genosys, Woodlands Texas). The predicted sequence amino acid sequence of 
pCLCA1 chosen for best antigenicity was CKEKNHNKEAPNDQNQK (residues 250-
266).  It should be noted that membrane topology predictions locate this region of the 




4.9. Western blot 
 Cellular proteins were separated by SDS PAGE, and transferred from 
polyacrylamide gels onto nitrocellulose blotting membrane using a high power wet cell 
transfer system (BioRad) to drive the protein from the gel onto the membrane. After 
protein transfer to the nitrocellulose the membrane was blocked with 3% skim milk 
powder in TTBS to prevent non-specific binding of the primary antibody to the 
membrane.  The blocked membrane was incubated with suitable dilutions of preimmune 
or immune rabbit antisera. Unbound primary antibody was removed by washing, and 
membranes were equilibrated with TTBS containing dilutions of secondary antibody 
conjugated to a detecting element to visualize the location of the pCLCA1 antigenic 
epitope on the blot (Burnette 1981). 
 
4.10. Flow Cytometry  
 Flow cytometry involves the projection of a beam of light from a diode laser 
through a liquid stream of cells which are labeled with fluorochromes that will fluoresce 
upon appropriate excitation.  The emitted fluorescence can then be filtered and detected 
with individual photomultiplier tubes to identify the presence of individual 
fluorochromes on each cell. The process permits simultaneous cell and fluorochrome 
counting to identify population responses to particular screening procedures using dye 
or antibody.  
 The Coulter® Epics® Elite ESP (Coulter corporation, Miami FL) flow 
cytometer was configured with forward and side scatter parameters in linear mode 
PMT5 (detecting propidium iodide) and PMT2 (detecting FITC) fluorescence channels 
in logarithmic modes. Compensation was set with Flow-Check Fluorospheres beads (10 
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µm Beckman Coulter Inc., Fullerton, CA), and photomultiplier gates were set with 
Caco-2 cells treated with preimmune serrum. 10,000 events were acquired for each 
experimental condition. The data were presented as two-parameter dot plot where the 
two lower quadrants identify intact cells negative for propidium iodide fluorescence, 
while the two right hand quadrants identify cells with surface pCLCA1 epitope display 
that interacts with primary antibody, and FITC-conjugated secondary antibody.  Hence 
the lower right hand quadrant contains intact cells expressing surface pCLCA1 epitope. 
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 The regulatory behavior, inhibitor sensitivity, and properties of the whole cell 
chloride conductance observed in cells expressing the cDNA coding for a chloride 
conductance mediator isoform of the CLCA gene family, pCLCA1, have been studied. 
CommonC-kinase consensus phosphorylation sites between pCLCA1 and the closely 
related human isoform hCLCA1 are consistent with a role for calcium in channel 
activation. Both channels are activated rapidly on exposure to the calcium ionophore 
ionomycin. Direct involvement of calcium in the activation of pCLCA1 was supported 
by the finding that treatment with the intracellular calcium chelator 1,2-bis(2-
aminophenoxy)ethane-N,N,N',N'-tetraacetic acid-AM reduced the rate of chloride efflux 
from NIH/3T3 cells expressing the pCLCA1 channel. No combination of A-kinase 
activators used was effective in activating chloride efflux via this channel despite the 
presence of a unique strong A-kinase consensus site in pCLCA1. Notable differences of 
pCLCA1 from the reported properties of CLCA family members include the failure of 
phorbol 12-myristate 13-acetate to activate chloride efflux in cells expressing pCLCA1 
and a lack of inhibition of chloride efflux from these cells after treatment with DIDS or 
dithiothreitol. However, selected inhibitors of anionic conductance inhibited pCLCA1-
dependent anion efflux. The electrogenic nature of the ionomycin-dependent efflux of 
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chloride from cells expressing pCLCA1 was confirmed by detection of outwardly 
rectifying chloride current and inhibition of this current by chloride conductance 




 There are a least three major types of chloride channels with the potential to act 
as gating molecules controlling the electrogenic release of chloride from the apical 
membrane of secretory epithelial tissues. The cystic fibrosis transmembrane regulator 
(CFTR) protein, some members of the related isoforms of the ClC protein family, and 
the CLCA family of calcium-dependent chloride channels are all expressed in the apical 
membrane of epithelial cells lining the surface of secretory tissues. There is 
experimental evidence supporting the roles of members of each of these channel 
families in transepithelial electrolyte and fluid transport (Anderson, Gregory et al. 1991; 
Anderson and Welsh 1991; Fuller and Benos 2000b; Mohammad-Panah, Gyomorey et 
al. 2001). Cystic fibrosis disease arises from mutations in the CFTR protein that directly 
or indirectly reduce chloride transport by the CFTR molecule (Quinton 1983; 
Berschneider, Knowles et al. 1988; Riordan, Rommens et al. 1989). ClC-2 is present in 
the apical membrane of intestinal epithelial cells and can contribute to chloride currents 
in these cells (Loewen, MacDonald et al. 2000; Mohammad-Panah, Gyomorey et al. 
2001). Isoforms bCLCA1, mCLCA1, and hCLCA2 are expressed in trachea and lung 
epithelium, and hCLCA1 expression was reported in the human gut, where it is 
postulated to participate with CFTR in regulated chloride transport (Chow, Uribe et al. 
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2000) (Gruber, Elble et al. 1998; Gruber, Gandhi et al. 1998; Fuller and Benos 2000b; 
Fuller and Benos 2000a).  
 Our laboratory has reported the cloning of a porcine (pCLCA1) isoform of the 
CLCA gene family (Gaspar, Racette et al. 2000). Nucleotide sequence data show that 
the pCLCA1 channel is most similar to the hCLCA1 isoform of that family, with 78% 
identity in the predicted amino acid sequence. Predicted amino acid sequence data also 
suggest a common transmembrane topology for pCLCA1 and hCLCA1. Monobasic 
proteolytic cleavage sites likely to be involved in post translational processing of 
hCLCA1 are common to pCLCA1.   
 Heterologous expression of hCLCA1 and hCLCA2 as well as mCLCA1, 
mCLCA2, and bCLCA1 in HEK-293 cells and Xenopus oocytes is accompanied by the 
appearance of a calcium-sensitive anion conductance(Gandhi, Elble et al. 1998; Gruber, 
Elble et al. 1998; Romio, Musante et al. 1999) The calcium-dependent anion 
conductance is reported to be sensitive to inhibition by 4,4'-diisothiocyanostilbene-2,2'-
disulfonic acid (DIDS) and by the reducing agent dithiothreitol (DTT). Weak consensus 
C-kinase phosphorylation sites in a predicted cytosolic loop at S535, T580, and T593 
and the strong site at T600 are common to the predicted amino acid sequences of 
hCLCA1 and pCLCA1. CLCA channel activation by A-kinase has not been reported. 
The strong RRSS587 A-kinase consensus site in the predicted cytosolic loop containing 
four conserved C-kinase phosphorylation sites is unique to predicted pCLCA1 amino 
acid sequence.  
 As with the bCLCA1 and hCLCA1 isoforms, pCLCA1 is expressed in tracheal 
and small intestinal epithelium, with highest levels in association with the secretory cell 
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types in the tracheal submucosal glands and the small intestinal crypts of Lieberkuhn 
(Racette, Gabriel et al. 1996; Gaspar, Racette et al. 2000). In addition to the expression 
sites for pCLCA1, two other lines of evidence relate to a potential role for this protein 
in epithelial electrolyte and fluid secretion. The initial evidence came from the 
monoclonal antibody used in expression cloning of the pCLCA1 gene. Incubation of 
this monoclonal antibody with apical membrane vesicles prepared from porcine ileum 
inhibited up to 95% of electrogenic chloride uptake by these vesicles (Racette, Gabriel 
et al. 1996). Expression of the pCLCA1 gene in permanently transfected 3T3 mouse 
fibroblasts introduced a calcium-dependent chloride efflux from the fibroblasts 
expressing pCLCA1 (Gaspar, Racette et al. 2000).   
 This report outlines the sensitivity of the pCLCA1 protein to second messenger 
activators and to some inhibitors of anion conductance, as well as some properties of 
the anion currents observed in whole cell patch-clamp measurements on 3T3 cells 
expressing pCLCA1. 
 




 Tissue culture media, G418 antibiotic, and Superscript II reverse transcriptase 
were purchased from GIBCO Life Technologies. Taq and Pfu DNA polymerases were 
obtained from Stratagene, dNTPs from Pharmacia, and restriction enzymes from New 
England Biolabs. Molecular biology grade chemicals and anion transport inhibitors 
including DIDS, glibenclamide, 5-nitro-2-(3-phenylpropylamino)benzoate (NPPB), α-
phenylcinnamate (α-PC), and diphenylamine carboxylate (DPC) were obtained from 
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Sigma-Aldrich. 36Cl- was purchased from New England Nuclear. Oligonucleotides were 
synthesized at the Core DNA Services Laboratory, University of Calgary (Calgary, 
Canada).  
 
5.3.2. Production of Cell Lines.  
 NIH/3T3 fibroblasts were grown in DMEM medium supplemented with 10% 
fetal bovine serum (FBS) and glutamine (2 mM) (complete DMEM medium). Optimum 
settings for plasmid transfection by electroporation used voltage and capacitance 
conditions sufficient to kill ~20% of freshly suspended recipient cells within 48 h of 
receiving a single electrical discharge. NIH/3T3 cells (8 × 106 cells) were mixed with 
100 µg of pcDNA3 plasmid containing pCLCA1 cDNA or pcDNA3 vector without 
insert and then subjected to a 250-V discharge at 250 µF in a 4-mm gap electroporation 
cuvette. After electroporation, cells were plated at 2 × 105 cells per well in 24-well 
plates. G418 (2.5 mg/ml) was added to wells 24 h later to select for successful 
transfectants. Cells were switched to maintenance medium (500  µg/ml G418 in 
complete DMEM) 7 days posttransfection.  
 
5.3.3. RT-PCR 
 Total RNA was isolated by extraction in guanidiniumthiocyanate-phenol 
(Trizol; GIBCO) and used as a template in a reverse transcriptase PCR reaction. Total 
RNA (5 µg) from transfected cells was used as a template in a reverse transcriptase 
reaction containing dNTPs, 200 units of Superscript reverse transcriptase, and 1 pmol of 
primer (5'-GAGAAAGCTTGCGGCCGCTCGTGCAGAAAGTCTAAAATG-3') 
specific to a section of unique sequence in the 3' untranslated region of pCLCA1 and 
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not found in any other CLCA isoform. The reverse transcriptase reaction product (1 µl) 
was used as template in a nested PCR reaction with sense (5'-
GTGAACACGCCACGCAGAAG-3') and antisense (5'-
GTCCAACCAGAATAGCTGTC-3') primers for 24 cycles at 94oC for 45 s, 52oC for 
45 s, and 72oC for 1 min to produce a 518-base pair product. PCR products were 
separated by electrophoresis in 0.1% agarose gels in Tris-borate-EDTA buffer and 
exposed to ethidium bromide, and the fluorescence of the ethidium bromide-DNA 
complex was recorded on a GelDoc visualizing system (Bio-Rad).  
 
5.3.4. Chloride Efflux Measurements 
 Stable pCLCA1 transfectants of mouse 3T3 fibroblasts were grown in DMEM 
supplemented with 2 mM glutamine, 10% fetal calf serum (FCS), and G418 (500  
µg/ml). Confluent 35-mm plates of these cells were loaded with 36Cl- by removing 
growth medium and incubating with loading buffer containing 4 mM KCl, 2 mM 
MgCl2, 1 mM KH2PO4, 1 mM CaCl2, 5 mM glucose, 10 mM HEPES, pH 7.5, and 140 
mM NaCl plus 2  Ci/ml 36Cl- for 2 h. Extracellular 36Cl- was removed by rapidly 
washing cells five times with 1 ml of efflux buffer (loading buffer without 36Cl-). The 
36Cl- content of the last wash was reported as the time 0 efflux value. The rate of release 
of chloride from the cells was determined by repetitively adding 1 ml of efflux medium 
and removing the medium 2 min later. The chloride efflux values reported at each 2-
min interval represent the amount of 36Cl- (measured by liquid scintillation counting) 
released from the cells during the preceding 2 min. Cells were removed from the plates 
at the end of the efflux by addition of 1.0 mM EDTA and mechanical agitation for the 




 Potential activators of pCLCA1 chloride conductance were added to the efflux 
buffer after the end of the last wash. When ionomycin (10 µM), phorbol 12-myristate 
13-acetate (PMA), or 8-(4-chlorophenylthio)-AMP (CPT-cAMP; 0.5 mM), 3-isobutyl-1 
methylxanthine (IBMX; 2.0 mM), and forskolin (10 µM) were added to the efflux 




 Potential inhibitors of cell signaling including the calcium chelator 1,2-bis (2 
aminophenoxy)ethane-N,N,N',N'-tetraacetic acid-acetoxymethyl ester (BAPTA-AM) 
and the calcium calmodulin kinase II (CaMKII) inhibitor 2-[N-(2-hydroxyethyl)-N-(4 
methoxybenzenesulfonyl)]amino-N-(4-chlorocinnamyl)- N-methylbenzylamine (KN-
93) were added to uptake medium during the 2-h 36Cl- loading period. DTT and 
potential chloride transport inhibitors with lipid-soluble anion properties presumed to 
interact with an anion channel in the conductance protein (DIDS, NPPB, etc.) were 
added to the wash solution during the five cell washes preceding efflux measurements 
and were also in the buffer during the subsequent timed 36Cl- efflux.   
 
5.3.7. Whole Cell Patch Clamp 
 Whole cell voltage-clamp studies. The pipette solution for intracellular dialysis 
contained 1 mM sodium pyruvate, 40 mM Tris - HCl, 90 mM D-gluconic acid lactone, 
90 mM Tris base, 5 mM N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid 
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(TES), 1 mM EGTA, 2 mM MgCl2, 0.1 mM CaCl2, 1 mM MgATP, and 0.1 mM 
Na2GTP (pH 7.4). Ca 2+ activity was buffered to ~40 nM (1.0 mM EGTA and 0.1 mM 
CaCl2). The routine bath solution contained 150 mM NaCl, 2 mM MgCl2, 1 mM CaCl2, 
5 mM TES, and 30 mM sucrose (adjusted to pH 7.4 with Tris). The low-chloride 
solution contained 40 mM NaCl, 2 mM MgCl2, 1 mM CaCl2, 5 mM TES, and 250 mM 
sucrose. Single-cell, rapid solution changes were applied by using a gravity-fed 
Perfusion Fast-Step SF-77B perfusion system (Warner Instrument, Hamden, CT). 
Ionomycin (10 µM) was added as a single-cell bath solution change. Patch-clamp 
electrodes were pulled and fire-polished from borosilicate glass capillaries (outer 
diameter 1.5 mm; inner diameter 1.17 mm) with an inner filament (Harvard Apparatus, 
Edenbridge, UK) on a DMZ universal puller (Dagan, Minneapolis, MN). Patch pipettes 
had a tip resistance of 3-5 MΩ with these solutions. Whole cell currents were acquired 
with an Axopatch-1D patch-clamp amplifier (Axon Instruments, Foster City, CA) at 
500 Hz, filtered at 100 Hz with Clampex 8, and analyzed with Clampfit 8 (Axon 
Instruments). The standard voltage-clamp protocol had a holding potential of 0 mV with 
voltage pulses applied for 600 ms from - 80 to +100 mV in 20-mV increments. After a 
(>1 G Ω) seal was obtained, capacitance compensation was carried out before whole 
cell access. Subsequent to whole cell access, all cells were dialyzed for 2 min before 
recording. Only those cells that had a membrane resistance ~100 times that of the access 
resistance before ionomycin activation were used. Current differences were normalized 
by the whole cell capacitance recorded from an integrated 10-mV hyperpolarizing 
pulse. All membrane potentials were corrected at the time of analysis for the measured 
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junction potentials of pipette to bath solution, 4.8 ± 0.2 mV in bath solutions containing 
150 mM Cl- and 0.8 ± 0.2 mV in bath solutions containing 40 mM Cl-.  
 
5.3.8. Statistical Methods  
 Two-way repeated-measures ANOVA was used to compare treatment over time 
or voltage effects. The Fisher least significant difference (LSD) method for pairwise 
multiple comparisons was used as a post-ANOVA test to determine treatment effects at 
individual points. Reversal potential (Erev) values were compared using Student's t-test.  
The SigmaStat statistical software package was used to perform all these comparisons.  
 
5.4. Results 
5.4.1. Cell Lines 
 Untransfected NIH/3T3 fibroblasts are killed by continuous exposure to 
complete DMEM medium containing 500 µg/ml of G418. The expression of pCLCA1 
mRNA in transfected cells resistant to G418 was verified by reverse transcriptase PCR. 
Amplification of a 518-base pair product from reverse transcribing 5 µg of total RNA 
from cells transfected with the pCLCA1-expressing construct (Figure 5.1) indicates that 
the construct was intact and that the transfected cells would be expected to synthesize 
the pCLCA1 protein.  
 
5.4.2. Agonists 
 The pCLCA1 mRNA was cloned from a porcine intestinal cDNA library 















Figure 5.1.  Identification of pCLCA1 mRNA expression in transfected NIH/3T3 
fibroblasts. Reverse transcriptase PCR reaction was carried out with total RNA isolated 
from 2,500 cells. Reverse transcriptase was primed with an antisense primer 
complimentary to a pCLCA1-specific 3' untranslated sequence. The reverse 
transcriptase reaction product (1 µl) was used as template for a PCR reaction with 
nested primers designed to amplify a 518-base pair product. Flanking standard lanes 
contain a 100-base pair ladder. Lane 1, PCR no-template control; lane 2, NIH/3T3 
mRNA RT template; lane 3, pcDNA3-transfected NIH/3T3 mRNA RT template; lane 4, 
pCLCA1-transfected NIH/3T3 mRNA RT template; lane 5, pCLCA1 cDNA control. 
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mucosa are activated in situ in response to treatment with cholera toxin, with the heat-
labile and heat-stable enterotoxins produced by enteropathogenic strains of Escherichia 
coli. The cyclic nucleotide phosphodiesterase inhibitors theophylline and IBMX are 
rapid and potent activators of apical chloride conductance. Various calcium ionophores 
including A23187 and ricinoleic acid are also recognized as in situ activators of apical 
chloride channel conductance and intestinal secretion. Exogenous expression of the 
pCLCA1 protein in mouse 3T3 fibroblasts provides a model that can be used to test for 
the sensitivity of this presumptive anion channel to activation by various second 
messenger substances.  
 The presence of a strong A-kinase consensus site in pCLCA1 raises the 
possibility of activation of this channel by cAMP. Addition of CPT-cAMP, forskolin, 
and IBMX to transfected 3T3 cells expressing pCLCA1 mRNA did not affect the rate of 
release of 36Cl- from cells loaded with this isotope (Figure 5.2.; ±pCLCA1 × time, P = 
0.482). This lack of response to A-kinase activation was also observed in control-
transfected 3T3 cells. The conditions used in this study should be sufficient for A-
kinase activation in most test systems, but significantly higher concentrations of IBMX 
(5-10 mM) are routinely used for in situ activation of secretion without any CPT-cAMP 
or forskolin. Exposure of pCLCA1-transfected 3T3 cells to 5 mM IBMX for 6 or 10 
min before extracellular 36Cl- was washed significant efflux response to the cyclic 
nucleotide phosphodiesterase inhibitor (data not shown). 
 There is a strong in situ secretory response to calcium ionophores including 
ricinoleic acid, bile acids, the A-subunit of cholera toxin, and A-23187 in porcine small 








Figure 5.2. Effect of pCLCA1 transfection on chloride release by NIH/3T3 fibroblasts 
treated with activators of protein kinase A (PKA). Medium on confluent cells in 3.5-cm 
dishes was replaced with loading buffer containing 4 mM KCl, 2 mM MgCl2, 1 mM 
KH2PO4, 1 mM CaCl2, 5 mM glucose, 10 mM HEPES, pH 7.5, and 140 mM NaCl plus 
2 µCi/ml 36Cl. After 2 h, cells were washed rapidly 5 times with 1 ml of efflux buffer 
(loading buffer without 36Cl-). The 36Cl- content of the last wash is reported as the time 
0 efflux value. 36Cl- release was measured by changing the efflux buffer at 2-min 
intervals. 8-(4-Chlorophenylthio)-AMP (CPT-cAMP; 0.5 mM), 3-isobutyl-1-
methylxanthine (IBMX; 2.0 mM), and forskolin (10 µM) were added to the efflux 
buffer at time 0 and at each subsequent buffer replacement interval to facilitate 
activation of PKA. ●, 3T3 cells (control) transfected with pcDNA3; ○ , 3T3 cells 
transfected with pcDNA3 containing pCLCA1. Values are means ± SE (n = 6  
 126
to pCLCA1-transfected 3T3 cells increased the rate of 36Cl- efflux from these cells. The 
ionomycin-dependent stimulation of 36Cl- efflux was not observed in control-transfected 
cells containing only the pcDNA3 vector (Fig 5.3.; ± pCLCA1 × time, P < 0.001). The 
calcium dependence of this ionomycin effect was investigated by adding the calcium 
chelator BAPTA-AM to the loading medium during the 2-h loading with 36Cl. Normal 
loading buffer was modified for trials with BAPTA-AM by omitting 1.0 mM CaCl2. 
There was a significant decrease in the rate of 36Cl- efflux from cells expressing 
pCLCA1 after treatment with BAPTA. (Fig 5.4.; ±BAPTA × time, P < 0.001). The 
activation of whole cell currents in Xenopus oocytes expressing a truncated form of the 
bCLCA1 channel by 10-7 M PMA was cited as evidence for channel activation by 
protein kinase C (PKC) (Ji, DuVall et al. 1998). The conservation of four C-kinase 
phosphorylation acceptor sites between hCLCA1 and pCLCA1 in the predicted 
cytoplasmic loop between TM3 and TM4 domains implies an importance of these sites 
in control of channel activity. However, there was only an insignificant effect of 1 × 10-
7 M PMA on 36Cl- efflux from 3T3 cells transfected with pCLCA1 (Fig 5.5.; ±pCLCA1 
in presence of PMA × time, P = 0.106). 
 
5.4.3 Antagonist and Blockers 
 There are also conserved CaMKII phosphorylation sites in hCLCA1 and 
pCLCA1. The CaMKII inhibitor KN-93 (Sumi, Kiuchi et al. 1991) was added to 
pCLCA1-transfected 3T3 cells to test for any effects of this reportedly specific inhibitor 
on the ionomycin-dependent increase in 36Cl- efflux rate from these cells. Although the 
KN-93 inhibitor is reported to have an inhibition constant of 0.37 µM, there was no 











Figure 5.3. Effect of ionomycin addition on chloride efflux from pCLCA1-transfected 
NIH/3T3 fibroblasts. See legend to Fig. 2 for efflux conditions. ●, pCLCA1-transfected 
3T3 cells with 10 µM ionomycin added at time 0; ○, pCLCA1-transfected 3T3 cells 
without ionomycin; ?, pcDNA3.1 (control)-transfected 3T3 cells with 10 µM 
ionomycin added at time 0; ▼, pcDNA3.1 (control)-transfected 3T3 cells without 10 
µM ionomycin. * Significant ionomycin effects on Cl- efflux in pCLCA1-transfected 
cells. ^ Significant effect of pCLCA1 transfection on ionomycin-dependent Cl- efflux. 












Figure 5.4. Effect of intracellular calcium chelation by 1,2-bis(2-aminophenoxy)ethane-
N,N,N',N'-tetraacetic acid (BAPTA) on chloride efflux from pCLCA1-transfected 3T3 
cells. BAPTA-AM (50 µM) was added to the 36Cl-containing loading buffer 90 min 
before the effect of ionomycin addition was measured on chloride release. ●, Ionomycin 
(10 µM) added at time 0; ○, cells pretreated with BAPTA and then with ionomycin (10 
µM) added at time 0; ▼, control, untreated cells. * Significant BAPTA effects on 

















Figure 5.5.  Effect of phorbol 12-myristate 13-acetate (PMA) on chloride efflux from 
control and pCLCA1-transfected NIH/3T3 fibroblasts. Cells were loaded and chloride 
efflux carried out as described in Fig. 2. PMA (100 nM) was added to efflux buffer at 
time 0. ○, 3T3 cells transfected with pCLCA1; ●, 3T3 cells transfected with pcDNA3.1 







20  µM KN-93 for 1 h before 36Cl- efflux was stimulated by addition of ionomycin 
(Figure 5.6.). Statistical analysis of ±KN-93 in the presence of ionomycin × time gave a 
significant ionomycin-KN-93 interaction (P = 0.03). Post-ANOVA analysis indicated 
KN-93 effects approaching significance (e.g., for 2-min time, P = 0.061). 
 In addition to being able to distinguish chloride transporters by the second 
messenger signal pathways involved in their activation, it would be helpful to 
distinguish channels or to be able to rule out particular channels as contributors to an 
endogenous chloride conductance through the use of specific ion channel inhibitors. 
DTT was reported to inhibit chloride currents that could be due to the native form of 
bCLCA1 (Cunningham, Awayda et al. 1995) as well as the other isoforms that have 
been the efflux of 36Cl- from 3T3 fibroblasts expressing pCLCA1 (data not shown) 
expressed for functional study. We found that the reducing agent DTT did not inhibit. 
DIDS is recognized as an inhibitor of whole cell and single-channel chloride currents 
mediated by CLCA proteins. Addition of DIDS to 3T3 cells transfected with pCLCA1 
had no effect on the rate of ionomycin-dependent release from these cells. The 36Cl- 
efflux response in the presence of 500 µM DIDS (Fig. 5.7.; ±DIDS in the presence of 
ionomycin × time, P = 0.71) was similar to the lack of effect observed at a concentration 
of 100 µM DIDS (not shown). 
 Glibenclamide has been reported to be a relatively specific inhibitor of the 
chloride transport activity of CFTR. Addition of glibenclamide to the cell wash 
solutions and to the efflux medium at a concentration of 100  µM reduced the initial rate 
of ionomycin dependent 36Cl- efflux from pCLCA1-transfected 3T3 cells (Figure 5.8; 









Figure 5.6   Inhibition of ionomycin-dependent chloride efflux from pCLCA1-
transfected 3T3 cells by calcium-calmodulin kinase inhibitor KN-93. Loading and 
efflux conditions were as described for Fig. 2. Ionomycin (10 µM) was added at time 0. 
○, Ionomycin alone; ▼, ionomycin plus 20 µM KN-93; ●, pCLCA1 control without 


















Figure 5.7.   Effect of 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS) on 
ionomycin dependent chloride efflux from pCLCA1-transfected 3T3 cells. Loading and 
efflux conditions were as described for Fig. 3. Ionomycin (10 µM) was added to all cells 
at time 0. ●, Ionomycin alone, with no DIDS added; ○, DIDS (500 µM) present in 
efflux buffer during the 5 washes and for the first 8 min of the efflux, with ionomycin 













Figure 5.8.   Inhibition of ionomycin-dependent chloride efflux from pCLCA1-
transfected 3T3 cells by glibenclamide. Loading and efflux conditions were as 
described for Fig. 2. Ionomycin (10 µM) was added to all cells at time 0. ●, Ionomycin 
alone, with no glibenclamide added; ○, glibenclamide (100 µM) present in efflux buffer 
during the 5 washes and for the first 8 min of the efflux, with ionomycin added at time 
0. * Significant effect of glibenclamide on ionomycin-dependent Cl- efflux. Values are 





36Cl- efflux from pCLCA1-transfected 3T3 cells was inhibited by other anion channel 
blockers that fall in the broad category of lipid-soluble anions. α-PC, DPC, and NPPB 
all inhibited 36Cl- efflux from loaded cells when used at concentrations employed by 
others for this purpose. Walsh et al. (Walsh, Long et al. 1999) have reported a Ki value 
of 130  µM for the inhibition of CFTR-mediated chloride conductance by NPPB. 
Preliminary investigations into the apparent affinity of DPC and NPPB for inhibition of 
36Cl- efflux indicated that both of these inhibitors were effective at concentrations as 
low as 10 µM for DPC (Fig.5.9; ±10  µM DPC, P = 0.012) and 50  µM for NPPB 
(Figure. 5.10.; ±50 µM NPPB, P < 0.001). Hence, it appears that distinctive inhibitor 
affinities could be investigated as a tool for discriminating between possibly competing 
chloride conductance proteins until a thorough search for specific inhibitors can be 
completed (Hipper, Mall et al. 1995). 
  α-PC has been reported to inhibit conductive chloride uptake by ileal mucosal 
brush border vesicles (Forsyth and Gabriel 1989b). The anion conductance in this 
vesicle system was inhibited by the monoclonal antibody that was used to clone 
pCLCA1 from a porcine small intestinal cDNA library. These circumstances would lead 
to the prediction that α-PC may be an inhibitor of expressed pCLCA1 activity. The rate 
of ionomycin-dependent chloride efflux from 3T3 cells transfected with pCLCA1 was 
significantly reduced by the inclusion of  α-PC in the efflux buffer (Figure 5.11.; ±  α-












Figure 5.9.   Inhibition of ionomycin-dependent chloride efflux from pCLCA1-
transfected 3T3 cells by diphenylamine carboxylate (DPC). Loading and efflux 
conditions were as described for Fig. 2. Ionomycin (10 µM) was added to all cells at 
time 0. ●, Ionomycin alone, with no DPC added; ○, ionomycin plus 10 µM DPC; ▼, 
ionomycin plus 50 µM DPC; ?, ionomycin plus 200 µM DPC. * Significant inhibition 
of Cl- efflux by 200 µM DPC. ^ Significant inhibition of Cl- efflux by 50 µM DPC.  ⎯ 



























Figure 5.10.   Inhibition of ionomycin-dependent chloride efflux from pCLCA1-
transfected 3T3 cells by 5-nitro-2-(3-phenylpropylamino) benzoate (NPPB). Loading 
and efflux conditions were as described for Fig. 2. Ionomycin (10 µM) was added to all 
cells at time 0. ●, Ionomycin alone, with no NPPB added; ○, ionomycin plus 2 µM 
NPPB; ▼, ionomycin plus 10 µM NPPB; ?, ionomycin plus 50 µM NPPB. * 
Significant effect of 50 µM NPPB on ionomycin-dependent Cl- efflux.Values are means 


















Figure 5.11.   Inhibition of ionomycin-dependent chloride efflux from pCLCA1-
transfected 3T3 cells by α - phenylcinnamate (α - PC). Loading and efflux conditions 
were as described for Fig. 2. Ionomycin (10 µM) was added to cells at time 0. ●, 
Ionomycin alone, with no α-PC added; ○, ionomycin plus 100 µM α-PC. * Significant 






5.4.4.  Whole Cell Patch Clamp 
 pCLCA1 contributes to an outwardly rectifying calcium-activated chloride 
current when expressed in the NIH/3T3 cell line. Transfection of NIH/3T3 cells with 
pCLCA1 significantly increased an outwardly rectifying calcium-activated chloride 
current above the levels present in cells transfected with pcDNA3 vector (Figure 5.12). 
The current density in a high-chloride bath solution (156 mM Cl) was significantly 
higher than in controls at 40, 80, and 100 mV in the pCLCA1-transfected cell line 
(±pCLCA1 vs. voltage, P < 0.001, n = 8). The Erev in the pCLCA1-transfected cell line 
(-10.3 ± 2.8 mV, n = 8) was significantly more negative than the Erev measured in the 
vector control cell line (0.7 ± 2.6 mV, n = 8, P = 0.027). 
 The current density in a low-chloride bath solution (46 mM Cl) was significantly 
higher than in controls at 80, 60, 80, and 100 mV in the pCLCA1-transfected cell line 
(±pCLCA1 vs. voltage, P < 0.001, n = 8). The Erev in the pCLCA1-transfected cell line 
shifted significantly from that seen in the high-chloride bath solution (0.7 ± 2.9 mV, n = 
8, P = 0.036), fulfilling one criterion of a chloride current (Figure 5.13).  However, the 
Erev did not shift on transfer of the pcDNA3, control-transfected cell line to the bath 
solution containing 46 mM Cl- (0.8 ± 2.1 mV, n = 8). No difference was found between 
the Erev of the two cell lines at low chloride concentrations. 
 The effect of anionic current inhibitors on whole cell currents in pCLCA1-
transfected and control cell lines was measured because the Erev deviated from the 
theoretical value for a pure chloride current. Whole cell currents were studied in the 
presence of inhibitory concentrations of DPC, α-PC, NPPB, and DIDS. The case for the 




















Figure 5.12.   Effect of ionomycin on whole cell chloride currents in NIH/3T3 
fibroblasts transfected with the pcDNA3.1 vector or with the vector containing 
pCLCA1 cDNA. Current (bottom) vs. 20-mV increments in transmembrane potential 
(top) are shown for control cells transfected with vector alone (A) and for cells 
transfected with pcDNA3 containing pCLCA1 cDNA (B).○ , 10 µm ionomycin added 
to cells at t = 0; ●, no ionomycin added. P < 0.001 for voltage × gene interaction (2-way 
repeated-measures ANOVA). * Voltages at which current is significantly higher in cells 
transfected with pCLCA1 (post-ANOVA multiple comparison analysis). At 42 mM 
internal Cl- and 156 mM external Cl, the mean Erev values were 0.74 ± 2.6 mV for 
control-transfected cells and  -10.3 ± 2.8 mV for pCLCA1-transfected cells (P = 0.027). 
Representative current-voltage tracings are given for each cell line. Values are means ± 














Figure 5.13. Whole cell current-voltage relationship in control- and pCLCA1-
transfected NIH/3T3 fibroblasts with symmetrical chloride concentrations. Erev values 
were 0.76 ± 2.1 mV for controls and 0.73 ± 3.0 mV for pCLCA1-transfected cells (P = 
0.99) with pipette and extracellular chloride concentrations at 44 and 46 mM, 
respectively. ○, control-transfected cells; ●, pCLCA1-transfected cells. P < 0.001 for 
voltage × gene interaction (2-way repeated-measures ANOVA). * Voltages at which 
current is significantly higher in cells transfected with pCLCA1 (post-ANOVA multiple 





whole cell current by DPC, α-PC, and NPPB (Figure 5.14.); compared with controls, P 
values were 0.027, 0.009, and 0.011, respectively, for these inhibitors. There was no 
significant effect of inhibitors on whole cell currents from control pcDNA3-transfected 
cells. 
 
5.5. Discussion  
 The presence of calcium-dependent electrogenic chloride currents in fibroblasts 
transfected with pCLCA1 cDNA is an indication of the identity of a component of the 
secretory apparatus in porcine small intestine. There is a significant amount of evidence 
pointing to a signaling role for calcium in this tissue. Ricinoleate and the bile acid 
deoxycholate have calcium ionophore activity and calcium-dependent secretory activity 
when placed in the lumen of the porcine small intestine (Maenz and Forsyth 1982). 
Even the secretory effects of cholera toxin have been reported to operate in this tissue 
through calcium ionophore activity present in the A-subunit of the enterotoxin (Maenz, 
Gabriel et al. 1987). This feature is particularly salient in the porcine small intestine 
where cholera toxin causes fluid secretion without detectable increases in cAMP 
concentration (Forsyth, Hamilton et al. 1978a). Though there is very little evidence for 
calcium-dependent chloride conductance in mouse and human small intestine, these 
species have calcium-dependent chloride conductance in other important secretory 
tissues including the tracheal epithelium (Grubb and Gabriel 1997; Gabriel, Makhlina et 
al. 2000). Upregulation of a calcium-dependent chloride conductance may occur as a 
compensatory response to a loss of CFTR function in the trachea(Gabriel, Makhlina et 















Figure 5.14. Effect of inhibitors on whole cell patch-clamp currents at +100 mV in 
pCLCA1- and pcDNA3 transfected 3T3 cells. Open bars, 3T3 cells expressing 
pCLCA1; hatched bars, 3T3 control cells. Final inhibitor concentrations were 100 µM 
DPC, 100 µM α-PC, 50 µM NPPB, and 300 µM DIDS. * Significant difference from 
whole cell current measured in uninhibited pCLCA1 cells (1-way ANOVA with post 





intestine of cystic fibrosis patients (Taylor, Baxter et al. 1988) may also be a reflection 
of a regulatory interdependence of proteins involved in chloride conductance.  
 The absence of a chloride efflux response to cAMP in pCLCA1-transfected cells 
raises questions about the role of the strong A-kinase consensus site located on what 
appears to be an important cytosolic loop of this protein. More complex combinatorial 
experiments are required to investigate possible interactions between A- and C-kinase 
phosphorylation acceptor sites that could be involved in regulating the conductance 
activity associated with pCLCA1 transfections. The effects of simultaneous activation 
of two or more classes of protein kinase acceptor sites remain to be determined.  
 Conservation of C-kinase sites between hCLCA1 and pCLCA1 isoforms could 
be construed as evidence of a role for these acceptor sites in channel regulation. This 
proposed role is supported by evidence of activation of bCLCA1 conductance by PMA. 
However, the failure of treatment with PMA to increase the rate of chloride efflux from 
pCLCA1-transfected cells creates significant uncertainty about the role of C-kinase in 
the stimulation of this conductance by calcium. Activation of the A-isoform of C-kinase 
by PMA or epidermal growth factor is reported to inhibit tissue short-circuit currents 
induced by forskolin or carbamyl choline (Chow, Uribe et al. 2000; Song, Hanson et al. 
2001). Although a component of these inhibitory effects could also be operating via a 
basal potassium conductance, it is clear that there is no necessary connection between 
C-kinase activation and increased calcium-dependent chloride conductance. At least the 
evidence in this study of the reduced rate of ionomycin-dependent 36Cl- efflux from 
cells treated with the intracellular calcium chelator BAPTA reinforces the assumption 
that Ca 2+ is directly involved in the regulation of pCLCA1 activity.  
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 The role of disulfide bonding in stabilizing CLCA channel structure and activity 
is somewhat controversial. Polypeptides arising from post translational cleavage of 
bCLCA1 may require disulfide bonding to retain conformation or aggregation 
properties necessary for function. However, the lack of an inhibitory DTT effect on 
chloride conductance activity of non glycosylated forms of bCLCA1 is not completely 
consistent with a role for disulfide bonding in structural stabilization (Fuller and Benos 
2000b; Fuller and Benos 2000a). The predicted amino acid sequence of pCLCA1 
contains conserved post translational cleavage sites found in bCLCA1 and hCLCA1, 
but post translational processing has not been investigated for this protein. We conclude 
that there is no evidence for a requirement for disulfide bonding in pCLCA1 translation 
products in assays measuring the rate of 36Cl- efflux from transfected 3T3 fibroblasts.  
 The chloride conductance of most endogenous calcium-activated chloride 
channels is inhibited by DIDS. The overall similarity of predicted amino acid sequence 
between hCLCA1 and pCLCA1 leads to a prediction of similar charge distribution and 
geometry for an anion pore involved in chloride transport. However, there are also 
significant differences in amino acid sequence that could affect the access of a bulky 
organic anion like DIDS to inhibitory sites. There is no information currently available 
concerning the three-dimensional structure of a possible anion pore in the CLCA 
proteins.  
 Both NPPB and DPC inhibited 36Cl- efflux at relatively low concentrations. 
There was significant inhibition at 50  µM NPPB, consistent with reports of Ki values in 
the range of 22  µM for blockage of calcium-activated chloride currents in Xenopus 
oocytes (Wu and Hamill 1992; Hipper, Mall et al. 1995). Chloride conductance by 
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CFTR is also reported to be inhibited by NPPB, but significantly higher concentrations 
of NPPB are required (Ki = 166  µM) (Hipper, Mall et al. 1995; Walsh, Long et al. 
1999). Hence, this inhibitor should be useful in distinguishing between the chloride 
conductance of pCLCA1 and CFTR.  
 Inhibitory concentrations of DPC and α-PC may also permit discrimination 
between alternate chloride conductance proteins as mediators of a measured chloride 
conductance. Nishikawa et al. (Nishikawa, Ishihara et al. 1995) reported that chloride 
influx into porcine tracheal submucosal glands was inhibited by 10-9 M DPC. Maximal 
inhibition of 36Cl- efflux from pCLCA1-transfected 3T3 cells was obtained at 10 µM 
DPC in this study, although lower concentrations were not investigated. Much higher 
concentrations of DPC are necessary to inhibit CFTR (reported Ki values of 280  µM 
for internal application) (Zhang, Zeltwanger et al. 2000).  α-PC is a potential specific 
inhibitor of pCLCA1, but its effects on CFTR-mediated chloride conductance have not 
been reported.  
 Previous investigations of cloned pCLCA1 function were based on net in situ 
36Cl- efflux from cells grown as confluent monolayers. Whole cell chloride current 
measurements provide the information necessary to distinguish between anion exchange 
and electrogenic ion transport (Racette, Gabriel et al. 1996; Gaspar, Racette et al. 2000). 
The increased current density in pCLCA1-transfected cell lines over control-transfected 
cells and the Nernstian shift of Erev on introduction to a low-chloride bath solution 
provide a rigorous demonstration of the electrogenic movement of chloride that cannot 
be supplied by 36Cl- efflux. However, in a bath solution with high chloride 
concentration, the calculated Erev using the Nernst equation at 25oC is 32.4 mV. This 
 146
calculated value is significantly different from the measured Erev of 10.26 ± 2.8 mV. 
This deviation of the measured from the calculated Erev is assumed to be caused by an 
undefined endogenous calcium-activated current. The contaminating endogenous 
current in control-transfected cells had an Erev of 0.738 ± 2.6 mV, in violation of the 
Nernst equilibrium potential for chloride with a bath solution concentration of 156 mM 
and a pipette solution at 44 mM Cl. The Erev of this current was unaffected upon a shift 
to low chloride concentration (46 mM) in the bath solution. The identity of the 
conductive ion affecting the Erev values for the channel is difficult to discern. The ionic 
compositions of bath and pipette solutions were set to permit direct identification of the 
ion producing the current from Erev values. However, the measured Erev was not 
consistent with a current attributable to any single ionic species in the bathing solution.  
 The activation of both cationic and anionic channels, or a channel with a high 
permeability to both cations and anions could have produced the observed result. The 
calculated Erev for sodium is 128.7 mV in our high-chloride bath solution. A significant 
increase in sodium permeability would cause a positive shift from the expected chloride 
Erev. Cation permeability of anion channels is known, and anion channels with 
PNa+/PCl- ratios as high as 0.2 have been reported (Franciolini and Nonner 1987; Qu 
and Hartzell 2000; Hille 2001). In our case an endogenous chloride channel with some 
cation permeability could alter the Erev at high bath chloride concentration without 
shifting the Erev when both sodium and chloride concentrations were reduced.  
 The identity of the anionic current associated with pCLCA1 expression was 
confirmed by an electrogenic response distinctive from endogenous contaminating 
currents and by the reduction of ionomycin-induced currents to control levels by anionic 
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conductance inhibitors. Additional confirmation was provided by the lack of effect of 
anion conductance inhibitors on the basal levels of contaminating current in cells 
transfected only with the expression vector. The nature of the contaminating current has 
not been pursued beyond its insignificant response to these inhibitors.  
 The pathophysiological significance of a calcium-activated chloride current in 
the airway epithelium is well established. Expression of pCLCA1 in tracheal epithelium 
has been documented (Gaspar, Racette et al. 2000). The current studies support the role 
of pCLCA1 as a chloride conductance mediator. The extent to which this protein 
contributes to the in vivo conductance in both the presence and absence of a functional 
CFTR molecule is an area for future investigation.
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Chapter 6. pCLCA1 BECOMES A cAMP-DEPENDENT CHLORIDE 
CONDUCTANCE MEDIATOR IN CACO-2 CELLS
 
6.1. Abstract 
 Members of the CLCA protein family are expressed in airway and intestinal 
epithelium, where they may participate in secretory activity as mediators of chloride 
conductance. A calcium-dependent chloride conductance has been observed upon 
expression of CLCA proteins in non-epithelial cell lines. The pCLCA1 gene, cloned in 
our laboratory, codes for a product containing a unique A-kinase consensus acceptor 
site not found in other CLCA proteins. Calcium-dependent, but not cAMP-dependent, 
chloride conductance increased when pCLCA1 was expressed in NIH/3T3 fibroblasts. 
We transfected the Caco-2 human colon carcinoma cell line with pCLCA1 to 
investigate the regulation of CLCA-associated chloride conductance in this 
differentiated epithelial cell line. Expression of pCLCA1 in the Caco-2 cell line 
enhanced cAMP-responsive 36Cl- efflux, short circuit current, and whole cell chloride 
current in these cells. This cAMP-dependent chloride conductance was localized to the 
apical membrane of polarized Caco-2 cells. 
 
6.2. Introduction 
 The CLCA protein family was named for the appearance of a calcium-activated 
chloride conductance upon its expression in undifferentiated HEK293 cells. The family 
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includes a group of structurally related proteins with diverse functions ranging from 
promoting chloride transport to cellular adhesion and anti-tumor actions (Elble, Widom 
et al. 1997; Gruber, Elble et al. 1998; Gruber and Pauli 1999c; Gaspar, Racette et al. 
2000). Chloride conductance in porcine enterocytes and net fluid secretion into the 
intestinal lumen can be activated by cAMP, cGMP, or by calcium ionophores (Scoot, 
Forsyth et al. 1980; Maenz and Forsyth 1987; Forsyth and Gabriel 1989a). A 
monoclonal antibody that inhibited cAMP-dependent chloride conductance in pig ileal 
brush border vesicles (Racette, Gabriel et al. 1996) was used to clone the pCLCA1 
cDNA (Gaspar, Racette et al. 2000). There was 78% amino-acid sequence identity of 
pCLCA1 compared to the hCLCA1 sequence reported by Gruber et al. (Gaspar, Racette 
et al. 2000). Prominent differences between the two predicted protein structures 
included a strong A-kinase consensus site on the cytoplasmic loop between the putative 
TM3 and TM4 domains of pCLCA1. Expression of the pCLCA1 protein in NIH/3T3 
fibroblasts induced a calcium-dependent chloride efflux and an outwardly rectified 
chloride current in transfected cells (Loewen, Gabriel et al. 2002). However, cAMP 
addition had no effect on the rate of chloride efflux from NIH/3T3 cells transfected with 
the pCLCA1 gene (Gaspar, Racette et al. 2000; Loewen, Gabriel et al. 2002). 
 We hypothesized that native physiological regulation and function of pCLCA1 
may require expression in an epithelial cell line. Caco-2 cells were chosen as an 
expression system for their polarized, epithelial, growth characteristics. In addition to a 
gut epithelial origin, the lack of endogenous CLCA expression makes these cells a 
convenient model to study pCLCA1 function. 
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 We report here that the expression of the pCLCA1 gene in the polarized Caco-2 
intestinal epithelial cell line increased the endogenous cAMP-sensitive chloride efflux, 
apical short circuit current, and linear whole cell current in these cells. 
6.3. Materials and Methods 
6.3.1. Materials  
 Tissue culture media, G418 antibiotic, and Superscript II reverse transcriptase 
were purchased from Gibco Life Technologies, Taq and Pfu polymerases were from 
Stratagene, and 36Cl- was from New England Nuclear. Oligonucleotides were 
synthesized at the Core DNA Services Laboratory, University of Calgary. 
 
6.3.2. Cell lines  
 Caco-2 cells were grown in DMEM as described previously (Gaspar, Racette et 
al. 2000). Permanent transfectants were maintained with 500 µg/ml of G418 in the 
growth medium. mRNA expression. RT-PCR was performed as previously described 
(Loewen, Bekar et al. 2002). Reverse transcriptase was primed with oligo dT. Antisense 
and sense primers chosen to amplify pCLCA1or hCLCA1 (5'-
CAGGTTGGTCTTATCGACAG-3') and (5'-ACGATGCAAATGGTCGATACAG-3') 
were used to produce a common 565 base-pair product from cDNA. PCR for CFTR was 
primed with CF4234a (5' GCACTGGGTTCATCAAGCAG-3') and CF3578s (5'-
CCAGCATAGATGTGGATAG-3') primers to amplify a 738 base-pair fragment. 
 
6.3.3. Chloride Efflux  
 Caco-2 cell 36Cl- efflux response to addition of 10 µM forskolin and 2.0 mM 
isobutylmethylxanthine (IBMX) was measured as reported previously (Gaspar, Racette 
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et al. 2000; Loewen, Gabriel et al. 2002). Briefly, confluent monolayers of cells grown 
in 3 cm dishes were loaded for 2 h in isotonic medium containing 36Cl- (2 Ci/ml). After 
five rapid washings, efflux was initiated at time zero by adding and replacing isotonic 
efflux solution at 2 min intervals. Efflux agonist (10 M forskolin and 2 mM IBMX) was 
present from time zero. 36Cl- removed at 2-min intervals, and remaining in cells at the 
end of a 10-min efflux protocol, was determined by liquid scintillation counting. The 
rate constant for chloride release was calculated as: (0.5 (ln ((cell [Cl-]t1)/(cell[Cl-
]t2)))). 
 
6.3.4. Short Circuit Current Measurements 
 Differentiated monolayers of Caco-2 cells expressing pCLCA1 or control cells 
transfected with the pcDNA3 vector were mounted in Ussing chambers and equilibrated 
for 20 min in standard Krebs Bicarbonate Ringer's solution with 10 mM basal glucose 
and 10 mM apical mannitol prior to recording short circuit current (Isc) responses to 
addition of 10 µM forskolin and 2.0 mM IBMX. The response to the A-kinase agonist 
mixture was also measured across the apical membrane of confluent differentiated 
Caco-2 monolayers following permeabilization of the basal membrane by nystatin 
(Devor, Singh et al. 1999). Chloride gradients were established across monolayers of 
permeabilized cells by replacing chloride with gluconate and sodium and potassium 
with Tris. The high Cl- solution contained 147 mM Tris–Cl, 30 mM mannitol, 5 mM N-
tris [hydroxymethyl]methyl-2-aminoethanesulfonic acid, 2 mM CaCl2, and 1 mM 
MgCl2, pH 7.4. The low Cl- solution contained 130 mM Tris–base, 130 mM -gluconic 
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acid, 17 mM Tris–Cl, 30 mM mannitol, 2 mM CaCl2, and 1 mM MgCl2, pH 7.4. A 100 
mV potential was also imposed to drive chloride from the basal to apical cell surface. 
 
6.3.5. Whole Cell Voltage–Clamp Studies 
 Patch clamp electrodes were pulled from borosilicate glass capillaries (outer 
diameter 1.5 mm; inner diameter 1.17 mm) with an inner filament (Harvard Apparatus, 
Edenbridge, UK) on a P-97 Flaming/Brown micropipette puller (Sutter Instrument). 
Patch pipettes had a tip resistance of 2–4 MΩ with solutions used in this study. Whole 
cell currents were acquired with an Axopatch 200B amplifier (Axon Instruments, Foster 
City, CA) at 10 kHz, and filtered at 2 kHz by a low pass Bessel filter with Clampex 8, 
and analyzed with Clampfit 8 (Axon Instruments). The standard voltage–clamp protocol 
had a holding potential of -80 mV, with voltage pulses applied for 800 ms from -100 to 
+100 in 20 mV increments. After a >1 GΩ seal was obtained, capacitance compensation 
was carried out before whole cell access. Subsequent to whole cell access, all cells were 
dialyzed for 2 min before recording. Only cells with a membrane resistance >10 times 
the access resistance were used. Current differences were normalized by whole cell 
capacitance recorded from an integrating 10 mV hyperpolarizing pulse. All membrane 
potentials were corrected at the time of analysis for the measured junction potential. 
 The pipette solution for intracellular dialysis contained 110 mM NaCl, 8 mM 
MgCl2, 2.4 mM K2HPO4, 0.8 mM KH2PO4, 4 mM Na2ATP, and 5 mM ethyleneglycol-
bis-(-aminoethylether) N,N'-tetraacetic acid (EGTA), pH to 7.4 with NaOH. The high-
chloride bath solution contained 135 NaCl, 2.4 mM K2HPO4, 0.8 KH2PO4, 3 mM 
MgCl2, 1 mM CaCl2, 10 mM glucose, and 80 mM sucrose, pH to 7.4 with NaOH. The 
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low-chloride bath solution contained 40 mM NaCl, 2.4 mM K2HPO4, 0.8 KH2PO4, 3 
mM MgCl2, 1 mM CaCl2, 10 mM glucose, and 270 mM sucrose, pH to 7.4 with NaOH. 
Single-cell, rapid solution changes were applied by using a gravity-fed Perfusion Fast-
Step SF-77B perfusion system (Warner Instrument, Hamden CT).  
 Addition of 10 µM forskolin and 1 mM IBMX and changes in chloride 
concentration in the bath solution were achieved through a single-cell bath solution 
change. 
 
6.3.6. Statistical Methods  
 Student's t-test was used to compare conductances in permeabilized cells. A 
two-way repeated measures ANOVA was used to compare overall and treatment by 
time effects.  The Fisher LSD method for pairwise multiple comparisons was used as a 
post-ANOVA test to determine treatment effects at individual points. 
 
6.4. Results 
6.4.1. Effect of pCLCA1 on cAMP-stimulated 36Cl- Efflux 
 Caco-2 cells have an endogenous cAMP-responsive chloride conductance 
associated with high CFTR expression (Sood, Bear et al. 1992). Expression of pCLCA1 
in Caco-2 cells caused a significant increase in the cAMP-sensitive rate of chloride 
efflux from these cells (Figure 6 .1., P<0.001). There was also a significant interaction 













Figure 6.1.  Effect of transfection of Caco-2 cells with pCLCA1 on rate of cAMP-
dependent chloride efflux.  pCLCA1-transfected Caco-2 cells with forskolin and IBMX 
●, without A-kinase activators ?; pcDNA3 control-transfected Caco-2 cells with 
forskolin and IBMX. ○; without A-kinase activators ? . *Significant effect of pCLCA1 
on A-kinase-stimulated chloride efflux rate. n=8±SE. 
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(P=0.003). The overall effect of pCLCA1 transfection was significant in unactivated 
cells (P<0.001), but the interaction between ±pCLCA1 and efflux time was not 
significant (P=0.51).  
 The relative expression of CFTR and CLCA1 mRNA species in the control and 
in pCLCA1-transfected Caco-2 cells is shown in Figure 6.2. The PCR result showed 
much lower levels of pCLCA1 mRNA expression than CFTR mRNA expression. 
Unequal lane loading (15 µl pCLCA1 PCR product vs 1 µl CFTR PCR product) had to 
be used to give good visual comparison of the relative expression of these mRNA 
species in Caco-2 cells. As noted for other tumorigenic cell lines (Gruber and Pauli 
1999c), we were not able to detect endogenous hCLCA1 mRNA expression in Caco-2 
cells.  
 
6.4.2. Effect of pCLCA1 on cAMP-stimulated Short Circuit Current 
 Changes in the rate of chloride efflux representing chloride conductance in 
polarized epithelial cells should be paralleled by changes in short circuit current (Isc). 
Caco-2 cells grown on semipermeable membranes produce a polarized epithelial cell 
layer with tight junction formation. The effect of forskolin and IBMX addition on the Isc 
measured across these polarized cells is shown in Figure.6.3. pCLCA1 transfection did 
not affect tissue resistance, but it significantly increased the increment in stimulated Isc 
at all times after A-kinase activation. Stabilized Isc values from 20 to 40 min after A-
kinase activation were 12±0.015 µA/cm2 for cells expressing pCLCA1 and 9.3±0.014 














Figure 6.2.  pCLCA1 mRNA in stable Caco-2 cell transfectants. Lane 1, RT-PCR 
primers to detect 565 base-pair fragment of CLCA1 mRNA in pcDNA3-transfected 
Caco-2 cells. Lane 2, RT-PCR-primers to detect 565 base-pair fragment of CLCA1 
mRNA in pCLCA1-transfected Caco-2 cells. Lane 3, PCR to detect 565 base-pair 
fragment of CLCA1 mRNA in pCLCA1-transfected Caco-2 cells without prior RT. 
Lane 4, 100 base-pair ladder. Lane 5, RT-PCR-primers to detect 738 base-pair fragment 
of CFTR mRNA in pcDNA3-transfected Caco-2 cells. Lane 6, RT-PCR-primers to 
detect 738 base-pair fragment of CFTR mRNA in pCLCA1-transfected Caco-2 cells. 
Lane 7, PCR to detect 738 base-pair fragment of CFTR mRNA in pCLCA1-transfected 
















Figure 6.3.  Average increments in short circuit current caused by A-kinase activation in 
monolayers of transfected Caco-2 cells. Isc differences due to addition of forskolin and 
IBMX at 1 min (↑) are recorded for Caco-2 cells transfected with; ● pCLCA1 insert, o 
pcDNA3 without an insert. P values for all differences at individual time points after A-




6.4.3. Effect of pCLCA1 on cAMP-Stimulated Apical Short Circuit Current 
 Permeabilization of the basal membrane of epithelial cells to monovalent cations 
and anions by addition of nystatin produces an electrically isolated apical membrane 
(Devor, Singh et al. 1999). This condition was used to prevent contributions of 
membrane hyperpolarization to changes in chloride current across the apical membrane. 
Transepithelial conductance increased and the transepithelial potential declined to 0 mV 
with the equilibration of intra- and extracellular sodium and potassium after nystatin 
addition. Activation of A-kinase in these permeabilized pcDNA3-transfected Caco-2 
cells produced a Isc that was dependent on the magnitude and the direction of the 
chloride ion gradient across the cell monolayer. The increment in cAMP-dependent Isc 
with high (150 mM) apical Cl- and 20 mM basal Cl- was significantly increased relative 
to control-transfected cells (Figure 6.4., P=0.003). There was no effect of pCLCA1 
expression on cAMP-dependent increments in Isc with the reverse Cl- gradient (150 
mM basal, 20 mM apical) (P=0.345). The effect of pCLCA1 on cAMP-dependent 
increments in Isc with 150 mM basal and 20 mM apical Cl- with a 100 mV potential 
difference imposed across the epithelial monolayer approached significance (P=0.06). 
The pCLCA1-associated Isc increments in Caco-2 cells with permeabilized basal 
membranes indicate that an apical cAMP-dependent chloride conductance increased 
independent of basal K+ conductance effects.  
 
6.4.4. Effect of pCLCA1 on cAMP-Stimulated Whole Cell Patch Clamp Current 
 The characteristics of the whole cell currents associated with pCLCA1-













Figure 6.4. Effect of pCLCA1 transfection on short circuit current changes caused by A 
kinase activation in Caco-2 monolayers with permeabilized basal membranes. Average 
changes in Isc 4 min after forskolin and IBMX addition to monolayers permeabilized by 
exposure to basal nystatin are reported. Electrical and chloride ion gradients responsible 
for generating the Isc in monolayers with permeabilized basal membranes are indicated. 
Negative changes represent apical to basal (absorptive) increments in Isc, positive 
increments in Isc represent basal to apical current flow. Black bars, pCLCA1-transfected 




pClCA1-transfected cells and nine vector control cells were successfully recorded. Data 
from cells failing to show an Erev shift on exposure to a bath solution containing low 
chloride concentration were not considered. A significant pCLCA1 overall gene effect 
on peak whole cell currents 30 s after the addition of 10 µM forskolin and 1 mM IBMX 
(P=0.017) is shown in Figure. 6.5A. Significant post-ANOVA differences occurred at -
100 mV and -80 mV (P<0.001), -60 mV (P<0.011), 80 mV (P=0.008), and 100 mV 
(P<0.001). The Erev values for the pClCA1-transfected cell line (1±1.6 mV) and the 
vector control (-5.1±3.4 mV) with 126 mM internal, and 143 mM external Cl- were 
similar (P=0.814) and neither value differed significantly from the calculated chloride 
Erev of -3.2 mV. The overall gene effect of pClCA1 on unstimulated whole cell currents 
(Figure. 6.5B) approached significance (P=0.089) and the voltage × gene interaction 
was significant (P<0.001). Post-ANOVA analysis detected significant gene effects at      
-100 mV (P=0.001), -60 mV (P=0.009), and -40 mV (P=0.048). The pClCA1-
transfected cell line had an Erev of -2.5±1.2 mV and the vector control Erev was -
19.5±6.9 mV. This difference of Erev under basal conditions with [Cl-i]=126 mM and 
[Cl-o]=143 mM was significant (P=0.016). 
 There was a significant change in Erev values (Fig. 6.5C) when cells stimulated 













Figure 6.5.  Effect of pCLCA1 expression on whole cell currents in Caco-2 cells. Caco-
2 cells were transfected with pcDNA3.1 vector, o, or with the vector containing 
pCLCA1 cDNA,● . (A) Peak whole cell currents 30 s after the addition of 10 µM 
forskolin and 1 mM IBMX to cells with 126 mM internal and 143 mM external Cl-. (B) 
Peak whole cell currents in unstimulated cells with 126 mM internal and 143 mM 
external Cl-. (C) Peak 10 µM forskolin and 1 mM IBMX-stimulated whole cell currents 
in cells exposed to 126 mM internal and low (48 mM) external chloride. *Voltages at 
which current was significantly higher in cells transfected with pClCA1 as determined 




concentration ([Cl- o] reduced from 143 to 48 mM Cl- in the bath, [Cl-i]- maintained at 
126 mM). Erev values of 18.83 ± 1.4 mV in pClCA1-transfected cells and 11±2.5 mV 
in the vector controls with 48 mM Cl- in the bath can be compared to the calculated 
chloride equilibrium potential of 24.45 mV. P values were 0.029 and 0.012 for this Erev 
shift in pClCA1-transfected and vector control cells, respectively. The pCLCA1 effect 
on the difference between the Erev in 48 mM [Cl-o] was not significant (P=0.607). As 
we observed for the high bath chloride concentration, there was a significant overall 
gene effect of pClCA1 to increase whole cell current in low bath chloride (P=0.007). 
Post-ANOVA analysis indicated significant pCLCA1 effects on elevation of current at -
100 mV, -80 mV, and -60 mV (P<0.001), -40 mV (P=0.006), and 100 mV (P<0.010). 
 
6.4.5. Discussion 
 The reduction or loss of a cAMP-dependent outwardly rectified chloride 
conductance in CF patients is thought to be the critical cellular component that is 
defective in CF disease (Frizzell, Rechkemmer et al. 1986) (Hayslett, Gogelein et al. 
1987). Functional reconstitution of the CFTR protein and the strong association of 
mapped mutations in CFTR with phenotypic variants of CF disease provide convincing 
evidence for the importance of this protein in exocrine chloride secretion (Bear, Li et al. 
1992; Clarke, Grubb et al. 1992; Tsui 1992). Defective chloride transport in CF disease 
is de facto evidence against independent chloride conductance of co-expressed CLCA 
or ClC proteins in the intestine. While this evidence supports the importance of the 
anion transport function for CFTR, it does not define the total requirements for in vivo 
chloride conductance. Other proteins could facilitate chloride conductance at several 
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levels. Accessory proteins may increase CFTR activity by affecting open-probability or 
numbers of functional CFTR channels in the apical membrane. There is also good 
evidence for a regulatory role of CFTR on other cAMP-dependent chloride conductance 
processes in exocrine tissues (Gabriel, Clarke et al. 1993; Guggino 1993). The 
outwardly rectified chloride conductance that is found to be defective in cystic fibrosis, 
and is reported to reside in a protein distinct from, but regulated by CFTR is a good 
example of this latter category. 
 Previous findings of a Ca2+- dependent release of 36Cl- from pCLCA1-
transfected NIH/3T3 cells (Gaspar, Racette et al. 2000; Loewen, Bekar et al. 2002) 
support the introduction of  anion conductance into the cytoplasmic membrane of 
transfected fibroblasts, or the activation of a quiescent endogenous chloride 
conductance. A-kinase activation did not stimulate this chloride conductance in 3T3 
cells, even though pCLCA1 contains a strong A-kinase consensus site and antibody 
used to clone pCLCA1 inhibited cAMP-dependent chloride conductance in jejunal 
brush border vesicles. In switching to the Caco-2 epithelial expression model we 
hypothesized that unique cell-specific accessory proteins related to the exocrine fluid 
secretion process may be required for cAMP-, but not for Ca2+ -responsiveness. 
Candidate accessory proteins that could be required for cAMP-responsiveness of 
pCLCA1, but could be under-expressed in fibroblasts, include ClC proteins, a cAMP-
sensitive K+ conductance, the Na+ K+/2Cl- cotransporter, and CFTR. 
 The elevation of both cAMP-dependent and unstimulated rates of 36Cl- efflux in 
pCLCA1-transfected Caco-2 cells in comparison to control-transfected cells was 
consistent with the background of the cloned pCLCA1 channel. The significant 
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pCLCA1 effect in the absence of a significant interaction between pCLCA1 transfection 
and efflux time in unstimulated cells would be expected if basal cAMP levels in these 
cells were responsible for a slight increase in open probability of a transfected or 
endogenous anion conductance. Significant group and group × time effects after 
addition of forskolin and IBMX were evidence for pCLCA1 effects on anion 
permeability that correlate with increases in the intracellular concentration of cAMP. 
 Reverse transcriptase-PCR data confirm that the Caco-2 cells do not express 
detectable levels of endogenous hCLCA1 mRNA. This finding is supported by 
observations of others who have shown loss of CLCA protein expression in tumorigenic 
cell lines (Gruber and Pauli 1999c). The data also identify significant expression of 
CFTR mRNA in this cell line. High CFTR expression correlates with the significant 
endogenous cAMP-dependent chloride conductance of Caco-2 cells. Relatively low 
amounts of pCLCA1 mRNA expression in the transfected Caco-2 cells were adequate 
to produce a significant impact on the endogenous cAMP-dependent chloride 
conductance of these cells. 
 Increased rates of chloride efflux could reflect activation of an anion exchange 
process. It is important to study polarized tissue in Ussing chambers to confirm that 
chloride efflux has an experimental counterpart in electrogenic chloride release from 
Caco-2 cells expressing pCLCA1 upon the activation of cAMP-sensitive anion 
channels. Our Ussing chamber experiments on intact polarized epithelium confirmed 
that the 36Cl- efflux response was representative of a unidirectional electrogenic chloride 
secretion. 
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 Increases in chloride conductance can occur without modulating chloride 
channel gating. Conditions that hyperpolarize the cell will increase the driving force for 
chloride exit through unstimulated apical anion channels. Rendering the basal 
membrane of an epithelial cell layer permeable to small anions and cations eliminates 
the endogenous electrical driving force. In this situation it is possible that cAMP-
dependent changes in the Isc produced by an imposed asymmetrical chloride 
concentration reflect an increase in open probability of an apical anion channel 
associated with pCLCA1 expression. 
 Significant increases in cAMP-dependent absorptive chloride current observed 
in Caco-2 cells expressing pCLCA1 (Fig. 6.4) were consistent with earlier observations 
of outward rectification of whole cell currents induced in NIH/3T3 cells expressing 
pCLCA1(Loewen, Bekar et al. 2002). Outwardly rectifying anion currents favor anion 
absorption, as we observed in the electrically isolated apical membrane of pCLCA1-
transfected Caco-2 cells. cAMP-dependent increments in outward (secretory) chloride 
currents, associated with pCLCA1 expression, only approached statistical significance 
in asymmetrical chloride solutions (150 mM basal, 20 mM apical) with an externally 
imposed 100 mV transmembrane potential difference. The combined effects of 
asymmetrical chloride and the imposed potential difference across the isolated apical 
membranes may approximate the normal forces driving chloride secretion in a cell with 
a significant apical transmembrane potential difference. 
 Whole cell patch clamp data confirm that cAMP-dependent increases in whole 
cell chloride current accompany pCLCA1 expression. The identity of the chloride 
currents was confirmed by shifts in the reversal potential as imposed chloride gradients 
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were changed. Deviations of the measured reversal potential from the calculated 
equilibrium potential for chloride were attributed to a combination of small amounts of 
contaminating Na+ current or leakage in the membrane-pipette seal. 
 This is the first instance of CLCA protein expression in a differentiated 
epithelial cell line. This is also the first report of activation of a member of the CLCA 
gene family by cAMP. How can the second messenger system controlling channel 
gating, be specific to the host cell used in the expression system? Electrical properties 
of the cytoplasmic membrane could differ significantly between fibroblast host and a 
polarized epithelial cell host, inducing different gating configurations and second 
messenger sensitivity for controlling chloride channel activity associated with pCLCA1 
expression. Current data support the hypothesis that pCLCA1 is not a chloride channel, 
but acts as a regulatory protein that can interact with and enhance the chloride 
conductance of ClC, CFTR, or ORCC chloride channels. Possible regulatory effects of 
pCLCA1 will be explored by expression in systems with variable levels of ClC and 
CFTR. Our results confirm that significant increments in cAMP-dependent chloride 
conductance can be induced in cells expressing pCLCA1. The novel findings from this 
model should be of broad interest, as they may have therapeutic applications in clinical 
disorders of exocrine secretion.
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Chapter 7.  CLCA PROTEIN AND CHLORIDE TRANSPORT IN CANINE 
RETINAL PIGMENT EPITHELIUM
 
7.1. Abstract:  
 Problems in ion and fluid transfer across the retinal pigment epithelium (RPE) 
are a probable cause of inappropriate accumulations of fluid between the photoreceptors 
of the retina and the RPE.  The activities of chloride transporters involved in basal fluid 
transfer across the RPE have been compared to determine whether calcium-dependent 
or cAMP-dependent channels may be responsible for basal housekeeping levels of 
secretory activity in this tissue. The role of a candidate calcium-dependent CLCA 
protein in the basal RPE transport of chloride has been investigated.  Low 
concentrations of the chloride conductance inhibitors glibenclamide and 5-nitro-2-(3-
phenylpropylamino) benzoate reduced the short circuit current in dog RPE preparations 
mounted in Ussing chambers, and decreased the calcium-dependent chloride efflux 
from fibroblasts expressing the pCLCA1 chloride conductance regulator.  However, 
these same agents did not inhibit the rate of chloride release from cultured fibroblasts 
expressing the cystic fibrosis transmembrane regulator (CFTR) conductive chloride 
channel. Addition of ionomycin to primary cultures of canine RPE cells or to fibroblasts 
expressing the pCLCA1 channel regulator increased the rate of release of chloride ion 
from both types of cultured cells.  However, the presence of pCLCA1 also increased 
cAMP-dependent chloride ion release from fibroblasts expressing CFTR. We conclude 
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that Ca2+-dependent chloride transport may be more important than cAMP-dependent 
chloride transport for normal fluid secretion across the RPE.  Further, it appears that 
CLCA proteins expressed in the RPE may regulate the activity of other chloride 
transporters, rather than functioning as primary ion transport proteins.  
 
7.2 Introduction 
 Ion transport activity in isolated RPE choroid preparations has been 
characterized by Tsuboi and co-workers (Tsuboi, Manabe et al. 1986; Tsuboi 1987) and 
by others (Bialek and Miller 1994). Their findings are consistent with a model where 
Na+/K+ ATPase activity in the apical RPE membrane, adjacent to the rod and cone 
photoreceptors, generates a sodium ion gradient across this membrane.  High 
extracellular levels of Na+ are harnessed to drive uptake of chloride and potassium by 
the RPE via a coupled Na+/ K+/2Cl- cotransporter localized to the same apical 
membrane. Activity of this cotransporter maintains RPE intracellular K+and Cl- 
concentrations above their respective equilibrium potentials. Net "absorptive" fluid 
movement (from the vitreous to the choroid) occurs with increased opening of basal 
chloride conductance channels on the choroidal side of the RPE, permitting Cl- release 
down its electrochemical potential. Sodium ions follow the released chloride to 
maintain electroneutrality, and osmotic forces draw water after the electrolytes to cause 
fluid to be "secreted" from the vitreous to the choriocapillaris. Disruptions in the 
direction or magnitude of this ion and fluid transport are one possible cause of 
conditions such as serous retinopathy (Hughes, Gallemore et al. 1998).  
 The activity of the basal chloride conductance channels that regulate this ion and 
fluid transport process is controlled by changes in the concentration of intracellular 
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second messenger molecules including 3',5'-adenosine monophosphate 
(cAMP)(Peterson and Miller 1995; Hughes, Gallemore et al. 1998) and intracellular 
Ca2+ (Joseph and Miller 1992; Ueda and Steinberg 1994).  However, there seems to be a 
significant degree of uncertainty about the relative importance of cAMP-dependent 
versus Ca2+-dependent chloride conductance in this tissue.  Recent studies on human 
fetal RPE indicate the presence of an apical adrenergic receptor in these cells (Quinn, 
Quong et al. 2001). Transepithelial potentials in the human fetal RPE cells responded 
positively to both cAMP and ionomycin, indicating activation of chloride conductance 
by A-kinase and by a Ca2+-dependent mechanism. Expression of the cystic fibrosis 
transmembrane regulator protein (CFTR) and variants of the ClC chloride channel, 
including ClC-3 has been reported in human RPE (Miller, Rabin et al. 1992; Wills, 
Weng et al. 2000).  
 Although there is much evidence for CFTR expression in this tissue there are no 
reports of serous retinopathy in cystic fibrosis patients.  Based on this evidence it seems 
likely that calcium-dependent chloride channels may be responsible for most of the 
basal housekeeping levels of secretory activity in RPE. 
 Studies on an inherited multifocal retinopathy (Grahn, Philibert et al. 1998), and 
on the distribution of a member of the CLCA choride conductance channel family 
(Fuller and Benos 2000b; Fuller and Benos 2000a) cloned recently in our laboratory 
(Gaspar, Racette et al. 2000) have led us to use inhibitor sensitivity profiles to examine 
the relative roles of cAMP-dependent CFTR versus Ca2+-dependent chloride 
conductance proteins in the basal housekeeping levels of secretory activity occurring in 
this tissue.  Basal and activated short circuit current has been measured across RPE-
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choroid preparations.  Extension of these studies to primary cultures of canine RPE cells 
has permitted comparisons of the importance of CFTR and Ca 2+-dependent chloride 
channels in this process.  The results of this study suggest a novel role for the canine 
isoform of pCLCA1 in RPE cells.  
 
7.3 Methods 
7.3.1. Ussing Chamber Electrophysiology  
 Guidelines of the Canadian Council on Animal Care were followed in 
harvesting eyes from healthy dogs that had been euthanized by others for non-medical 
reasons. The posterior portion of the eye was bisected to separate tapetal and non-
tapetal areas.  After removing the sclera and the retina the RPE-choroid preparations 
were mounted in Costar 5mm diameter vertical diffusion chambers.  The bathing 
solution was Krebs Ringer bicarbonate buffer pH 7.5 containing 5.5 mM glucose and 
5.0 mM K+ ion.  Tissues were maintained at 37 o C, and oxygenated with 95% O2, 5% 
CO2.  Electrical measurements were made with glass barreled microelectrodes 
(Navicyte) using an EVC 400 Precision voltage/current clamp (World Precision 
Instruments).  Measurements were made after stable transepithelial potentials were 
achieved (20 to 30 minutes after mounting tissues). Chloride conductance inhibitors 
were added to tissue bathing solutions from stock solutions in dimethylsulfoxide 
(maximum final DMSO concentration of 0.1%).  
 
7.3.2. Conditions for Primary Culture of Dog RPE.    
 Enucleation was carried out under sterile conditions.  Eyes were rinsed with 
Betadine disinfectant and dissected in a sterile environment.  The anterior segment and 
 171
the vitreous were removed, a small area of retina was peeled away, creating a well that 
was filled with 0.5% trypsin (Gibco).  After 5 minutes RPE cells were dislodged by 
pipetting, collected by centrifugation, washed and suspended in DMEM (Gibco) 
buffered with 20 mM HEPES pH 7.4 supplemented with 10% fetal bovine serum 
(Gibco), 10 ng/ml basic fibroblast growth factor (Gibco), and 50  µg/ml Pen-Strep.  
Cells were grown to confluence on 35 mm Primera plates coated with mouse laminin 
(2.5  µg/cm2).  Identity of the RPE cells was confirmed by immunohistochemical 
staining for  cytokeratin and vimentin (McLellan and Bedford 1997).   
 
7.3.3. RT PCR conditions 
 Reverse transcriptase PCR was carried out on total RNA from confluent cultures 
of RPE cells at passage number 3.  Cells were frozen in 0.15 M NaCl, 5 mM 
dithiothreitol, 10 mM Tris pH 8.0 containing 10% (v/v) RNAse inhibitor (RNA-Guard, 
Gibco).  Total RNA from 12.5 cells was reverse transcribed with antisense primer 
specific to unique 3' untranslated sequence in pCLCA1 (5'-
GAGAAAGCTTGCGGCCGCTCGTGCAGAAAGTCTAAAATG-3'), or to a 
conserved region of CFTR (5'-GCACTGGGTTCATCAAGCAG - 3').   The cDNA 
from the reverse-transcription reaction was used as template in a PCR reaction 
containing: dNTPs 200  µM, primers 25 pmol, 5% DMSO, 1.25  units of Taq and 1.25 
units of Pfu DNA polymerases. Pfu was omitted from PCR reactions intended for TA 
cloning. Antisense primers were the same as used in the reverse transcriptase, while 
sense primers were CFTR 3578 (5'-CCAGCATAGATGTGGATAG-3') and pCLCA1 
33 (5'-ACGATGCAAATGGTCGATACAG-3').  PCR was run for 30 cycles with 
annealing for 45 seconds at 52 oC, extension for 1 min at 72 oC, and denaturation at 94 o 
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C  for 45 seconds. The identity of the amplified cDNA in the PCR of pCLCA1 was 
determined by TA cloning and sequencing of three independent clones (University of 
Calgary, Core DNA Services).  
 cRNA templates were produced from CFTR cDNA in Bluescript (American 
Type Culture Collection clone T16-4.5) and pCLCA1 cDNA cloned into the Not I site 
of pcDNA3 (Gaspar, Racette et al. 2000). 10 µg of DNA from each vector with insert 
was linearized by a single cut at the 3' end of the insert, using Xba I for pCLCA1 and 
Spe I for CFTR, run through a Qiagen PCR cleanup column, and used as template for 
cRNA synthesis. The synthesis system also contained 0.1 M dithiothreitol (DTT), 250 
µM dNTPs, 1 µl of RNAguard (Gibco), and 100 units of T7 RNA polymerase in a final 
volume of 100 µl.  The reaction was allowed to proceed for two hours at 37 o C.  The 
cRNA product was incubated with 10 units of pancreatic DNAse for 30 minutes at 37 o 
C and separated from DNA digestion products using a Qiagen RNeasy column. The 
cRNA products were quantitated by optical absorbance at 260 and 280 nm, and known 
amounts of the cRNA were used in parallel RT-PCR experiments to quantitate mRNA 
in cell extracts. 
 
7.3.4. Immunohistochemistry.   
 Polyclonal rabbit antiserum was raised to a KLH-conjugated 17-mer peptide 
sequence CKEKNHNKEAPNDQNQK, corresponding to deduced amino acid sequence 
residues 250 to 266 in pCLCA1.  Immunohistochemistry was carried out with the 
capillary gap method (Fisher Code-On IHC stainer) and with the Venta Benchmark 
flatbed IHC stainer. Formalin-fixed, paraffin embedded sections from a normal dog eye 
were deparaffinized, treated to inactivate endogenous peroxidase, exposed to protease 
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(Code-On) or heat (Benchmark) for epitope retrieval, and blocked before exposing 
overnight to 1:1000 diluted rabbit anti-pCLCA1 17-mer peptide.  Secondary antibody 
was biotinylated anti-rabbit IgG.  Avidin-peroxidase complex was added after 
secondary antibody, followed by NovaRED peroxidase substrate (Vector).  Slides were 
then counterstained with hematoxylin and prepared for viewing.     
 
7.3.5. Chloride Efflux   
 Stable CFTR and pCLCA1 transfectants of mouse 3T3 fibroblasts expressed 
under the control of the CMV promoter were grown in DMEM with 10% fetal calf 
serum, and maintained by selection on G418 (500  µg/ml).  These stable transfectants, 
or cultured canine RPE cells (P2) were grown to confluence on 35 mm plates and 
loaded with 36Cl- by removing growth media and incubating with loading buffer 
containing 5 mM glucose, 10 mM HEPES pH 7.5, and 120 mM NaCl plus 2  Ci/ml 36Cl- 
for 90 minutes. Release of 36Cl- from cells equilibrated with the loading buffer was 
measured after rapidly washing cells four times with one mL of efflux buffer (loading 
buffer without 36Cl-) to remove extracellular chloride ion.  Then the rate of release of 
chloride from the cells was determined by removing and replacing one ml of the efflux 
medium at two minute intervals with liquid scintillation counting of 36Cl. The 
sensitivity of chloride release from loaded cells to perturbations in cell second 
messenger systems was studied with 10  µM ionomycin in efflux buffer of cells 
expressing pCLCA1, or 10  µM forskolin and 0.5 mM CPT cAMP plus 2 mM 
isobutylmethylxanthine (IBMX) in cells expressing CFTR.  These efflux agonists were 
added after the fourth wash and were present in solutions during sampling for 36Cl- 
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release.  Inhibitor effects on chloride release were determined by including inhibitor (or 
vehicle) in the wash solution and during the subsequent timed 36Cl- efflux. 
 
7.4. Results 
7.4.1. Basal RPE Short Circuit Current 
 Secretory fluid transport across the RPE should transfer any accumulated serous 
fluid from between the retina and the RPE, through the RPE epithelial layer, into the 
choroidal capillary drainage. The highest frequency of focal serous retinopathy lesions 
has been observed in tapetal areas (Grahn, Philibert et al. 1998).  This situation could be 
caused by the tapetal pigments acting as a physical barrier to ion and fluid transport 
across tapetal regions of the retina.  The short circuit current and resistance 
measurements across canine RPE-choroid preparations from tapetum and from non-
tapetal areas mounted in Ussing chambers are shown in Figure 7.1.   Averaged short 
circuit currents in the non-tapetal area measured with the transepithelial potential 
reduced to zero exceeded the values in the tapetal area at each observation time. There 
was also a consistent trend to larger transepithelial potential differences in non-tapetal 
preparations (data not shown).  These findings were consistent with greater ion and 
fluid transport activity in the RPE cell layer of the non-tapetal tissue. Tissue from this 
non-tapetal region of the canine eye was used for subsequent measurements of 














Figure 7.1. Short circuit current and resistance values in dog RPE-choroid preparations 
mounted in Ussing chambers. Tissues were mounted in 5 mm diameter aperture Ussing 
chambers and bathed in oxygenated Krebs Ringer buffer. Data collection commenced 
after parameters stabilized.  Filled symbols, tapetum, n = 6; open symbols non-tapetal, n 






7.4.2. RPE Agonist Induced Short Circuit Current 
 Previous reports of cAMP and Ca 2+-dependent chloride conductance in RPE 
indicate that two regulatory processes, and possibly two ion transport processes may be 
present in these tissues (Hughes and Segawa 1993; Hughes, Gallemore et al. 1998).  
Increments in RPE short circuit current following addition of forskolin and IBMX, or 
the Ca2+-ionophore ionomycin to non-tapetal RPE tissues mounted in Ussing chambers 
are shown in Figure 7.2.  These results reveal that agonists operating through activation 
of adenylate cyclase or increases in free intracellular Ca2+ ion are both capable of 
stimulating chloride ion transfer from the retina to the choroidal vessels in this tissue.  
 
7.4.3. Inhibitors of Basal RPE Short Circuit Current 
 Basal levels of ion transport processes are presumed to be responsible for 
housekeeping transfer of fluid from the vitreous to the choroid.  The issue of which type 
of chloride ion transporter was responsible for this basal transport was investigated by 
the following studies, employing inhibitors of conductive chloride transport.  The non-
specific chloride channel antagonist 4-acetamido-4'-isothiocyanostilbene-2,2'- 
disulfonate (SITS) has been reported to inhibit active chloride transport in RPE (Hughes 
and Segawa 1993).  Those findings were confirmed in the non-tapetal RPE-choroid 
 preparations used in this study by a reduction of short circuit current to about 50% of 
the normal value on addition of 1 mM SITS (Figure 7.3.).  The inhibitory action of 













Figure 7.2.  Increments in short circuit current caused by activation of chloride 
conductance in RPE choroid tissue preparations.  Tissues were mounted in Ussing 
chambers as described in Fig 7.1.  Activation agonists were added at zero time, and the 
increment in Isc following agonist addition are reported.  A) addition of forskolin 

















Figure 7.3.  Effect of addition of SITS on the short circuit current measured in canine 
RPE.  SITS (1.0 mM) was added at time zero to stabilized canine RPE-choroid 
preparations mounted in Ussing chambers.  Control (●), n = 8; SITS addition short 
circuit current (○) and tissue resistance (□), n = 4; ± SE.
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 The rapid drop in short circuit current was consistent with other observations 
suggesting a role for anion conductance in the short circuit currents seen in this tissue. 
The oral hypoglycemic sulfonylurea compound glibenclamide is reported to be a 
relatively specific inhibitor of chloride transport occurring through the CFTR chloride 
conductance channel (Illek, Yankaskas et al. 1997). Addition of 50 µM glibenclamide 
to RPE-choroid preparations had no effect on transepithelial resistance, but the short 
circuit current measured across the tissue was reduced by about 40% (Figure 7.4).  
These are the results that would be expected if canine CFTR or some other 
glibenclamide-sensitive chloride conductance activity contributes to the ion and fluid 
transport across the canine RPE.  5-nitro-2-(3-phenylpropylamino) benzoate (NPPB) is 
a relatively potent inhibitor of chloride conductance activity. Addition of 10 µM NPPB 
to the RPE-choroid preparations caused a significant inhibition of the short circuit 
current (Figure 7.5.). Earlier investigations with this compound have indicated that 10 
µM concentrations were not inhibitory for the chloride conductance activity of CFTR 
(Hipper, Mall et al. 1995).  Recently Walsh and coworkers reported a Kd of 166  µM 
for the interaction of  NPPB with CFTR (Walsh, Long et al. 1999).   
7.4.4. Inhibitor of CLCA Modulated Calcium Activated Efflux vs cAMP  CFTR 
Efflux  
 Short circuit current in secretory epithelium is believed to be to a large extent a 
measurement of chloride release through basal or apical chloride conductance channels 















Figure 7.4. Effect of glibenclamide on short circuit current in dog RPE-choroid 
preparations in Ussing chambers. Vehicle (●), or glibenclamide (50 µM) were added at 
zero time. Short circuit current (○) and tissue resistance (□) in preparations treated with 














Figure 7.5.  Effect of NPPB on short circuit current in dog RPE-choroid preparations in 
Ussing chambers. Vehicle (●), or NPPB (10 µM) were added at zero time. Short circuit 







circuit current in RPE-choroid was significantly less than the levels reported to inhibit 
the CFTR chloride conductance we extended these studies to compare the activity of 
CFTR and of a calcium-activated chloride conductance channel in a cell culture system.  
Mouse fibroblasts expressing CFTR under the control of the CMV promotor have a 
significant cAMP-dependent chloride efflux when loaded with 36Cl. This cAMP-
dependent chloride efflux is much less prominent in control mouse fibroblasts 
transfected with the vector alone, without the CFTR cDNA insert (data not shown).  
The concentrations of glibenclamide (50 µM) and NPPB (10 µM) used in the short 
circuit current experiments with canine RPE-choroid preparations had no inhibitory 
effect on the efflux of 36Cl- from mouse fibroblasts transfected with and expressing the 
CFTR chloride conductance channel (Figure 7.6.).   
 The recently cloned chloride conductance regulator pCLCA1 is a member of a 
family of proteins named for a Ca2+-dependent chloride channel activity (Gaspar, 
Racette et al. 2000; Loewen, Bekar et al. 2002; Loewen, Gabriel et al. 2002).  We 
investigated the sensitivity of chloride transport activated by pCLCA1 expression to the 
concentrations of inhibitors shown to reduce short circuit current in canine RPE-choroid 
preparations. Efflux of 36Cl- from mouse fibroblasts transfected with the pCLCA1 
channel increased significantly upon exposure of these cells to the Ca2+-ionophore 
ionomycin (Gaspar, Racette et al. 2000; Loewen, Gabriel et al. 2002). There was no 
significant chloride efflux response in these cells to treatment with the cAMP agonists 
that activated the CFTR channel. Ionomycin- or cAMP-dependent stimulation of 36Cl- 










Figure 7.6.  Effect of glibenclamide or NPPB on chloride efflux from mouse fibroblasts 
expressing CFTR or pCLCA1.  Permanently transfected fibroblasts grown to 
confluence in 35 mm dishes, and loaded with 36Cl- for two hours were removed from 
loading medium, washed rapidly 4x in the presence of the indicated inhibitors and then 
used to measure the rate of chloride release.  Efflux medium (1 ml) was added to plates, 
and replaced at two minute intervals for quantifying 36Cl- release.  Chloride 
conductance was activated by zero time additions of IBMX (2 mM), 5-chlorophenyl-
3',5'-cAMP (50 µM), and forskolin (10 µM) to fibroblasts expressing CFTR, or 10 µM 
ionomycin to fibroblasts expressing pCLCA1. Changes in the rate of chloride efflux 
caused by inhibitor are shown two minutes after agonist addition to cells loaded with 
36Cl.  n = 6 ± SE. 
 
 184
36Cl- efflux from the pCLCA1-transfected mouse fibroblast cell line was inhibited 
significantly by 50 µM glibenclamide and by 10 µM NPPB; concentrations that reduced 
short-circuit current in the intact canine RPE-choroid preparations (Figure 7.6.).   
 
7.4.5. Detection of CLCA in RPE 
 The possibility that a pCLCA1 like chloride channel regulator cCLCA1 was 
expressed in canine RPE cells was investigated by reverse-transcriptase/PCR.  With 
primary cultures of canine RPE cells as a source of RNA, and the reverse transcriptase 
reaction primed with an antisense primer located in the 3' untranslated region of the 
pCLCA1 cDNA sequence, the resulting cDNA was tested in PCR for the presence of 
pCLCA1.  An 861 base pair cDNA fragment was generated in these PCR reactions. 
Template contamination by genomic DNA is ruled out by alignments of pCLCA1 
(GenBank accession # AF095584) that indicate a minimum of two introns in the 
genomic sequence between the locations of the PCR primer pair. The 861 base pair 
PCR product was ligated directly from the PCR reaction into Invitrogen's TA cloning 
vector.  Three independent clones isolated from the resulting transformation had 99% 
sequence identity to the reported pCLCA1 sequence (seven base changes out of 830 
bases in the clones). These sequence changes give one conservative amino acid 
replacement (I845 —>V) and three non-conservative replacements (Figure 7.7.).  In 
contrast to these minor, cross-species differences for canine and porcine pCLCA1, there 
















Figure 7.7.  Alignment of predicted amino acid sequence from a partial clone of canine 
CLCA with related  CLCA proteins. Predicted sequence of a partial clone of the canine 
isoform of pCLCA1 (c1), the porcine isoform (p1), and h1 (hCLCA1), the closest 





that canine pCLCA1 (cCLCA1) is not a species isoform of hCLCA1.  The 3'-
untranslated sequence contained in three dog pCLCA1 (cCLCA1) clones was identical 
to the reported sequence of pCLCA1. 
 Semi-quantitative reverse transcriptase-PCR gave an estimate of 37±7 copies of 
the cCLCA1 mRNA expressed in each canine RPE cell growing in tissue culture 
(Figure 7.8 A).  CFTR mRNA was expressed in the same cells at about 5 copies per cell 
(Figure 7.8 B).  Expression of cCLCA1 antigen in the formalin-fixed canine eye was 
prominent in RPE cells, using both heat and protease-induced epitope retrieval (Figure 
7.9.). Antibody dilutions from 1:100 to 1:10,000 produced positive identification of the 
RPE (data not shown).  Staining indicated that the cCLCA1 antigen was present at 
highest concentrations on the choroidal (basal) side of the RPE epithelial layer.  There 
was relatively less cCLCA1 epitope evident on the apical membrane processes that 
interdigitate with, and feed the photoreceptor cells (note the reverse nomenclature for 
apical and basal relative to other secretory epithelial tissues).  This polarized 
localization of cCLCA1 is consistent with the known direction of net fluid transport by 
the RPE from the vitreous to the choroid. 
 
7.4.6. CLCA Modulates CFTR Conductance 
 Evidence for the coexistence of the canine isoforms of pCLCA1 ( cCLCA1 )and 













Figure 7.8.   A) Reverse transcriptase- PCR quantitation of RPE mRNA species.  DNA 
bands produced by PCR, separated by agarose gel electrophoresis and stained with 
ethidium bromide were quantitated by image analysis software (BioRad Discovery). A: 
Fluorescence intensity (adjusted volume, with background subtracted) of an 861 base 
pair product amplified with primers specific to pCLCA1 cDNA template.  cDNA 
template was produced by reverse transcribing 50 (– ● –), 250 (– ■ –) or 500 (– ▲ –) 
molecules of pCLCA1 cRNA, or total RNA from 12 RPE cells (– ◊ –). The cDNA 
product of the reverse transcriptase reaction was used as a template for PCR  for the 
indicated number of cycles. The calculated mRNA copies per RPE cell at 22, 24 and 26 
cycles of PCR is shown on the figure.  B)  DNA banding at PCR cycle # 22.  Lane 1 is 
100 bp standards; PCR from cDNA templates produced by reverse transcribing 50 (lane 
2), 250 (lane 3), or 500 (lane 4) molecules of pCLCA1 cRNA or RNA from 12 RPE 
cells (lane 5); lane 6, positive control, lane 7 no template control.  B: DNA banding 
patterns of a 650 base pair product amplified with primers specific to canine CFTR 
cDNA template. Lane 1,100 base pair standards; PCR from cDNA templates produced 
by reverse transcribing; lane 2, total RNA from 12 RPE cells, lanes 3, 4, 5 and 6,  10, 
100, 1000 and 10000  molecules of CFTR cRNA. Lane 7, positive control, lane 8, 









of pCLCA1 antigen (cCLCA1) 
in canine RPE. The RPE cell 
bodies on the choroidal side of 
the polarized epithelium are 
indicated by black arrows. The 
“apical” membrane processes 
that interdigitate with the 
(missing) photoreceptors are 
identified by white arrows.   
Counterstaining was with 
hematoxylin.  Antibody binding 
was identified by NovaRED 
peroxidase substrate. Panels A 
and C, 1:1000 dilution of anti-
pCLCA1 ( cCLCA1) immune 
serum primary antibody.  Panel 
A, heat-induced epitope 
retrieval, panels B and C, 
enzymatic (protease) epitope 
retrieval.  Panel B, preimmune 
serum primary antibody.  Bars 








dependent, and the cAMP-dependent increases in short circuit current in the RPE 
reported in Figure 7.2.  
 This point was investigated indirectly by producing dual transfectants of 
NIH/3T3 fibroblasts with both CFTR and pCLCA1.  When 36Cl- efflux from NIH/3T3 
cells expressing both pCLCA1 and CFTR was examined in the presence of forskolin 
and IBMX, the cells expressing both proteins had a significant increase in the rate of 
chloride efflux relative to the parental cell line only expressing CFTR (Figure 7.10.).  
This finding resembles results of a previous report that pCLCA1 stimulates the cAMP-
dependent chloride transport occurring when CFTR is expressed (Loewen, Bekar et al. 
2002).  Since other Ca2+-dependent chloride conductance proteins have been reported in 
the canine RPE, it is possible that pCLCA1 may play a regulatory role for chloride 
channels, rather than functioning as a channel itself. 
 
7.4.7. Inhibition of Calcium Activated, CLCA Modulated Efflux in RPE 
 The chloride efflux system in cultured canine RPE cells was investigated by the 
same system used to assess threshold inhibitor concentrations for transfected mouse 
fibroblasts.  The pattern of ionomycin (Ca2+)-dependent 36Cl- efflux from the cultured 
RPE cells was similar to that observed with pCLCA1-transfected mouse fibroblasts, 
although the maximum efflux rate was greater in RPE cells. This ionomycin-dependent 
increase in the rate of 36Cl- efflux was completely blocked by addition of 10 µM NPPB.  
Unlike the situation observed with in situ RPE in Ussing chambers (Figure 7. 2.), there 
was no stimulation of 36Cl- release from primary cultures of RPE cells in response to 












Figure 7.10.  A-kinase activation in NIH/3T3 fibroblasts co-transfected with pCLCA1 
and CFTR.  A 3T3 cell line transfected with CFTR (pcDNA3, G418 selection) was 
subsequently transfected with pCLCA1 (pcDNA3.1, hygromycin selection).  36Cl- 
release from loaded cells is reported.  All cells were treated with 10 µM forskolin and 2 
mM IBMX from time zero.  ○, cells expressing pCLCA1 and CFTR, ? cells expressing 
only CFTR, ●, cells expressing only pCLCA1, ▼ control cells transfected with 














Figure 7.11.  36Cl- efflux from cultured canine RPE cells.  RPE cells grown to 
confluence on laminin-coated 35 mm dishes were loaded with 36Cl-, washed rapidly 
four times, and the release of 36Cl- was measured in media containing the following 
additions: 10 µM ionomycin (●), 10 µM ionomycin plus 10 µM NPPB (?), 10 µM 
forskolin, 2 mM isobutylmethylxanthine, 500  µM  CPT cAMP (?), control (○).  n = 6 






 Effects of the tapetum on tissue electrical properties, including slight reductions 
in short circuit current and the reduced trans-RPE-choroid potential difference between 
tapetal and non-tapetal fundic regions have not been previously described. The 
significance of the tapetal pigments as a barrier to ion transport across the RPE is an 
interesting question, as the difference in driving force for transport observed in this 
study correlates with reports of a distinct tapetal sparing effect on retinal degeneration 
secondary to glaucoma the dog, cat and horse (B. Grahn, unpublished). We have also 
noted an increased incidence/severity of RPE dysplasias in the tapetal region (Grahn 
and Cullen 2001).  The association of tapetal structure with localized differences in ion 
transport raises significant questions concerning a causal relationship between regional 
RPE transport differences and the manifestations and pathogenesis of retinal disease.  
 Transient changes in the rate of fluid absorption across the RPE could set up 
pressure gradients that increase the probability of retinal detachment from the RPE or 
RPE separation from the choroid.  Information about the identity of the proteins 
responsible for chloride conductance across the RPE could be an important contribution 
to understanding the pathology of serous retinopathies. The cystic fibrosis 
transmembrane regulator protein is expressed in human, canine and bovine RPE 
(Miller, Rabin et al. 1992; Wills, Weng et al. 2000) and the expression site has been 
localized to the basal membrane (Peterson, Quong et al. 1999).  However, uncertainties 
remain concerning the contribution of the CFTR channel to chloride conductance in the 
RPE.  There are no reports of increased risk of serous retinopathy or retinal detachments 
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in cystic fibrosis patients.  Hence it is possible that chloride transport through other 
conductance channels co-expressed with CFTR could account for the general 
housekeeping levels of tissue short circuit current, and intracellular chloride release 
from the RPE.  The comparative inhibition strategy employed in this study provides 
evidence that, under the conditions employed, CFTR may be less important than other 
chloride conductance channels as a mediator of basal RPE-choroid chloride transport.  
However it is clear that there is a significant cAMP-dependent chloride conductance in 
RPE choroid preparations.  Signaling cascades that might activate A kinase in vivo in 
response to increased requirements for trans-RPE fluid movement have not been 
reported.   
 The loss of cAMP-dependent chloride conductance in cultured RPE cells has 
been reported previously in chick and bovine RPE (Kuntz, Crook et al. 1994; Strauss, 
Steinhausen et al. 1999).  The A-kinase agonist mixture that failed to activate chloride 
conductance activity in cultured canine RPE cells was able to increase the rate of 36Cl- 
release from transfected mouse fibroblasts expressing CFTR under the control of the 
cytomegalovirus promoter (see Figure 7. 7. A). Since we have demonstrated the 
presence of CFTR mRNA in cultured canine RPE cells there may be a problem with the 
activation of cAMP-dependent protein kinase in these cells.  
 Our findings of a significant calcium-dependent chloride release from cultured 
canine RPE cells are in agreement with a role for intracellular calcium in controlling 
chloride conductance, as reported by Strauss et al. (Strauss, Steinhausen et al. 1999) in 
cultured rat RPE cells. Expression of pCLCA1 mRNA in canine RPE cells was 
considered to be a probable source of a Ca2+-dependent chloride conductance in this 
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tissue.  Protein expression of CLCA and basal membrane localization was confirmed by 
immunohistochemistry. The basal side of the RPE that locates against the 
choriocapillaris is functionally equivalent to the apical membrane of secretory epithelial 
cells in the trachea or small intestine. Hence the basal membrane of the RPE is the site 
of chloride conductance proteins involved in active ion transport. Concentration of the 
pCLCA1 ( cCLCA1 ) antigen on the basal side of RPE cells was consistent with a role 
in either chloride transport or in the regulation of chloride transport proteins (Loewen, 
Bekar et al. 2002; Loewen, Gabriel et al. 2002).  However, the regulatory effect of 
pCLCA1 on cAMP-dependent chloride transport that we have reported previously in 
Caco-2 cells has also been observed in the fibroblast cell model used in this study.  
These results suggest that the primary function of the CLCA protein may involve 
regulation of the activity of other proteins that mediate chloride conductance.      
 These studies indicate that cAMP-dependent ion channels are less important 
than Ca 2+-dependent channels to basal, housekeeping levels of conductive chloride 
transport in canine RPE.  The extension from pCLCA1 expression in RPE cell 
membranes to regulatory effects on chloride transport activity in 3T3 fibroblasts raises 
questions about the function of this protein as Ca 2+-dependent chloride channel in 
canine RPE. However, the localization of the CLCA protein at the basal RPE cell 
membrane is consistent with the regulatory effects of this protein on Ca 2+ and cAMP-
dependent chloride conductance reported previously in the Caco-2 human colon 





Chapter 8.  pCLCA1 LACKS INHERENT CHLORIDE CHANNEL ACTIVITY 
IN AN EPITHELIAL COLON CARCINOMA CELL LINE 
 
8.1. Abstract  
 The effects of CLCA protein expression on the regulation of chloride 
conductance by intracellular Ca2+ and cyclic AMP have been studied previously in 
non-epithelial cell lines chosen for low backgrounds of endogenous chloride 
conductance.  However, CLCA proteins have been cloned from, and normally function 
in differentiated epithelial cells.  In this study, we examine the effects of differentiation 
of the Caco-2 epithelial colon carcinoma cell line on modulation of chloride 
conductance by pCLCA1 protein expression. Chloride transport was measured as 36Cl- 
efflux, as transepithelial short circuit currents, and as whole cell patch clamp 
current/voltage relationships.  The rate of 36Cl- efflux and amplitude of currents in patch 
clamp studies after addition of the Ca2+ionophore A23187 were increased significantly 
by pCLCA1 expression in freshly passaged Caco-2 cells. However, neither endogenous 
nor pCLCA1-dependent Ca2+-sensitive chloride conductance could be detected in 14-
day post-passage cells.  Unlike Ca2+-sensitive chloride conductance, endogenous 
cAMP-dependent chloride conductance does not disappear upon Caco-2 differentiation.  
cAMP-dependent chloride conductance was modulated by pCLCA1 expression in 
Caco-2 cells, and this modulation was observed both in freshly passaged, and in mature 
14-day post-passage Caco-2 cultures.  pCLCA1 mRNA expression, antigenic pCLCA1 
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protein epitope expression, and pCLCA1 function as a modulator of cAMP-dependent 
chloride conductance were retained through differentiation in Caco-2 cells, while 
calcium-dependent chloride conductance disappeared. We conclude that pCLCA1 
expression may increase the sensitivity of preexisting endogenous chloride channels to 
Ca2+ and cAMP agonists, but apparently lacks inherent chloride channel activity under 
growth conditions where endogenous channels are not expressed.  
 
8.2. Introduction 
 Chloride transport across the apical membrane is a defining property of 
secretory epithelial cells.  This apical chloride conductance is activated in small 
intestinal and tracheal tissues by increasing local concentration of either cAMP or Ca 2+.  
The cAMP-dependent cystic fibrosis transmembrane regulator (CFTR) is thought to be 
the principle chloride channel responsible for this chloride conductance.  The CFTR 
was identified by reverse genetics as the protein directly involved with the secretory 
defects of cystic fibrosis disease (Rommens, Iannuzzi et al. 1989).  However, members 
of the Ca 2+-dependent CLCA protein family were discovered when small intestinal 
(Gaspar, Racette et al. 2000) and tracheal (Cunningham, Awayda et al. 1995) 
expression libraries were screened with monoclonal antibody that inhibited  conductive 
chloride transport. Related murine and human CLCA proteins with reported chloride 
conductance activity have also been cloned (Gandhi, Elble et al. 1998; Gruber, Elble et 
al. 1998; Gruber, Gandhi et al. 1998; Gruber, Schreur et al. 1999; Romio, Musante et al. 
1999).   
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 The role of the CLCA proteins in the apical chloride conductance that drives 
intestinal fluid secretion has been investigated by heterologous expression in cell lines 
from non-epithelial sources that have low levels of endogenous chloride channel 
activity.  Expression of CLCA proteins in HEK 293 and NIH/3T3 cell lines caused the 
appearance of an enhanced Ca2+-dependent chloride channel activity in these cell lines 
(Gruber, Schreur et al. 1999; Gaspar, Racette et al. 2000).  The chloride conductance 
appearing upon CLCA expression in HEK cells and 3T3 cells was activated by treating 
cells with Ca2+ ionophores, but not by A-kinase activation (Gaspar, Racette et al. 2000). 
If cAMP-dependent CFTR is the most significant chloride conductor in intestinal 
epithelium it is curious that antibody which inhibits chloride conductance should 
identify a Ca2+-dependent chloride channel.  
 Functional expression of CLCA proteins in simple, undifferentiated cells may 
give limited information about the physiological potential of this protein (Loewen, 
Gabriel et al. 2002), since the protein normally functions in differentiated epithelial 
cells.  This study was initiated to determine how pCLCA1 may affect the regulation of 
chloride conductance in a true secretory epithelial cell line.  Caco-2 cells are of 
intestinal epithelial origin, and they differentiate in culture to produce enterocyte-like 
monolayers complete with tight junction formation and surface mucus secretion.  Caco-
2 cells normally express CFTR, and have an endogenous cAMP-dependent chloride 
conductance (Sood, Bear et al. 1992).  We have previously reported the enhancement of 
endogenous cAMP-dependent chloride conductance in Caco-2 cells expressing 
pCLCA1 (Loewen, Gabriel et al. 2002).   This cell type-specific, functional response to 
pCLCA1 transfection could reflect a need for a basal Na+K+/2Cl- cotransporter and 
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K+conductance to demonstrate the activity of a cAMP-dependent chloride conductance 
mediated by pCLCA1 (Loewen, Bekar et al. 2002).  However, it is also possible that 
chloride conductance effects attributed to pCLCA1 expression may be due to increased 
responsiveness of existing conductance channels to normal agonists, either Ca2+ or 
cAMP.  In this study we present evidence from differentiating Caco-2 cells that 
distinguishes between these alternative explanations for pCLCA1 effects on chloride 
conductance. 
 Differentiation of maturing epithelial cell cultures during in vitro growth is 
accompanied by the loss of Ca2+dependent chloride conductance as they polarize and 
form tight junctions (Anderson and Welsh 1991; Davenport, Mergey et al. 1996; 
Tarran, Loewen et al. 2002).  We confirm that Caco-2 cells lose Ca2+-dependent 
chloride conductance during differentiation, and we exploit this phenomenon to show 
that pCLCA1 may modulate the chloride conductance attributed to other ion channels, 
but is not sufficient, by itself, to conduct chloride.  
 
8.3. Materials and Methods 
8.3.1.Materials 
  Tissue culture media and G418 antibiotic were purchased from Gibco Life 
Technologies. Peptide synthesis, conjugation and polyclonal antibody production was 
carried out by Sigma Genosys.  Sigma/Aldrich was the source of molecular biology 
grade chemicals including ionomycin, A23187, forskolin and isobutylmethylxanthine 
(IBMX).  36Cl- was purchased from New England Nuclear. 
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8.3.2. Cell lines 
 Caco-2 cells were grown in DMEM medium supplemented with 10 % fetal 
bovine serum, 2 mM glutamine,  MEM non-essential amino acids (0.1 mM), 1 % MEM 
vitamin solution, and 1 mM sodium pyruvate (complete DMEM medium).   Stable 
transfections of Caco-2 cells with pcDNA3 plasmid with, and without the pCLCA1 
cDNA, were carried out as described previously (Loewen, Bekar et al. 2002). After 
electroporation cells were plated at 2 x 105 cells per well in 24 well plates. G418 (2.5 
mg per ml) was added to wells 24 hours later to select for successful transfectants.  
Cells were switched to maintenance medium (500  µg per ml of G418 in complete 
DMEM) 7 days post-transfection. For pCLCA1 and pcDNA3 control transfections, cells 
from three separate wells showing good growth under selection pressure and randomly 
designated as lines 1, 2 and 3 were passaged and used subsequently to test for clonal 
selection effects.  
 
8.3.3. Production of Transient Transfectants 
 Recipient Caco-2 cells were plated at low density (2.5 x 105 cells per 75 ml 
flask) in complete DMEM medium, grown for 24 hours, and then transfected with the 
pIRES2-EGFP vector (Invitrogen) containing a polycistronic construct of pCLCA1 and 
EGFP.  For transfections, 2 µg of vector DNA was mixed with10 µL of lipofectamine 
2000TM (Invitrogen) in 800  µL of DMEM 20 min prior to addition to the flask 
containing 5 ml of complete DMEM without antibiotic.  The transfection media was 
replaced with fresh media after 12 hours, and cells were grown for a further 48 hours 
before plating on 35 mm dishes. Cells showing EGFP fluorescence were patched about 
10 hours after transfer to 35 mm dishes.  
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8.3.4. RT-PCR    
 The conditions for RT-PCR have been described previously (Loewen, Bekar et 
al. 2004).  We used an antisense primer uniquely specific for pCLCA1 in the reverse 
transcriptase reaction (5'-TTTAGTCGACCATATCTAGTTGTTTAGATTG-3'), with  
nested antisense primer (5'-CAGGTTGGTCTTATCGACAG-3') and a sense primer (5'-
GTGAACACGCCACGCAGAAG-3') to generate a 518 bp cDNA in PCR.  The PCR 
negative control was produced by omitting the antisense primer from the RT reaction.  
 
8.3.5. Western blot  
 For protein comparisons by Western blotting cells were washed with phosphate 
buffered saline (PBS), removed from plates by adding one ml of PBS containing 10 
mM EDTA, and suspended by gentle pipetting.  Washed cells were collected by 
centrifugation and resuspended in 40 mM Tris buffer, pH 9.0 containing 
phenylmethylsulfonylfluoride (1 mM), pepstatin (0.1 µM), and leupeptin (10 µg/mL).  
Cell protein was separated by SDS PAGE electrophoresis, and transferred to 
nitrocellulose membranes by wet cell electrophoresis.  Membranes were blocked with 
5% non-fat milk dissolved in Tris-buffered saline containing 0.1% 
polyoxyethylenesorbitan monolaurate (TTBS).  They were incubated with diluted 
polyclonal rabbit antiserum prepared to a KLH conjugate of the 17-mer peptide 
CKEKNHNKEAPNDQNQK, corresponding to deduced amino acid sequence residues 
250 to 266 in pCLCA1.  Secondary mouse anti-rabbit alkaline phosphatase conjugate 
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(Sigma) was diluted in TTBS, and equilibrated with the nitrocellulose membrane prior 
to exposure to alkaline phosphatase substrate.  
 
8.3.6. Flow Cytometry 
  Stable pCLCA1 and control-transfected Caco-2 cells were grown in flasks for 
24 hours or 14 days after passaging. Medium was removed from flasks, and replaced by 
phosphate-buffered saline (PBS) containing 10 mM EDTA.  Cells were dislodged, 
filtered through 30  M nylon mesh, and suspended at a density of 106 cells per ml in 
PBS plus 3% bovine serum albumen.  Diluted preimmune or anti-pCLCA1 serum was 
incubated with cell suspensions for 30 minutes at 4 oC. Cells were washed 3x, and 
suspended in diluted fluorescein-conjugated goat anti-rabbit fab secondary antibody for 
a second 30 minute incubation.  The first of three washings contained 50 µg/ml 
propidium iodide.  Washed cells were analyzed for fluorescence by flow cytometry 
using photomultiplier gates optimized for discrimination between emission of 
fluorescein and propidium iodide.     
 
8.3.7. Chloride Efflux  
 Stable pCLCA1 and control-transfected Caco-2 cells were plated at a density of 
5 x 105 in 35 mm culture dishes and grown in DMEM supplemented with 2 mM 
glutamine, 10% fetal calf serum and G418 (500  µg/ml).  After 24 hours or 14 days of 
growth the confluent monolayers were loaded with 36Cl- by removing growth media, 
and incubating for two hours with loading buffer containing 4 mM KCl, 2 mM MgCl2, 
1 mM KH2PO4, 1 mM CaCl2, 5 mM glucose, 10 mM HEPES pH 7.5, and 140 mM 
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NaCl plus 2  Ci/ml 36Cl-.  Extracellular 36Cl- was removed by rapidly washing cells five 
times with one ml of efflux buffer (loading buffer without 36Cl) prior to time zero.  
Agonists (10 µM ionomycin or 10 µM forskolin plus 2 mM IBMX) were added to the 
efflux buffers from time zero, through to the end of the timed efflux. 36Cl- release from 
the cells was determined by consecutively adding and removing one ml of efflux 
medium. Residual cell 36Cl- at the end of the efflux was determined by washing cells 
from the plates with 1.0 mM EDTA, and liquid scintillation counting. The rate constant 
for chloride release was calculated as: (0.5 (ln ((cell [Cl-]t1) / (cell [Cl-]t2)))). 
 
8.3.8. Short Circuit Current Measurements   
 Differentiated monolayers of Caco-2 cells expressing pCLCA1 or control cells 
transfected with the pcDNA3 vector were mounted in Ussing chambers and equilibrated 
for 20 min in standard Krebs Bicarbonate Ringers solution with 10 mM basal glucose 
and 10 mM apical mannitol prior to adding agonists. Chloride gradients were 
established across monolayers of permeabilized cells by replacing chloride with 
gluconate and Na+ and K+ with Tris. The high Cl- solution contained 147 mM Tris Cl, 
30 mM mannitol, 5 mM N-tris[hydroxymethyl]methyl-2-aminoethanesulfonic acid 
(TES), 2 mM CaCl2 and 1 mM MgCl2, pH 7.4. The low Cl- solution contained 130 mM 
Tris base, 130 mM D-gluconic acid, 17 mM Tris Cl, 30 mM mannitol, 2 mM CaCl2 and 





8.3.9. Whole Cell Patch-Clamp.   
 Transfected cells were identified using an Axiovert 10 inverted microscope 
(Zeiss) equipped with a mercury lamp and excitation and emission filters of 425 and 
540 nm, respectively.  Transfected cells were patched using a MP-285 computer 
controlled micromanipulator (Sutter Insturments) and Grass AM8 audio monitor 
(Grass-Telefactor West Warwick, RI).  After a seal was obtained (> 1 GΩ), capacitance 
compensation was carried out before gaining whole cell access. Subsequent to whole 
cell access, all cells were dialyzed for 1 min before recording. 
 Whole cell currents were acquired with an Axopatch 200B amplifier (Axon 
Instruments, Foster City, CA) at 10 kHz and filtered at 2 kHz by a low pass Bessel filter 
with Clampex 8 and analyzed with Clampfit 8 (Axon Instruments). Cells were held at 0 
mV with voltage pulses applied for 800 ms from - 100 to +100 mV in 20 mV 
increments. Current differences were normalized by whole cell capacitance recorder 
from an integrating 10 mV hyperpolarizing pulse.  The pipette offset was adjusted upon 
immersion into the bath solution.  A single-cell bath solution change (Perfusion Fast 
Step SF-77B perfusion system; Warner Instruments, Hamden CT) was used to add 
agonists and change bath chloride concentration.  
 The pipette solution for intracellular dialysis contained 110 mM CsCl, 1 mM 
MgCl2, 3mM MgATP, 5mM TES, 1 mM EGTA, 0.38 mM CaCl2. pH was adjusted to 
7.4 by adding CsOH (~ 9.2 mM Cs added). The high chloride bath solution contained 
135 mM CsCl, 3 mM MgCl2, 5 mM TES, 2 mM CaCl2, 90 mM mannitol, and ~ 2.7 mM 
CsOH to adjust pH to 7.4. The low chloride bath solution contained 40 mM CsCl, 3 
mM MgCl2, 5mM TES, 2mM CaCl2, 280 mM mannitol and ~ 2.2 mM CsOH to adjust 
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pH to 7.4.  Calculated junction potential corrections for these solutions (-2 mV) were 
less than the error for recorded reversal potentials, so no corrections for junction 
potentials were made. 
 Bath solution for recording with A23187 agonist contained of 135 mM N-
methyl-D-glucamine HCl, 3 mM MgCl2, 5 mM TES, 2 mM CaCl2, and 80 mM D-
mannitol (pH 7.4). The pipette solution for intracellular dialysis was 90 mM D-gluconic 
acid, 90 mM Tris, 40 mM Tris HCl, 5 mM TES, 1 mM sodium pyruvate 1 mM EGTA, 
2 mM MgCl2, 0.1 mM CaCl2, 1 mM MgATP, and 0.1 mM Na2GTP (pH 7.4).  
Corrections were applied for junction potentials.  
 
8.3.10. Statistical Methods  
 Two way repeated measures ANOVA was used to compare overall and 
treatment over time or voltage interactions.  The Fisher LSD method for pairwise 
multiple comparisons was used as a post-ANOVA test to determine statistical 




 We have previously reported agonist effects on chloride efflux rates from Caco-
2 cells plated at a density of 5 x 105 per 3.5 cm plate, and grown for 24 hours after 
passaging (Loewen, Bekar et al. 2002).  However, calcium-dependent chloride 
conductance has been shown to decrease significantly in fully differentiated epithelial 
cells (Anderson and Welsh 1991; Tarran, Loewen et al. 2002).  For this reason, this 
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study compares 24 hour undifferentiated Caco-2 cultures with 14 day-old differentiated 
cultures for effects of pCLCA1 expression on Ca2+ and cAMP-dependent chloride 
efflux. 
 
8.4.1. Effect of pCLCA1 on Endogenous Ca2+-Dependent Chloride Efflux in One 
Day-Old and Mature Cultures    
 pCLCA1 was found  to enhances endogenous Ca2+-dependent chloride efflux in 
one day-old cultures, but shows no chloride conductance activity in mature cells. 
 The effect of pCLCA1 expression and Ca2+ ionophore addition on the rate of 
release of 36Cl- from Caco-2 cells is shown in Figure  8.1.  Ca2+-sensitive chloride 
transport was present in cells assayed 24 hours after passage. The effect of Ca2+ 
ionophore A23187 addition on the rate of 36Cl- efflux from these cells occurred 
immediately, as observed previously in NIH/3T3 cells.  pCLCA1 transfection increased 
the rate of  Ca 2+-sensitive chloride efflux from these freshly passaged cells.  In contrast, 
the addition of Ca2+ ionophore to mature differentiated Caco-2 cells had no effect on the 
rate of 36Cl- release from these cells.  Mature differentiated cells expressing pCLCA1 
also failed to increase the rate of chloride release upon addition of Ca2+ ionophore.  We 
conclude that heterologous pCLCA1 expression was not sufficient to confer calcium-
dependent chloride efflux to mature Caco-2 cells lacking endogenous Ca 2+-dependent 





Figure 8.1.  Loss of Ca2+ activated chloride efflux  in 14 day old cells expressing 
pCLCA1.  A) Efflux rates for both pCLCA1-transfected, and vector-control transfected 
cells, grown 1 or 14 days after passage, in response to A23187 (10 µM ) added at time 
zero.  A23187 added to pCLCA1 transfected (●); or vector-control transfected (○) cells.  
No additions to pCLCA1 transfected (▼), or vector-control transfected (?) cells.  (*) 
P< 0.05 compared to agonist stimulated control.  For 1 day post-passage cultures; P = 
0.031 for overall pCLCA1 effect on A23187-dependent rate of chloride efflux when 
compared to vector agonist control, and P = 0.004 for gene x time interaction.  There 
were significant rate responses to A23187 compared to vector-control cells at 2, 4 and 8 
minutes (P = 0.009, P = 0.021 and P < 0.001, respectively).  For 14 day post-passage 
cultures; P= 0.002 for gene x time effect. By post- ANOVA analysis, A23187 and 
pCLCA1 transfection caused a significant decrease (P= 0.009) in chloride efflux rate 
constant 2 min after A23187 addition, compared to stimulated vector-control. n = 9 ± 
SE. B) Peak A23187-stimulated chloride efflux rate constant for cells grown 1 and 14 
days post-passage.  After A23187 addition, pCLCA1-dependent rate increase in 1 day 
cells (P = 0.009), and pCLCA1-dependent rate decrease in 14 day cells (P= 0.009) are 
shown.   n = 9 ± SE 
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8.4.2. Effect of pCLCA1 on cAMP-dependent chloride efflux on one day old and  
mature cultures   
 pCLCA1 enhancement of endogenous cAMP-dependent chloride efflux is 
maintained through differentiation and polarization 
 The disappearance of Ca 2+-dependent chloride conductance from mature Caco-
2 cells raised questions about the effects of differentiation and tight junction formation 
on other chloride conductance in these cells.   We have shown previously that freshly 
plated Caco-2 cells conductance(Loewen, Bekar et al. 2002)  or NIH/3T3 cells 
expressing CFTR (Loewen, Bekar et al. 2004) have a cAMP-dependent chloride efflux 
that is enhanced by expression of pCLCA1.  This response to cAMP and pCLCA1 
transfection in freshly plated cells is shown in Figure 8.2., in comparison to the rates of 
36Cl- efflux observed in mature, confluent Caco-2 monolayers.  Within the first two 
minutes of agonist addition there was no immediate effect of pCLCA1 transfection on 
the rate of PKA-dependent 36Cl- efflux.  
 However, there was a delayed effect of PKA agonists to increase the rate of 
chloride efflux in both freshly plated and mature Caco-2 cells expressing pCLCA1.  
pCLCA1-dependent increases in Cl- efflux rates appeared at 4 minutes (freshly plated 
cells) or 6 minutes (mature differentiated monolayers) after forskolin and IBMX 
addition compared to control transfected cells.  It is significant that, unlike the Ca 2+ 
effect, cAMP-dependent chloride conductance was not lost from mature cells.  And the 
ability of pCLCA1 expression to modulate that cAMP-dependent chloride conductance 






Figure 8.2. Retention of pCLCA1 modulation of cAMP stimulated efflux in 14 day old 
cells. Efflux rates for pCLCA1-transfected or vector-control transfected cells grown 1 
or 14 days after passage in response to forskolin and IBMX added at time zero.  
Forskolin (10 µM) and IBMX (2 mM) added to pCLCA1 transfected ( ●); or vector-
control transfected (○) cells.  No additions to pCLCA1 transfected (▼), or vector-
control transfected (?) cells.    (*) P< 0.05 compared to agonist stimulated control.  For 
1 day post-passage cells; P = 0.012 for overall pCLCA1 effect on forskolin-IBMX -
dependent rate of chloride efflux compared to vector agonist control, and P = 0.004 for 
gene x time interaction.  There were significant rate responses to forskolin-IBMX 
compared to vector-control cells at 4, 6 and 8 minutes (P = 0.012, P = 0.001 and P < 
0.027, respectively).  For 14 day post-passage cells; P= 0.035 for overall pCLCA1 
effect on forskolin-IBMX -dependent rate of chloride efflux, and there was a significant 
gene x time interaction (P= 0.006).  By post-ANOVA analysis forskolin-IBMX 
stimulated pCLCA1-transfected cells had larger rates of efflux 6 (P = 0.011) and 8 (P < 
0.001) minutes after agonist addition when compared to stimulated control-transfected 





pCLCA1 expression in mature Caco-2 cells are interpreted as evidence for protein 
expression despite the absence of a Ca 2+-dependent conductance. 
8.4.3 Effect of pCLCA1 on Ussing chamber cAMP- and Ca2+-dependent chloride 
conductance.  
  The presence of cAMP- but not Ca2+-dependent chloride conductance in 
polarized Caco-2 cells in Ussing chambers 
 The chloride efflux rate constants reported in Figure 8.1 represent the rate of 
release of isotopically labeled chloride from these cells.  Release rate constants should 
reflect permeability of the cytoplasmic membrane to chloride ion.  However, release 
rates measured in the presence of unlabelled 140 mM extracellular chloride are not 
definitive measurements of a chloride uniport.  Membrane leakage, KCl cotransport, 
and exchange of intracellular 36Cl- for extracellular 35Cl or bicarbonate will contribute to 
release rates.  In contrast, short circuit current (Isc) measured across polarized epithelial 
cell layers reflects active ion transport processes that define net ion conductance. The 
conductive nature of the enhanced anion transport response to forskolin and IBMX in 
cells transfected with pCLCA1 was tested by measuring transepithelial electrical 
parameters in confluent Caco-2 monolayers mounted in Ussing chambers.  The 
movement of negative ions to the lumen is expressed as a positive Isc.  The addition of 
forskolin and IBMX caused a significantly greater increase in Isc in cells transfected 
with pCLCA1, compared to control cells transfected only with the pcDNA3 expression 
vector (Figure 8.3 A).  P < 0.001 for the overall gene effect, and for gene x time 














Figure 8.3. Agonist-induced short circuit current changes in transfected Caco-2 cells. 
pCLCA1 (●) and vector-control (○) transfected Caco-2 cells were grown 14 days on 
semipermeable membranes prior to mounting in Ussing chambers. Changes in Isc in 
response to agonists A) 10 µM forskolin and 2 mM IBXM added at the indicated time.  
pCLCA1 transfected cells had a larger Isc response to forskolin and IBMX (overall 
gene effect P < 0.001) compared to vector control cells. B) 10 uM A23187 added at 
indicated time.  The overall gene effect for A23187 on Isc was not significant(P = 0.257) 




transport rates reported in Figure 8.2. 
 CLCA ion channels were identified by activation of chloride conductance upon 
exposure to Ca 2+ ionophores(Gandhi, Elble et al. 1998; Gruber, Elble et al. 1998; 
Gruber, Schreur et al. 1999; Romio, Musante et al. 1999) .  Isc increments in response 
to treatment of Caco-2 cell monolayers with 10 µM A23187 are shown in Figure 8.3B.  
There was no evidence for an apical Ca2+-dependent chloride conductance in mature 
confluent monolayers of control pcDNA3-transfected Caco-2 cells.  Transfection with 
pCLCA1 failed to confer Ca 2+-dependent chloride conductance to these mature 
polarized cell monolayers.  P = 0.25 for overall gene effect, and 0.992 for gene x time 
interaction.  Hence, the Isc response of mature polarized cells in Ussing chamber studies 
confirms both the retention of the cAMP effect and the loss of Ca2+ effect on 36Cl- 
efflux seen in mature 14 day monolayer Caco-2 cultures.  
 Isc associated with chloride conductance could be elevated by an increase in the 
permeability of the apical membrane of the polarized cells to chloride ion, or from an 
increase in the driving force for chloride release (cell hyperpolarization).  If pCLCA1 
expression affects chloride channel activity, its primary effect should be on the former 
process; ie: membrane permeability to chloride.  The permeability of the apical 
membrane to chloride was determined by measuring Isc changes in response to imposed 
chloride gradients after the basolateral membrane of polarized cells was made 
permeable to Na+ and K+ ions (electrically isolated) by treatment with nystatin. The 
nature of the cAMP-dependent increase in chloride conductance in pCLCA1-transfected 
cells was determined by measuring Isc changes in response to an imposed 
transmembrane chloride gradient; 153 versus 21 mM chloride.  Isc changes caused by 
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A-kinase activation in pCLCA1, and in pcDNA3 transfected cells are shown in Figure 
8.4 A.  Isc changes in response to A-kinase activation were significantly larger in Caco-2 
cells expressing pCLCA1 than in control cells transfected with pcDNA3.  These 
increments in chloride permeability were independent of the direction of the imposed 
chloride gradient, as predicted for a truly electrically-isolated apical membrane (basal to 
apical P = 0.001, apical to basal P = 0.023).   
 In contrast to the findings with A-kinase activation, there was no significant 
Ca2+-dependent increase in apical membrane permeability (Figure 4B).  Neither the 
control nor the pCLCA1-transfected cells responded to A23187 treatment with 
significant increments in Isc (basal to apical P = 0.91, apical to basal P = 0.66).  These 
findings support an effect of A-kinase activation on the apical permeability of mature 
differentiated Caco-2 cells.  They also confirm a functional effect of expressed 
pCLCA1 in mature cells lacking Ca2+-dependent chloride conductance.  
 
8.4.4. pCLCA1 Expression is Maintained Throughout Differentiation/Maturation    
 Some CLCA gene products, including bCLCA1 and hCLCA1, are reported to 
code for proteins that function as chloride channels that are regulated by changes in free 
cytosolic Ca2+ concentration (Cunningham, Awayda et al. 1995; Gruber, Elble et al. 
1998).  The loss of a Ca2+-dependent chloride conductance in mature, differentiated 
Caco-2 cells transfected with pCLCA1 raises questions about the effect of cell 












Figure 8.4.  Agonist-induced short circuit changes across the electrically-isolated apical 
membrane of transfected Caco-2 cells.  Changes in Isc in response to imposed apical to 
basal or basal to apical chloride gradients.  Black bars, permanent pCLCA1 
transfectants, white bars, permanent vector- control transfectants. Panel A): changes 
induced by addition of 10 µM forskolin and 2 mM IBMX. Panel B): changes induced 





promoter in the pcDNA3-pCLCA1 construct reduces the probability that pCLCA1 
expression should be affected by cell maturation.  Persistent functional effects of 
pCLCA1 expression on cAMP-dependent chloride efflux and short circuit current 
changes in transfected cells are direct evidence for the continued expression of pCLCA1 
in mature, differentiated Caco-2 cells.  Additional evidence can be obtained by 
measuring specific pCLCA1 mRNA and protein expression.  
 RT-PCR using primers specific for pCLCA1 confirmed expression of pCLCA1 
mRNA in cells grown for one and 14 days post-passage (Figure  8.5. A). Western 
blotting of whole cell protein from 24 hour and 14 day old transfected Caco-2 cells 
showed comparable levels of a ~58 kDa processed N-terminal fragment of pCLCA1 
protein present at these two growth stages (Figure 8.5. B).  Alkaline phosphatase-
conjugated mouse anti-rabbit IgG did not bind to duplicate blots when preimmune 
rabbit serum was substituted for immune antiserum as primary antibody (not shown). 
Persistent pCLCA1 antigen expression from 24 hours post-passage through to 14 days 
was consistent with the retention of pCLCA1-dependent enhancement of cAMP effects 
on chloride conductance, but did not correlate with age-related loss of Ca2+-dependent 
chloride conductance. 
 Cell surface expression of pCLCA1 may be a significant prerequisite for 
interaction with ion channel proteins located in the plasma membrane. Cell surface 
localization of pCLCA1 epitope was investigated using rabbit anti-pCLCA1 antiserum, 














Figure 8.5. Expression of pCLCA1 in transfected Caco-2 cells at one and 14 days  A) 
RT-PCR of pCLCA1 mRNA in transfected cells at day one and day 14 post-passage. B) 
Western blot of pCLCA1 protein in transfected Caco-2 cells. Sixty µg of total cell 
protein from tranfected Caco-2 cells grown for one or 14 days was applied per lane for 





Freshly plated and mature monolayers of Caco-2 cells were dispersed by mechanical 
disruption following exposure to EDTA, and exposed to the impermeant propidium 
iodide marker.  Trypsin treatment was avoided to protect any extracellular pCLCA1 
epitope.  Fluorescence energy gates on the flow cytometer were set to distinguish 
between emission energy of fluorescein and propidium iodide.  Mechanical disruption 
of confluent monolayers with adherent tight junctions caused significant plasma 
membrane damage, as indicated by the proportion of cells with propidium iodide 
fluorescence (Figure 8. 6).  Of the cells with intact plasma membrane (cells excluding 
propidium iodide), the peptide epitope corresponding to amino acids 250 to 266 of 
pCLCA1 was detected on 30% of intact 14 day cultured cells, versus 20% of intact 24 
hr cultured cells (Table 8.1).  Stable pCLCA1 transfection approximately doubled the 
percent of cells expressing surface CLCA epitope compared to control pcDNA3-
transfected Caco-2 cells.  These results confirm the presence of pCLCA1 epitope on the 
surface of mature differentiated cells that show cAMP-dependent effects of transfection, 
but have lost  Ca 2+-dependent chloride conductance. 
 
8.4.5. pCLCA1 Caco-2 Clones in Efflux and Whole Cell Patch Clamp   
The effect of pCLCA on Cl- Efflux and Whole Cell Current are Not Clonally Specific. 
 Caco-2 cell populations may not be totally uniform in chloride channel 
expression, activity, or susceptibility to regulatory agonists.  Random clonal selection 
during passage of permanently transfected cells could give a pCLCA1-transfected cell 













Figure 8.6.  Effect of Caco-2 cell maturation on surface expression of CLCA epitope.  
Surface- expressed pCLCA1 epitope was protected by mechanically removing 
permanently pCLCA1-transfected cells from plates without trypsin.  Cells were 
incubated with primary antiserum to a peptide with sequence of aa250-266 of pCLCA1.  
Secondary antibody was labeled with FITC.  Photomultiplier gains for flow cytometry 
were set to differentiate damaged versus intact cells (exclusion of propidium iodide (50 
µg/ml, 5 min) followed by three washings)) and cells with FITC fluorescence.  10,000 





Table 8.1.  Percent of intact Caco-2 cells with attached fluorescein-labeled secondary 
antibody to rabbit anti-pCLCA1 
number of intact cells(/10,000) excluding propidium iodide are shown in parentheses 





Transfection stats            pcDNA3         pCLCA1  
 
Post-passage interval          1 day   14 day 1 day  14 day 
 
Preimmune serum 2.6% (3951)  6.4% (5417) 3.9% (2932) 6.6% (3834) 
 
Anti-pCLCA1 serum  12.5% (3890)           17.3% (4530)   20.4% (2770)  30.1% (4146) 
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available for activation by pCLCA1 expression and agonist addition. This point was 
investigated by examining the effects of agonist on two additional permanently 
transfected Caco-2 cell lines (two more pcDNA3 controls and two more pCLCA1 test 
lines).  The percent change in chloride efflux rate induced by pCLCA1 expression 
compared to a paired pcDNA control is shown in Figure 8. 7.  In three independently 
selected cell lines plated for 24 hours, the pCLCA1-transfected cells had an enhanced 
rate of 36Cl- release in response to either C- or A-kinase agonist addition in cells.  The 
cAMP response persisted to maturation in all three lines, but the Ca 2+-dependent 
response to pCLCA1 transfection disappeared in three of three cell lines studied.   
 The issue of clonal selection in permanent transfections can also be addressed  
by producing transient transfections.  The pIRES2-EGFP vector was used to permit 
independent bicistronic expression of pCLCA1 and EGFP with identification of 
successful transfectants by fluorescence microscopy.  Transient transfections were 
carried out on freshly passaged cells comparable to 24 hour cells at the time of patch 
clamp studies.  Caco-2 cells expressing pCLCA1 showed an enhanced whole cell 
conductance response to A-kinase activation compared to cells transfected only with the 
pIRES2-EGFP vector (Figure 8.8. A). Reversal potential measurements confirmed the 
involvement of chloride ion in the observed conductance (Figure 8. 8 B).  Measured Erev 
in the 145 mM Cl- external bath solution for cells expressing pCLCA1 was -1.78  ± 
0.85 mV, and - 4.43  ± 1.05 mV for control transfected cells. These measured values 
were close to the calculated Erev of - 6.4 mV for chloride at 21oC.  Upon switching the 













Figure 8.7. The effect of Caco-2 differentiation on Cl- efflux response to agonist 
addition in independent pCLCA1-transfected cell lines.  Responses were measured in 
three independent, randomly-identified, pCLCA1-transfected cell lines, and compared 
against three more randomly-identified, pcDNA3 control-transfected cell lines.  A) Cl- 
efflux response to forskolin / IBMX at one and 14 days in three independent pCLCA1-
transfected cell lines.  Chloride efflux rates are expressed as a percent of the agonist-
stimulated efflux rate of three independent control cell lines (controls set as 100 %) 
randomly paired to the pCLCA1 expressing lines.  B) Cl- efflux response to A23187 at 
one and 14 days in three independent pCLCA1-transfected cell lines. Cl- efflux rates 
expressed as a percent of the agonist-stimulated efflux rate as in A. Solid bars, 24 hour 













Figure 8.8.  Normalized whole cell currents after addition of forskolin and IBMX to 
transiently-transfected Caco-2 cells. Control cells were transfected with PIRES2-EGFP 
vector (○), and pCLCA1 test cells with pIRES2-EGFP containing pCLCA1 (●). A) 
internal 112 mM Cl- and external 145 mM Cl-. Gene x voltage P = 0.002. B) 
corresponding representative tracing of A. C ) Low chloride shift, 112 mM internal Cl- 
and 50 mM external Cl-. Gene x voltage P = 0.011. Voltages at which current was 
significantly higher in cells transfected with pCLCA1 as determined by post- ANOVA 
analysis (* )(P > 0.005).  n = 8   ± SE.
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EGFP containing pCLCA1 and 12.64mV  ± 1.46 mV for control-pIRES2-EGFP shifted 
toward the calculated Erev of 20.33 mV at 21 oC.   
 Stimulation of pCLCA1-transfected Caco-2 cells with A23187 produced 
significantly larger increments in normalized current than in control pIRES2-EGFP 
cells (Figure 8. 9.).  Measured Erev values (-26 ± 3.1 and -24 ± 2.1 mV) did not 
significantly differ from each other, and were close to the calculated chloride Erev value 
of -31 mV for the bath and pipette solutions.   
 These observations after transient transfection support the data collected from 
permanently transfected cells (Figure 8.7.), and exclude clonal selection as a basis for 
the enhanced chloride channel responsiveness to activation associated with pCLCA1 
expression.  They also confirm an increase in Ca2+-dependent chloride conductance 




 The loss of Ca2+ -dependent chloride conductance in differentiated secretory 
epithelial tissues is relatively well recognized (Anderson and Welsh 1991; Tarran, 
Loewen et al. 2002).  Exploitation of this phenomenon to investigate association of 
pCLCA1 with Ca 2+ -dependent chloride conductance is complicated by a need for 
independent verification of the developmental effect by different analytical techniques.  
Chloride efflux studies are suited to comparing exogenous protein expression effects 
and agonist effects in newly passaged and in mature differentiated cell cultures, but 






















Figure 8.9. Normalized whole cell currents induced by A23187 addition in transiently-
transfected Caco-2 cells. A)  Control cells were transfected with pIRES-EGFP vector 
(○) and pCLCA1 test cells with pIRES2-EGFP containing pCLCA1 (●) P = 0.0022 for 
overall gene effect, gene x voltage P< 0.001. Voltages at which currents was 
significantly higher in cells transfected with pCLCA1 (as determined by post ANOVA 
analysis (*)(P < 0.05),  n = 10 ± SE..  B) Corresponding representative tracing for A
 224
are good measurements of conductance effects, but they are not amenable to studies on 
freshly plated cells that have maximal levels of Ca 2+ -dependent chloride conductance 
activity.  The I/V dependence of whole cell conductance can be measured by patch 
clamp, but this technique is difficult to apply to confluent differentiated cells. Hence it 
seems best to use each of these techniques where it is most applicable to search for a 
consistent answer to the question of Ca 2+ -dependent chloride conductance activity 
associated with pCLCA1 expression.   
 Chloride efflux and Ussing chamber measurements confirm the loss of Ca 2+ -
dependent chloride conductance from mature Caco-2 cells.  Simple interpretations of 
the inability of pCLCA1 transfection to correct this loss could be; (1) a failure to 
express the pCLCA protein in mature Caco-2 cultures, (2) a failure of proper pCLCA1 
insertion into the cytoplasmic membrane.  (3) loss of sensitivity of differentiated Caco-2 
cells to calcium ionophore effects of A23187, (4) the presence of an inhibitor of Ca2+-
dependent chloride conductance in differentiated Caco-2 cells, or (5)  an inability of 
pCLCA1 to confer Ca 2+ -dependent chloride conductance in the absence of some 
accessory protein. 
 Parallel measurements on alternate functions, namely cAMP-dependent chloride 
conductance, provide chloride efflux and Ussing chamber evidence that functional, 
membrane-located effects of pCLCA1 expression are retained as cells differentiate and 
Ca2+ -dependent chloride conductance disappears.  RT-PCR data and Western blotting 
confirm that Caco-2 cells maintain exogenous pCLCA1 expression while losing Ca2+ -
dependent chloride conductance.  
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 Quantitative extracellular pCLCA1 epitope expression measurements required 
dispersion of confluent monolayers for flow cytometry without protease assistance.  In 
spite of the loss of significant numbers of cells to mechanical dispersion forces, the 
similarities in surface expression of the pCLCA1 epitope between freshly plated and 14-
day old Caco-2 cultures suggest that pCLCA1 expression is independent of the stages of 
cell differentiation. There was a small endogenous background of antibody binding in 
control-transfected Caco-2 cells, assumed to be due to hCLCA1 expression.  The 17-
mer peptide antigen used for antibody production (pCLCA1 aa 250-266) has the 
following differences in hCLCA1; K2 –> T, K4 –>Q, and D13 –> K.  The lack of 
coincidence of pCLCA1 epitope expression and Ca2+-dependent chloride conductance 
supports the independence of these two processes. 
 Some property of well-differentiated Caco-2 cells could interfere with the access 
of the calcium ionophore to the cells, and prevent the calcium signaling effect from 
occurring. The issue of A23187 access to the membranes of mature Caco-2 cells has 
been addressed by others (Rutten, Cogburn et al. 1991; Wenzel, Kuntz et al. 2002).  
Both direct effects of A23187 on calcium flux, and indirect effects of A23187 on 
signaling responses to changes in intracellular calcium concentration were maintained 
in differentiated Caco-2 cells grown on permeable supports identical to our culture 
conditions. 
 The use of independent permanently-transfected cell lines and the measurements 
of whole cell current in transiently transfected Caco-2 cells confirm the presence of an 
increased activity of Ca2+-dependent chloride conductance following pCLCA1 
transfection.  Disappearance of this activity upon cell differentiation was also 
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confirmed.  Hence the combined results of measurements using a range of independent 
techniques are all consistent with option (4) or (5) from above; the presence of an 
endogenous inhibitor, or an inability of pCLCA1 to confer Ca2+-dependent chloride 
conductance in the absence of some accessory protein.  
 Inhibition of Ca2+-dependent chloride conductance by some substance found in 
mature differentiated Caco-2 cells could account for the disappearance of endogenous 
conductance from these cells and the inability to restore it by transfection with 
pCLCA1.  Inositol 3,4,5,6 tetrakisphosphate is reported to inhibit Ca2+-dependent 
chloride conductance in epithelial cells (Kachintorn, Vajanaphanich et al. 1993; Xie, 
Kaetzel et al. 1996) (Barrett, Smitham et al. 1998).  However, sustained activation of 
phospholipase C is required to produce inhibitory concentrations of inositol 3,4,5,6 
tetrakisphosphate (Vajanaphanich, Schultz et al. 1994). There is no agonist present in 
these mature cultures to constitutively activate phospholipase C. Annexin IV and 
epidermal growth factor may also participate in inhibition of Ca2+-dependent chloride 
conductance (Xie, Kaetzel et al. 1996), but no manipulations have been carried out to 
elevate the concentrations of these substances. While known inhibitors of Ca2+-
dependent chloride conductance are unlikely to be responsible for the loss of the 
conductance response it is difficult to rule out the presence of some unknown inhibitor 
until the molecular identity of the endogenous channel is clarified. 
 It is also noteworthy that the electrical signature of chloride currents seen in 
pCLCA1-transfected cells are variable, depending on the cell type or the agonist 
involved in channel activation.  The Ca2+-dependent chloride currents seen in pCLCA1-
transfected NIH/3T3 cells were outwardly rectifying (Loewen, Gabriel et al. 2002), but 
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linear current/voltage relationships of the cAMP-activated conductance channel in 
whole cell patch clamp of pCLCA1-transfected Caco-2 cells are consistent with current 
passing through a non-rectifying endogenous chloride channel (Loewen, Bekar et al. 
2002). 
 The identity of accessory proteins that may be necessary for pCLCA1 
expression to generate chloride conductance is speculative at this time.  HEK293 and 
NIH/3T3 cell lines chosen for low backgrounds of endogenous chloride conductance 
have been used to functionally characterize exogenously expressed Ca2+-dependenct 
CLCA chloride channels (Gabriel, Price et al. 1993; Gruber, Elble et al. 1998; Loewen, 
Gabriel et al. 2002).  Low levels of endogenous chloride channel activity in these cells 
have not been widely acknowledged, but addition of Ca2+ ionophore to untransfected 
HEK293 and NIH/3T3 cells produced a small endogenous conductance of low 
cation/anion selectivity, as indicated by reversal potential measurements (Ye, Rogers et 
al. 1996; Loewen, Gabriel et al. 2002).  Such a channel could be one possible target for 
activation upon expression of suitable regulatory proteins.  A precedent has been 
reported describing interaction of a potassium channel subunit with mCLCA1 
(Greenwood, Miller et al. 2002). 
 The recent localization of the bestrophin proteins to the basolateral plasma 
membrane of the retinal pigment epithelium (RPE) by Marmorstein et al. (Marmorstein, 
Marmorstein et al. 2000), and implication of these proteins in CaCC activity by Qu et 
al.(Qu, Wei et al. 2003) suggests that the molecular identity of the CaCC may reside in 
bestrophins.  In addition to expression in secretory areas of the small intestine and the 
trachea,  pCLCA1 expression has also been localized to the RPE where it has been 
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postulated to function as a regulator of CaCC activity (Loewen, Bekar et al. 2004). 
Taken together, these findings may be evidence against an independent chloride channel 
activity for pCLCA1, and increase interest in pursuing possible functional or regulatory 
interactions between CLCA and other ion channel proteins.  
 We conclude that the disappearance of calcium-dependent chloride conductance 
from mature Caco-2 cells due to the accumulation of some inhibitory compound cannot 
be excluded.  However, the difference in the conductance properties associated with 
pCLCA1 expression in different systems increases the probability that pCLCA1 may 
function chiefly as a modulator of endogenous chloride conductance channels.  The 
Ca2+ and cAMP-dependent chloride conductances that are modulated by pCLCA1 
expression are assumed to represent the activity of distinct ion channels, indicating a 
possible pleiotropic effect of pCLCA1 expression on the activity of apparently 
unrelated chloride channels with different regulatory and I/V signatures.  Young 
secretory cells arising from stem cell populations in the ileal crypts (Karam 1999) or 
tracheal submucosal glands (Borthwick, Shahbazian et al. 2001) may be the best 
physiological counterpart of the pCLCA1-sensitive Ca2+-dependent chloride 
conductance present in Caco-2 cells 24 hours post-passage.  Differentiated Caco-2 cells 
that lack endogenous Ca2+-dependent chloride conductance may be better models for 
the mature senescent absorptive cells on the villus tip.  The association of pCLCA1 with 
the actions of both Ca2+ and cAMP in secretory epithelial cells shows that it may be 
fruitful to study the role of this protein as a modulating element in normal ion transport 
and in pathophysiological conditions involving abnormal epithelial fluid secretion
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Chapter 9. GENERAL DISCUSSION, CONCLUSIONS, AND FUTURE 
STUDIES 
 
9.1 General Discussion 
 The work contained within this thesis provides some novel information on the 
molecular mechanisms behind epithelial transport. It demonstrates that pCLCA1 has a 
significant impact on the modulation of epithelial ion transport.  
 In a non-epithelial cell, the NIH 3T3 mouse fibroblast line, CLCA expression 
increases both the 36Cl- efflux and an outwardly rectifying, time-dependent chloride 
current. This study provided the first independent confirmation of the Pauli and Fuller's 
collaborative work (Gruber, Gandhi et al. 1998; Gruber, Schreur et al. 1999).  However, 
the results also highlighted the problem of background currents which were not very 
well addressed in the original studies. This problem was also addressed by an Italian 
group studying a bovine CLCA isoform (Romio, Musante et al. 1999).  They found that 
that protein increased chloride conductance, but they where unable to confirm intrinsic 
chloride conductance properties for the CLCA isoform.  
 Similarly, because of the small background 36Cl- efflux and currents observed in 
our studies, it was impossible to confirm intrinsic conductance for the pCLCA1.  In the 
efflux assay, it was possible that pCLCA1 was only increasing the activity of an 
existing chloride channel conductance. The untransfected cells exhibited an endogenous 
outwardly rectifying current in whole cell patch clamp studies. However, the 
conductance was not anion-specific.  Simultaneous lowering of both anion and cation 
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concentration should have altered the Erev in Nernstian fashion towards the contributing 
conducting ion. However, no such shift was observed, indicating the background 
conductance was a mixed current of both anion and cation conductance. This could  
result from the activity of two different ion-specific conducting channels or one non-
specific channel (Ye, Rogers et al. 1996; Zhu, Zhang et al. 1998).  However, expression 
of pCLCA1 resulted in an increase in the outwardly rectifying current and an anionic 
Nernstian shift when external anion solution was lowered. This was strong evidence 
that pCLCA1 contributed to a Ca2+-activated, electrogenic anion condutance.  
Unfortunately, the background currents made it impossible to determine if pCLCA1 
was only modulating the activities of one of the endogenous channels or whether it had 
intrinsic channel properties.  The observed effects of pCLCA1 expression could occur 
through pCLCA1 either increasing the conductance of an existing chloride channel, or 
changing a non-specific ion channel to one which is more anionic in nature.    
 The presence of calcium-activated chloride conductance in the human and 
mouse gastrointestinal tract in regions where pCLCA1 is expressed in the pig raises 
questions about the intrinsic Ca2+-activated chloride channel properties of pCLCA1. 
(Taylor, Baxter et al. 1988; Hardcastle, Hardcastle et al. 1991; Grubb 1997; Mall, 
Bleich et al. 1998; Grubb 1999; Mall, Wissner et al. 2000). When CFTR is absent or 
pharmacologically inhibited only a strong mucosal to lumen potassium conductance is 
seen, and there is no Ca2+-activated current produced upon intracellular Ca2+ 
mobilization by carbachol or ionophore(Hardcastle, Hardcastle et al. 1991; Mall, Bleich 
et al. 1998). However, it is possible that a small luminal Ca2+-activated chloride 
conductance is masked by the strong potassium conductance in the human and most of 
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the mouse GIT.  This may account in part for the strong Ca2+-activated negative 
potential seen in distal colon in the CF mouse which is unlike the positive potential seen 
in other portions of the GI tract (Grubb 1999). This anatomic difference in the CF 
mouse is also seen in a subset of CF patients who maintain a negative lumenal response 
on carbachol simulation (Veeze, Sinaasappel et al. 1991). Thus, the absence of Ca2+-
activated chloride conductance in the gut in the face of CLCA expression may not be 
the best evidence for showing the lack of intrinsic chloride channel activity in CLCA.  
 The strongest support for a mucosal Ca2+-activated chloride channel comes from 
comparative secretory studies between pig and rabbit. The  porcine ileal response to 
cholera toxin, and to E. coli heat labile and heat stable enterotoxins has been well 
documented (Hamilton 1974; Hamilton, Forsyth et al. 1978; Hamilton, Johnson et al. 
1978b). The response differs significantly from that seen in the lagomorph (Field 1971; 
Hamilton, Johnson et al. 1978a). In the rabbit, cholera toxin and heat labile enterotoxin, 
but not heat stable E. coli enterotoxin, induce intestinal secretion.  However, all three 
enterotoxins will produce secretion in the pig.  Furthermore, cholera toxin and heat 
labile, but not heat stable enterotoxin, elevated rabbit mucosal cAMP concentrations, 
while in the pig none of the enterotoxins had significant effect on mucosal cAMP 
concentration (Forsyth, Hamilton et al. 1978a; Hamilton, Johnson et al. 1978a). These 
findings support a very different mechanism by which the two species respond to 
enteroxin. The lagomorph response conforms to the conventional hypothesis while the 
porcine response differs (Evans, Chen et al. 1972; Field 1974). This difference may be 
due to the significantly lower levels of adenylate cyclase reported in the pig mucosa 
(Forsyth, Hamilton et al. 1978b).  Additionally, failure to reverse cholera toxin-induced 
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intestinal secretion by agents which decrease mucosal cAMP supported the presence of 
an alternative major second messenger such as Ca2+ for seacretory activation (Forsyth, 
Hamilton et al. 1979).  This hypothesis was supported by observed ionophoric 
properties of cholera toxin and heat labile enterotoxin (Tosteson and Tosteson 1978; 
Maenz and Forsyth 1986; Maenz, Gabriel et al. 1987; Krasilnikov, Muratkhodjaev et al. 
1991; Krasilnikov, Sabirov et al. 1992).  Support was also shown by removing Ca2+ 
from the bath solution, and significantly reducing secretory effects of enterotoxins on 
pig mucosal epithelium (Forsyth, Wong et al. 1985).  All this evidence pointed towards 
Ca2+-activated chloride conductance in the porcine gut.  
 It is very likely that pCLCA1 plays an integral role in this response as seen in its 
role in increasing the Ca2+-activated chloride conductance of mouse NIH 3T3 fibroblast 
cells lines. Similarly, inhibitor profiles and expression data also support a role for 
pCLCA1 in the Ca2+-activated chloride conductance of primary canine RPE cells.  
However, both pig gut epithelium and canine RPE also have a strong cAMP-activated 
chloride conductance. Because the role of pCLCA1 as a channel or modulator was not 
clear, and in vivo co-expression of CLCA and CFTR is known to occur, we expressed 
pCLCA1 in Caco-2 cell lines which express a large amount of CFTR.  And we also co-
expressed pCLCA1 and CFTR in NIH 3T3 cells. pCLCA1 unexpectedly increased the 
cAMP-activated chloride conductance in both NIH 3T3 cells expressing CFTR and 
Caco-2 cells which have high endogenous CFTR expression.  These findings were 
unlike previous reports which have shown a negative correlation between increased 
cAMP-activated chloride and Ca2+-activated chloride conductance (Kunzelmann, Mall 
et al. 1997). Expression of CFTR decreased the endogenous Ca2+-activated channel in 
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Xenopus oocytes. Similar results were reported in CF mouse tracheal cells where a 
decrease in CFTR resulted in an increase in Ca2+-activated chloride channels (Tarran, 
Loewen et al. 2002).  Here, in these in vitro expression systems, we see a simultaneous 
increase in both activities. This finding indicates that pCLCA1 may have a modulating 
role rather than intrinsic channel properties. However, it is important to note that 
pCLCA1 is being expressed under the control of a CMV promoter in these experiments 
and is not under normal physiological control.  
 A model which lacked background chloride current was needed to expand the 
investigation of the channel or modulating effect of pCLCA1. We approached this 
problem by allowing the epithelial Caco-2 cells to polarize, differentiate and to form 
mature epithelial monolayers. The phenomenological developmental loss of Ca2+-
dependent chloride conductance has been reported previously in epithelial cells 
(Anderson and Welsh 1991) (Tarran, Loewen et al. 2002). All growing and dividing 
cells generally have some level of Ca2+-activated background current. Freshly plated 
Caco-2 cells that are in a state of division, expansion and growth have both endogenous 
cAMP- and Ca2+-activated chloride conductance. Although there are significant 
differences in the kinetics of the efflux induced each agonist, pCLCA1 expression 
increased responsiveness to both. Similar enhanced responses to both agonists were 
seen in whole cell patch clamp. pCLCA1 increased the current density of a linear non 
voltage-dependent cAMP-activated current as well as that of an outwardly rectifying 
time-dependent current activated by Ca2+ ionphore.  However, as the cells mature 
endogenous Ca2+-activated chloride conductance is lost along with any modulatory 
effect of pCLCA1 expression on Ca2+-activated chloride conductance. Disappearance of 
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the pCLCA1 effects on Ca2+-dependent chloride conductance occur despite maintained 
pCLCA1 expression and continued modulation of remaining cAMP-sensitive chloride 
currents by pCLCA1. 
 It would seem then that pCLCA1 modulates two apparently unrelated types of 
epithelial chloride conductance. The evidence indicates that pCLCA1 is unlikely to 
have intrinsic channel activity itself, but is more likely to interact as a subunit of yet 
other unidentified channels. 
 Overall, this thesis provides novel information pertaining to the function of a 
member of the CLCA gene family.  Alternative interpretations of the data are possible, 
but the simplest conclusion is that pCLCA1 is not a channel, but is a modulator of 
chloride conductance.  This general conclusion does not minimize the importance of 
this protein. Given the presence of multiple regulator consensus sequences for 
phosphorylation sites, the metal binding domain, and the involvement of the CLCA 
protein family in several correlated pathophysiological processes, there are a number of 
reasons why CLCA might become a valuable therapeutic target for a range of 




1) pCLCA1 increases Ca2+-activated chloride conductance in a non-epithelial cell line. 
 
2) pCLCA1 increases cAMP-activated chloride conductance in epithelial and non- 
epithelial cell lines. 
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3) Ca 2+-dependent chloride transport may be more important than cAMP-dependent 
chloride transport for normal fluid secretion across the RPE.  Further, it appears that 
CLCA proteins expressed in the RPE may regulate the activity of other chloride 
transporters, rather than functioning as primary ion transport proteins.  
 
4) When pCLCA1 is present, it enhances endogenous Ca2+- and cAMP-dependent 
chloride currents in Caco-2 cells, but it lacks inherent Ca 2+-dependent chloride 
channel activity. 
 
9.3. Future Studies 
 
9.3.1. Channel or Modulator? More Direct Evidence.  
 Several independent lines of evidence support a chloride channel modulating 
ability of pCLCA1, and a lack of intrinsic chloride channel activity in this protein. The 
following studies would clarify the role of CLCA in anion conductance: 
 
a)  Single channel study study of CaCC and CFTR cell lines transfected with pCLCA1   
 The effect of pCLCA1 expression on the frequency/number of CFTR channels 
in the membrane, on the unit channel conductance and on the open probability should 
be assessed.  These studies would clarify whether the modulation of CFTR activity was 
due to an increased insertion into the plasma membrane or to a direct effect on 
modulating the channel kinetics or conductance.  Cell-attached single channel 
recordings would likely answer these questions.   
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 If a channel interaction effect involving unit conductance or open probability is 
found, rather than an effect on channel density in the membrane, then indirect protein 
interactions that might be mediated via the cytoskeleton would be examined. 
Experiments to disrupt the cytoskeleton or prevent its assembly could begin to probe 
this question. A similar study should also be conducted on CaCC.  
  
b) Protein purification and reconstitution in a defined system.  
 Recombinant, tagged hCLCA1 protein could be affinity purified and 
reconstituted into an artificial bilayer membrane for channel studies. Purified protein 
fragments from post-translational processing of the full length protein could be 
introduced into a black lipid membrane produced from isolated phospholipids and 
cholesterol. If chloride conductance is not associated with purified pCLCA1 addition 
into bilayers, gradual increase in the percentage of native cellular membrane from cells 
displaying channel activity after transfection with pCLCA1 according to patch clamp 
experiments could be added back to the artificial membrane until channel activity is 
obtained.  If it becomes clear that pCLCA1 channel activity depends on endogenous 
cellular membrane components, then co-immunopreciptation and partner identification 
by protein sequencing via mass spectroscopy may be feasible.  
 
c)  Solve protein structure. 
 There is currently no hard structural data for any CLCA family member. The 
protein must be crystallized and its structure solved to determine the validity of 
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competing structural models, and whether the MIDAS domain has any role in metal ion 
interactions.  
 
9.3.2. Interactions with Other Molecular Candidates 
 The recent studies on the Bestrophin family have identified these proteins as 
possible molecular candidates for the calcium-activated chloride conductance. 
However, as explained in the introduction, it likely that the bestrophins are only a part 
of CaCC. Our functional data support the possibility of an interaction between CaCC 
and CLCA.  These two proteins should be coexpressed.  Together they may expand our 
understanding of the molecular identity of CaCC. 
 
9.3.3. Role in Pathophysiology 
 The close similarity between hCLCA1 and pCLCA1 suggests that pCLCA1 may 
behave like hCLCA1 in regulating mucin production. For this reason, the effect of the 
chloride channel regulated by interactions with pCLCA1 on mucin synthesis, 
condensation and exocytosis should be investigated through various methods including 
protein-protein interactions, fluorescence imaging and yeast two-hybrid screening.  
Although CaCC is involved in many of the pathophysiological processes mentioned in 
the literature review, its role in mucin production may have the most immediate impact 
on human health.  
 Answering, the basic question of how pCLCA1 contributes to chloride 
conductance should then subsequently answer how directly CLCA1 is involved in the 
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